Mettler-Toledo International
Annual Report 2014

Plain-text annual report

Annual Report 2014 www.mt.com e e s n e f i e r G , y c n e g A g n i s i t r e v d A l a n r e t n I : n o i t a e r C . c n I l a n o i t a n r e t n I o d e l o T - r e l t t e M © . A . S . U n i d e t n i r P is a leading global supplier of precision instruments and services. is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in a majority of believe we hold global number-one market positions in a majority of them. Specifically, we are the largest provider of weighing instruments them. Specifically, we are the largest provider of weighing instruments for use in laboratory, industrial and food retailing applications. We for use in laboratory, industrial and food retailing applications. We are also a leader in analytical instruments, reaction engineering and are also a leader in analytical instruments, reaction engineering and real-time analytic systems, process analytics instruments and end- real-time analytic systems, process analytics instruments and end- of-line product inspection systems. Our solutions are critical in key of-line product inspection systems. Our solutions are critical in key R&D, quality control and manufacturing processes for customers in a R&D, quality control and manufacturing processes for customers in a wide range of industries. Our global sales and service network is one wide range of industries. Our global sales and service network is one of the most extensive in the industry. We have subsidiaries and sales of the most extensive in the industry. We have subsidiaries and sales and service operations in 38 countries, with principal manufacturing and service operations in 38 countries, with principal manufacturing sites located in Switzerland, the United States, China, Germany and sites located in Switzerland, the United States, China, Germany and the United Kingdom. the United Kingdom. Sales Sales $2.486 billion Gross Margin Gross Margin 54.7% Earnings per Share Earnings per Share $11.44 Operating Cash Flow Operating Cash Flow $419 million Workforce 13,100 On the cover: Our New Classic precision balances feature a On the cover: Our New Classic precision balances feature a large, intuitive touchscreen interface while maintaining a compact large, intuitive touchscreen interface while maintaining a compact size. METTLER TOLEDO is a global leader in balances for size. METTLER TOLEDO is a global leader in balances for laboratory applications. laboratory applications. Portions of this report may contain “forward-looking statements” under the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual events or results to differ materially from those expressed in or implied by the statements. Further information concerning issues that could materially affect financial performance is contained in the “Forward-Looking Statements Disclaimer” and “Factors Affecting Our Future Operating Results” sections of the 10-K. Corporate Information Officers Olivier A. Filliol President and Chief Executive Officer Board of Directors Thomas Caratsch Laboratory Marc de La Guéronnière Europe and North America William P. Donnelly Finance, IT and Supply Chain Michael Heidingsfelder Industrial Simon Kirk Product Inspection Christian Magloth Human Resources Waldemar Rauch Process Analytics Richard Wong Asia / Pacific Corporate Offices Mettler-Toledo International Inc. 1900 Polaris Parkway Columbus, Ohio 43240-4035 Phone 614-438-4511 Im Langacher 44 CH-8606 Greifensee, Switzerland Phone +41-44-944 22 11 www.mt.com Transfer Agent and Registrar Computershare Shareowner Services LLC acts as primary Transfer Agent and Registrar for the Company. Questions should be sent to: Computershare P.O. Box 30170 College Station, TX 77845-3170 Phone 866-322-7862 www.computershare.com/investor Shareholders The Company estimates it has approximately 34,700 shareholders. Annual Meeting The annual meeting of shareholders will be held at 8:00 a.m. on Thursday, May 7, 2015 at the offices of Fried, Frank, Harris, Shriver & Jacobson LLP at 375 Park Avenue, New York, NY. A notice of the meeting, together with a form of proxy and a proxy statement, will be mailed to shareholders on or about March 16, 2015. Investor Relations Direct requests for information to: Mary T. Finnegan Treasurer / Investor Relations 1900 Polaris Parkway Columbus, Ohio 43240-4035 Phone 614-438-4748 Fax 614-438-4646 mary.finnegan@mt.com Robert F. Spoerry Chairman of the Board Director since 1996 Wah-Hui Chu Retired Non-Executive Chairman – Asia, PepsiCo International Director since 2007 Francis A. Contino Retired Executive Vice President – Strategic Planning and Chief Financial Officer, McCormick & Company, Inc. Director since 2004 Olivier A. Filliol President and Chief Executive Officer Director since 2009 Michael A. Kelly Executive Vice President – Electronics and Energy, 3M Company Director since 2008 Martin D. Madaus* Chairman and Chief Executive Officer, Ortho-Clinical Diagnostics, Inc. Director since 2009 Hans Ulrich Märki Retired Chairman, IBM Europe / Middle East / Africa Director since 2002 George M. Milne, Jr. Retired Executive Vice President, Pfizer Global R&D, Retired President, Worldwide Strategic and Operations Management, Pfizer Inc. Director since 1999 Thomas P. Salice Co-Founder and Managing Member, SFW Capital Partners, LLC Director since 1996 * Retiring from Board effective May 7, 2015 Financial Highlights Sales ($ in millions) Gross Margin (in %) 2,500 2,300 2,100 1,900 1,700 1,500 1,300 1,100 900 6 3 9 700 Local Currency CAGR 6 % (1) 4 9 7 , 1 5 9 5 , 1 2 8 4 , 1 4 0 4 , 1 4 0 3 , 1 4 1 2 , 1 8 4 1 , 1 6 9 0 , 1 5 6 0 , 1 6 8 4 , 2 9 7 3 2 , 9 0 3 , 2 2 4 3 , 2 3 7 9 1 , 8 6 9 1 , 8 6 9 1 , 9 2 7 , 1 9 2 7 , 1 56 54 52 50 48 46 44 44.4 8 9 9 1 9 9 9 1 0 0 0 2 1 0 0 2 2 0 0 2 3 0 0 2 4 0 0 2 5 0 0 2 6 0 0 2 7 0 0 2 8 0 0 2 9 0 0 2 0 1 0 2 1 1 0 2 2 1 0 2 3 1 0 2 4 1 0 2 (1) CAGR in USD for the period 1998 - 2014 is 6%. 42 8 9 9 1 9 9 9 1 0 0 0 2 1 0 0 2 2 0 0 2 3 0 0 2 4 0 0 2 5 0 0 2 6 0 0 2 7 0 0 2 8 0 0 2 9 0 0 2 0 1 0 2 1 1 0 2 2 1 0 2 3 1 0 2 4 1 0 2 Operating Cash Flow ($ in millions) Sales by Customer Destination 450 400 350 300 250 200 150 100 50 0 9 1 4 6 4 3 8 2 3 Asia and Other 30% Americas 35% Europe 35% CAG R 1 2 % 2 9 1 7 7 1 6 6 1 1 8 2 8 6 2 8 2 2 3 2 2 3 3 2 7 1 1 5 1 1 2 0 1 1 9 5 8 2 7 8 9 9 1 9 9 9 1 0 0 0 2 1 0 0 2 2 0 0 2 3 0 0 2 4 0 0 2 5 0 0 2 6 0 0 2 7 0 0 2 8 0 0 2 9 0 0 2 0 1 0 2 1 1 0 2 2 1 0 2 3 1 0 2 4 1 0 2 Earnings per Share (in dollars) 12.00 54.7 10.00 8.00 6.00 4.00 2.00 0.00 4 4 1 1 . 6 9 9 . 4 1 . 9 CAGR 17 % 1 2 8 . 0 8 . 6 9 7 . 5 3 0 . 5 0 7 . 4 6 8 . 3 2 5 . 2 7 3 . 2 1 2 . 2 1 1 . 2 6 6 . 1 8 6 . 1 6 1 . 1 2 9 . 0 8 9 9 1 9 9 9 1 0 0 0 2 1 0 0 2 2 0 0 2 3 0 0 2 4 0 0 2 5 0 0 2 6 0 0 2 7 0 0 2 8 0 0 2 9 0 0 2 0 1 0 2 1 1 0 2 2 1 0 2 3 1 0 2 4 1 0 2 EPS includes the following items: 1998 $(0.27) acquisition-related charges and other items and $0.09 one-time tax benefit 1999 $(0.24) charge for the transfer or close-down of certain product lines and other items 2000 $(0.04) charge related to close-down and consolidation of operations within our retail product lines 2001 $(0.34) charge related to headcount reductions and manufacturing transfers 2002 $0.51 one-time tax gain due to tax restructuring program and related tax audits and $(0.45) charge related to headcount reductions and manufacturing transfers 2003 $(0.08) charge related to final union settlement on the closure of French manufacturing facility 2004 $(0.08) expense related to investigation 2005 $(0.30) charge for a non-cash intangible asset write-off and legal costs in conjunction with pipette litigation and $(0.12) charge for non-recurring tax items 2006 $0.20 benefit from discrete tax items 2007 $0.03 benefit from discrete tax items 2008 $0.17 benefit from discrete tax items and $(0.14) restructuring charge related to workforce reduction 2009 $(0.67) restructuring charge related to workforce reduction, $0.24 benefit from discrete tax items and $(0.04) debt extinguishment and financing costs 2010 $0.15 benefit from discrete tax items, $(0.11) restructuring charge primarily related to workforce reduction and $(0.07) related to loss on sale of retail software business for in-store item and inventory management solutions offset in part by benefit from previous acquisition 2011 $0.11 benefit from discrete tax items, $(0.13) restructuring charge primarily related to workforce reduction and $(0.01) related to debt extinguishment and financing costs 2012 $(0.39) restructuring charge primarily related to workforce reduction 2013 $(0.49) restructuring charge primarily related to workforce reduction and $(0.01) related to debt extinguishment and financing costs 2014 $(0.15) restructuring charge primarily related to consolidation of operations and workforce reduction 1 Providing Solutions Across Our Customer’s Value Chain R&D Laboratory Quality Control Lab Scaleup & Production R&D Laboratory Quality Control Lab Scaleup & Production Our precise instruments are the foundation of research and quality control labs all over the world. High- performance weighing solutions offer a basis for solid R&D results. Pipettes are an essential tool for life science research. Thermal analysis instruments help to improve materials and their thermal behavior. Automated chemistry solutions accel- erate the development of new chemicals. Quality control relies on fast and precise analytical measurement as well as good data management. Our analytical balances, titrators, pH meters, den- sity meters, refractometers, melting point meters and pipettes can be tailored to each customer’s application and provide a fully docu- mented workflow for every quality control lab. Our sensors for measuring critical liquid analytical parameters, such as pH and oxygen levels and water conductivity and resistivity as well as total organic carbon, enable pharmaceutical, biotech and other companies to continuously ensure product quality and meet regulatory standards. Our transmitters and connectivity solutions make data collection and integration into control sys- tems efficient and flexible. 2 Production & Filling Packaging Logistics Food Retail pcs Production & Filling Packaging Logistics Food Retail We offer industrial scales in all sizes and formats, terminals and software to control and monitor manufacturing processes. Specialized solutions for formulation, piece-counting and many other applications help to improve productivity and reduce errors. Product inspection solutions help to safeguard product quality, safety and integrity, inside and out. Our systems for metal detection, check- weighing, x-ray and vision inspection provide confi- dence that product quality is maintained, compliance with industry standards is achieved, and consumers and brands are protected. Our vehicle scale systems offer the highest level of accuracy and can prevent unexpected downtime thanks to a unique design and remote diagnostics capabilities. For express carriers, in-motion weighing, dimensioning and identifi- cation software solutions increase throughput and provide revenue recovery opportunities. From retailers’ receiving docks to their checkout counters, we enhance efficient handling of fresh goods with weighing, packaging, pricing, wrap- ping and labeling solutions. Internet-enabled scales greatly facilitate in-store marketing, fresh item management, promotions and more. 3 Olivier A. Filliol President and Chief Executive Officer Dear Fellow Investors 2014 saw many positive developments for METTLER TOLEDO. We delivered good financial results and made excellent progress on many strategic initiatives. Notably, our product pipeline is better than ever and we are seeing tangible gains from our Spinnaker sales and marketing programs. Equally important, we launched an important offensive strategy to increase field resources, which should allow us to gain share and outgrow our markets. In 2014, we achieved good top-line growth, further margin improvement and strong earnings and cash flow growth. Our performance was driven by continued diligent execution of our strategies. Our cost structure remains in good shape and we continue to show outstanding organizational agility as we shift resources to faster, more profitable growth opportunities. 4 Here are our financial highlights for 2014: • Sales were $2.5 billion, reflecting growth in local currency of 5 percent. • Gross margins were 54.7 percent, an improvement of 80 basis points over the prior year. • Adjusted net earnings per diluted share were $11.72, an increase of 11 percent over 2013, despite 3 percent of currency headwinds. • Free cash flow was $343 million, an increase of 21 percent. We used our free cash flow to repurchase 1.6 million shares and reduced our weighted shares outstanding by 4 percent from 2013. • Our balance sheet remains strong, which provides the ability to incrementally purchase shares in excess of our free cash flow and pursue strategic acquisitions. We continue to operate in a global economy characterized by regional differences. The Americas performed well in 2014, and the outlook for 2015 remains positive. Our European business performed very well despite signs that the region’s growth was slowing. Our teams are executing exceptionally well in Europe, and we expect growth to continue in 2015 although recent economic news may point to a weaker climate. Markets in Asia and the rest of the world, specifically China, improved in the second half of 2014. We expect better growth in those regions in 2015, though still below long-term expectations. As a global company with important operations in Switzerland, we are facing challenges from the recent strengthening of the Swiss franc against our major selling currencies. In addition, the strong gains of the U.S. dollar in recent months are also adversely impacting our earnings. We have had similar challenges in the past and have overcome them through determined efforts to maintain our cost competitiveness and profitability. We are currently evaluating and analyzing various initiatives to offset these headwinds and are confident that we can maintain our cost competitiveness and strong profitability levels. As we have often discussed with you, organic growth is our best way to create value for the franchise. Our fragmented markets provide ample opportunities for us to gain share, and we believe investing in field resources to further penetrate these markets is our biggest lever for growth. In a strategy we refer to as “field turbos,” we are making significant, targeted investments in field resources to capture specific growth opportunities. 5 In 2014, we completed a detailed penetration analysis of our markets by product category, geography and customer segment, and identified gaps where additional sales coverage can accelerate growth. We are starting to add sales personnel, telesales and other support personnel to pursue these underpenetrated market segments. We expect to increase our front-end resources by more than 5 percent around the world. If this strategy proves as effective as we predict, we will make further additions to field personnel in the coming years. One important item to note is that we are increasing our sales force this year while only modestly increasing our overall cost structure. This achievement is possible because of productivity gains in other parts of our organization. This approach significantly reduces the financial risk of the investment. Our other major strategic initiatives remain well on track. Our marketing programs continue to drive growth. 2014 marked the 10-year anniversary of our Spinnaker sales and marketing programs. The heart of Spinnaker remains our marketing database of more than 5 million contacts. However, what has made Spinnaker vibrant for so long is the cultural mindset to achieve continuous improvement and true excellence in sales and marketing. We expect the program to continue to drive sales productivity and share gains for many years to come. Our service business is another important competitive advantage. Service makes up about 22 percent of our total sales and had good growth in 2014, increasing by 8 percent in local currency. Initiatives to globalize and harmonize our service offering continue to bring benefits. Our current focus is on growth as we invest in sales and marketing activities aimed at increasing the proportion of our installed base that is under service contract. This is a significant opportunity as we have an installed base of millions of instruments that are not under contract today. We strongly believe in the growth potential of emerging markets. The consequence of GDP per capita growth moving toward Western levels means more opportunities to sell our products. While these markets are currently growing below our long-term expectations, we see signs of improvement and expect better growth in the next two years. XPE Precision Balance Our new precision balance contains novel technologies that make weighing in the lab significantly faster, easier and more reliable. Features include an innovative weighing pan, color status indicators, ergonomic design and a high-speed weighing cell. 6 Reliable and Precise Our balance’s SmartPan reduces the effect of air on the weighing result, dramatically cutting stabilization times in half and improving precision by up to 50 percent. The user is easily guided through setup and daily weighing routines on the large color touchscreen. Smooth surfaces and easy dismantling make for quick and safe clean-up after spills. R&D Laboratory Quality Control Lab 7 China is our largest emerging market and represents 16 percent of our total sales. Our long-term outlook in China is strong, driven by the country’s transition to a more consumer-focused economy, with a greater emphasis on packaged food, product quality and food safety. We also should benefit from the Chinese government’s focus on higher-value industries, including science and the resulting increase in graduating scientists. In the short term, we expect that our lab and product inspection businesses will have good growth. Our core industrial business there continues to be impacted by overcapacity in certain sectors and will take time to fully recover. Other emerging markets generally performed well in 2014, with the exception of Russia and nearby countries. We expect continued good growth rates in emerging markets in 2015. Product innovation remains central to our strategy for growth. New products reinforce our market leadership position, and our products’ strong return on investment helps trigger the replacement cycle. Our portfolio is robust, with many new products to be launched in 2015, particularly in balances and product inspection. Overall, we believe this is the fullest and best product line-up in many years. Our margin expansion continues, with important contributors: • We have good pricing results thanks to the nature of our products and our customers’ understanding of our products’ value. In recent years, we have benefitted from well-conceived pricing strategies and well-executed pricing processes. We expect to be able to achieve improved realized pricing again in 2015. • Our Blue Ocean program to globalize and integrate business processes will be an important enabler for further margin development in the future. We currently have approximately 60 percent of manufacturing, 80 percent of material spend and 33 percent of our sales and service organizations on Blue Ocean. It will take several years to fully capture the potential of this program, but we are already benefitting from greater integration and transparency, which is supporting savings in our supply chain, improved pricing, productivity gains in service and other benefits. Lab of the Future We are working with large pharma- ceutical customers to help realize their visions for the Lab of the Future. Typically these projects integrate several automated chemistry platforms and in-situ analytical instruments with a common software platform to increase R&D productivity, speed up develop- ment and eliminate scaleup issues. 8 R&D Laboratory Automated and Accelerated Under pressure to improve productivity and reduce R&D costs, many pharmaceutical companies lack a standardized and automated method of determining how to mass produce a new drug in the most efficient and safest way. Our new solutions help to decrease time-to-market for new medicines and increase R&D productivity by automating the process and gathering data at each step. 9 We believe we are well positioned to take advantage of growth opportunities in 2015 and beyond. We have a strong foundation, based on market-leading products, best-in-class marketing programs and successful margin-improvement initiatives. Combined with our investment in field turbos, we believe these advantages provide an effective formula to gain share. In recent years, we have made significant investments in our people, infrastructure and systems as well as in the products and services we offer to customers. We are confident in our Company’s direction and positioning for future growth. We offer sincere thanks to our employees, who continue to execute our strategies with integrity and excellence. We also wish to thank our customers and shareholders for the trust and support that we hold in the highest regard. Sincerely, Olivier A. Filliol President and Chief Executive Officer February 6, 2015 CM3570 Checkweigher/ Metal Detector The new CM3570 system combines accurate checkweighing and highly sensitive metal detection sensors in a single instrument on the production line. This easily integrated system also offers centralized inventory manage- ment, with reports on product weight, defects and other data. 10 Faster and Safer Our dual system enables manufacturers of food, pharmaceuticals and cosmetics to simultaneously ensure their products are the correct weight and free from metal, while saving valuable space on their manufacturing lines. Benefits include increasing production line throughput by up to 33 percent, as well as enhancing customer safety and protecting brand reputation. pcs Packaging 11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-13595 Mettler-Toledo International Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 13-3668641 (I.R.S. Employer Identification No.) 1900 Polaris Parkway Columbus, OH 43240 and Im Langacher 44 CH 8606 Greifensee, Switzerland (Address of principal executive offices) (Zip Code) 1-614-438-4511 and +41-44-944-22-11 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Common Stock, $0.01 par value Preferred Stock Purchase Rights Name of Each Exchange on Which Registered New York Stock Exchange New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: NONE Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. Yes No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company (Do not check if a smaller reporting company) Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No As of January 31, 2015 there were 28,127,235 shares of the registrant’s Common Stock, $0.01 par value per share, outstanding. The aggregate market value of the shares of Common Stock held by non-affiliates of the registrant on June 30, 2014 (based on the closing price for the Common Stock on the New York Stock Exchange as of the last business day of the registrant’s most recently completed second fiscal quarter, June 30, 2014) was approximately $7.3 billion. For purposes of this computation, shares held by affiliates and by directors of the registrant have been excluded. Such exclusion of shares held by directors is not intended, nor shall it be deemed, to be an admission that such persons are affiliates of the registrant. Documents Incorporated by Reference Document Certain Sections of the Proxy Statement for 2014 Annual Meeting of Shareholders Part of Form 10-K Into Which Incorporated Part III METTLER-TOLEDO INTERNATIONAL INC. ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014 PART I Item 1. Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 1A. Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 1B. Unresolved Staff Comments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 2. Legal Proceedings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Executive Officers of the Registrant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 3. PART II Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 6. Selected Financial Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations . . . . . . . . . . . . . . . Item 7A. Quantitative and Qualitative Disclosures about Market Risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Financial Statements and Supplementary Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 8. Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure . . . . . . . . . . . . . . . Item 9A. Controls and Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 9B. Other Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . PART III Item 10. Directors, Executive Officers and Corporate Governance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 11. Executive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters . . . . . . Item 13. Certain Relationships and Related Transactions and Director Independence . . . . . . . . . . . . . . . . . . . . . . . . . . . Item 14. Principal Accounting Fees and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . PART IV Item 15.. Exhibits and Financial Statement Schedules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . SIGNATURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 4 13 23 23 23 23 24 27 28 44 45 45 45 45 46 47 47 47 48 48 49 2 FORWARD-LOOKING STATEMENTS DISCLAIMER You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties. You can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential,” or “continue.” We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position, capital expenditures, cash flow, tax-related matters, compliance with laws, and effects of acquisitions. Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements. See in particular “Factors Affecting Our Future Operating Results” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” 3 PART I Item 1. Business We are a leading global supplier of precision instruments and services. We have strong leadership positions in our businesses and believe we hold global number-one market positions in a majority of them. Specifically, we are the largest provider of weighing instruments for use in laboratory, industrial, and food retailing applications. We are also a leading provider of analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development, and process analytics instruments used for in-line measurement in production processes. In addition, we are the largest supplier of end-of-line inspection systems used in production and packaging for food, pharmaceutical, and other industries. Our business is geographically diversified, with net sales in 2014 derived 35% from both Europe and North and South America and 30% from Asia and other countries. Our customer base is also diversified by industry and by individual customer. Mettler-Toledo International Inc. was incorporated as a Delaware corporation in 1991 and became a publicly traded company with its initial public offering in 1997. Business Segments We have five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. See Note 16 to the audited consolidated financial statements and Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations under “Results of Operations by Operating Segment” for detailed results by segment and geographic region. We manufacture a wide variety of precision instruments and provide value-added services to our customers. Our principal products and services are described below. We also describe our customers and distribution, sales and service, research and development, manufacturing, and certain other matters. These descriptions apply to substantially all of our products and related segments. Laboratory Instruments We make a wide variety of precision laboratory instruments in the sample preparation, synthesis, analytical bench top, and material characterization areas. Our portfolio includes laboratory balances, liquid pipetting solutions, titrators, physical value analyzers, thermal analysis systems, and other analytical instruments, such as moisture analyzers and density refractometers. The laboratory instruments business accounted for approximately 47% of our net sales in 2014 and 46% in both 2013 and 2012. Laboratory Balances Our laboratory balances have weighing ranges from one ten-millionth of a gram up to 64 kilograms. To cover a wide range of customer needs and price points, we market our balances in a range of product tiers offering different levels of functionality. Based on the same technology platform, we also manufacture mass comparators, which are used by weights and measures regulators as well as laboratories to ensure the accuracy of reference weights. Laboratory balances are primarily used in the pharmaceutical, food, chemical, cosmetics, academia, and other industries. 4 Pipettes Pipettes are used in laboratories for dispensing small volumes of liquids. We operate our pipette business with the Rainin brand name. Rainin develops, manufactures, and distributes advanced pipettes, tips and accessories, including single- and multi-channel manual and electronic pipettes. Rainin maintains service centers in the key markets where customers periodically send their pipettes for certified recalibrations. Rainin’s principal end markets are pharmaceutical, biotech, and academia. Analytical Instruments Titrators measure the chemical composition of samples and are used in environmental and research laboratories as well as in quality control labs in the pharmaceutical, food and beverage, and other industries. Our high-end titrators are multi-tasking models, which can perform two determinations simultaneously on multiple vessels. Our offering includes robotics to automate routine work in quality control applications. Thermal analysis systems measure material properties as a function of temperature, such as weight, dimension, energy flow, and viscoelastic properties. Thermal analysis systems are used in nearly every industry, but primarily in the plastics and polymer industries and increasingly in the pharmaceutical industry. pH meters measure acidity in laboratory samples. We also sell density and refractometry instruments, which measure chemical concentrations in solutions. In addition, we manufacture and sell moisture analyzers, which precisely determine the moisture content of a sample by utilizing the loss on drying method. Laboratory Software LabX, our PC-based laboratory software platform, manages and analyzes data generated by our balances, titrators, pH meters, moisture analyzers, and other analytical instruments. LabX provides full network capability; assists with workflow automation; has efficient, intuitive protocols; and enables customers to collect and archive data in compliance with the U.S. Food and Drug Administration’s traceability requirements for electronically stored data (also known as 21 CFR Part 11). Automated Chemistry Solutions Our current automated chemistry solutions focus on selected applications in the chemical and drug discovery process. Our automated lab reactors and in situ analysis systems are considered integral to the process development and scale-up activities of our customers. Our on-line measurement technologies, based on infrared and laser light scattering, enable customers to monitor chemical reactions and crystallization processes in real time in the lab and plant. We believe that our portfolio of integrated technologies can bring significant efficiencies to the development process, enabling our customers to bring new chemicals and drugs to market faster. Process Analytics Our process analytics business provides instruments for the in-line measurement of liquid and gas parameters used primarily in the production process of pharmaceutical, biotech, beverage, microelectronics, chemical, and refining companies, as well as power plants. Close to half of our process analytics sales are to the pharmaceutical and biotech markets, where our customers need fast and secure scale-up and production that meet the validation processes required for GMP (Good Manufacturing Processes) and other regulatory standards. We are a leading solution provider for liquid analytical measurement to control and optimize production processes. Our solutions include sensor technology for measuring pH, dissolved oxygen, carbon dioxide, conductivity, turbidity, ozone, total organic carbons, sodium, and silica, as well as laser analyzers for gas measurement. Intelligent sensor diagnostics 5 capabilities enable improved asset management solutions for our customers to reduce process downtime and maintenance costs. Our instruments offer leading multi-parameter capabilities and plant-wide control system integration, which are key for integrated measurement of multiple parameters to secure production quality and efficiency. With a worldwide network of specialists, we support customers in critical process applications, compliance, and systems integration questions. Industrial Instruments We manufacture numerous industrial weighing instruments and related terminals and offer dedicated software solutions for the pharmaceutical, chemical, food, and other industries. In addition, we manufacture metal detection and other end-of-line product inspection systems used in production and packaging. We supply automatic identification and data capture solutions, which integrate in-motion weighing, dimensioning, and identification technologies for transport, shipping and logistics customers. We also offer heavy industrial scales and related software. The industrial instruments business accounted for approximately 44% of our net sales in 2014 and 45% in both 2013 and 2012. Industrial Weighing Instruments We offer a comprehensive line of industrial scales and balances, such as bench scales and floor scales, for weighing loads from a few grams to several thousand kilograms in applications ranging from measuring materials in chemical production to weighing packages. Our products are used in a wide range of applications, such as counting applications and formulating and mixing ingredients. Industrial Terminals Our industrial scale terminals collect data and integrate it into manufacturing processes, helping to automate them. Our terminals allow users to remotely download programs or access setup data and can minimize downtime through predictive rather than reactive maintenance. Transportation and Logistics We supply automatic identification and data capture solutions, which integrate in-motion weighing, dimensioning, and identification technologies. With these solutions, customers can measure the weight and cubic volume of packages for appropriate billing, logistics, and quality control. Our solutions also integrate into customers’ information systems. Vehicle Scale Systems Our primary heavy industrial products are scales for weighing trucks or railcars (i.e., weighing bulk goods as they enter or leave a factory or at a toll station). Heavy industrial scales are capable of measuring weights up to 500 tons and permit accurate weighing under extreme environmental conditions. We also offer advanced computer software that can be used with our heavy industrial scales to facilitate a broad range of customer solutions and provides a complete system for managing vehicle transaction processing. Industrial Software We offer software that can be used with our industrial instruments. Examples include FreeWeigh.Net, statistical quality control software, Formweigh.Net, our formulation/batching software; and OverDrive, which supports the operation of vehicle scales. FreeWeigh.Net and Formweigh.Net provide full network capability and enable customers to collect and archive data in compliance with 21 CFR Part 11. 6 Product Inspection Increasing safety and consumer protection requirements are driving the need for more sophisticated end-of-line product inspection systems (e.g., for use in food processing and packaging, pharmaceutical, and other industries). We are a leading global provider of metal detectors, x-ray and camera-based visioning equipment, checkweighers, and track-and-trace solutions that are used in these industries. Metal detectors are most commonly used to detect fine particles of metal that may be contained in raw materials or may be generated by the manufacturing process itself. X-ray-based vision inspection is used to detect metallic contamination in metallized packaging and many types of non-metallic contamination, such as glass, calcified bone, stones, and pits. Our x-ray systems can be used for mass control and for determining and controlling the fat content in meat. Our camera-based vision inspection solutions provide in-line inspection of package quality, labels, and content, which are needs for food and beverage, consumer goods, and pharmaceutical companies. Vision inspection systems with associated specialist software enable our pharmaceutical customers to implement traceability and serialization tracking, as required by regulation. Checkweighers are used to control the filled weight of packaged goods such as food, pharmaceuticals, and cosmetics. All of our technologies are integrated with material handling systems to ensure the correct presentation of the customer’s product to the device and the secure rejection of non- conforming product. Our technologies may also be used together as components of integrated packaging lines. ProdX Inspect is our quality and productivity control software for helping customers comply with regulations and optimize process efficiency, either as a stand-alone solution or through integration with the customer’s manufacturing and enterprise systems. Retail Weighing Solutions Supermarkets, hypermarkets, and other food retail businesses make use of multiple weighing and food labeling solutions for handling fresh goods (such as meats, vegetables, fruits, and cheeses). We offer networked scales and software, which can integrate backroom, counter, self-service, and checkout functions and can incorporate fresh goods item data into a supermarket’s overall food item and inventory management system. The device displays allow in-store marketing, which permits customers to make more decisions at the point of sale. In addition, we offer stand-alone scales for basic counter weighing and pricing, price finding, and printing. The customer benefits of our retail solutions are in the areas of enterprise-wide article and price management, merchandising, and regulatory compliance. In North America, our offering includes automated packaging and labeling solutions for the meat backroom, which are fully integrated with the scales in the store. The retail business accounted for approximately 9% of our net sales in 2014, 2013, and 2012. Customers and Distribution Our principal customers include companies in the following key end markets: the life science industry (pharmaceutical and biotech companies, as well as independent research organizations); food and beverage producers; food retailers; chemical, specialty chemicals, and cosmetics companies; the transportation and logistics industry; the metals industry; the electronics industry; and the academic community. Our products are sold through a variety of distribution channels. Generally, more technically sophisticated products are sold through our direct sales force, while less complicated products are sold through indirect channels. Our sales through direct channels exceed our sales through indirect channels. A significant portion of our sales in the Americas is generated through indirect channels, including sales of our “Ohaus” branded products. Ohaus-branded products target markets, such as the educational market, in which customers are interested in lower cost, a more limited set of features, and less comprehensive support and service. 7 We have a diversified customer base, with no single customer accounting for more than 1% of 2014 net sales. Sales and Service Market Organizations We maintain geographically focused market organizations around the world that are responsible for all aspects of our sales and service. The market organizations are customer-focused, with an emphasis on building and maintaining value-added relationships with customers in our target market segments. Each market organization has the ability to leverage best practices from other units while maintaining the flexibility to adapt its marketing and service efforts to account for different cultural and economic conditions. Market organizations also work closely with our producing organizations (described below) by providing feedback on manufacturing and product development initiatives, new product and application ideas, and information about key market segments. We have one of the largest and broadest global sales and service organizations among precision instrument manufacturers. At December 31, 2014, our sales and service group consisted of approximately 6,500 employees in sales, marketing and customer service (including related administration) and post- sales technical service, located in 38 countries. This field organization has the capability to provide service and support to our customers and distributors in major markets across the globe. This is important because our customers increasingly seek to do business with a consistent global approach. Service Our service business continues to be successful with a focus on providing uptime and calibration services, as well as further expansion of our offerings to provide value-added services for a range of market needs, including regulatory compliance, performance enhancements, application expertise and training, and remote services. We have a unique offering to our pharmaceutical customers in promoting the use of our instruments in compliance with FDA and other international regulations, and we can provide these services to most customers' locations around the world. Our global service network is also an important factor in our ability to expand in emerging markets. We estimate that we have the largest installed base of weighing instruments in the world. Service (representing service contracts, on demand services, and replacement parts) accounted for approximately 22% of our net sales in both 2014 and 2013 and 21% in 2012. A significant portion of this amount is derived from the sale of replacement parts. Beyond revenue opportunities, we believe service is a key part of our solution offering and helps significantly in customer retention. The close relationships and frequent contact with our large customer base allow us to be the trusted advisor of our customers, which provides us with high-quality sales opportunities as well as innovative product and application ideas. Research and Development and Manufacturing Producing Organizations Our research, product development, and manufacturing efforts are organized into a number of producing organizations. Our focused producing organizations help reduce product development time and costs, improve customer focus, and maintain technological leadership. The producing organizations work together to share ideas and best practices, and there is a close interface and coordinated customer interaction among marketing organizations and producing organizations. 8 Research and Development We continue to invest in product innovation to provide technologically advanced products to our customers for existing and new applications. Over the last three years, we have invested $352.2 million in research and development ($123.3 million in 2014, $116.3 million in 2013, and $112.5 million in 2012) which is approximately 5% of net sales for each year. Our research and development efforts fall into two categories: • • technology advancements, which generate new products or features and increase the value of our products. These advancements may be in the form of enhanced or new functionality, new applications for our technologies, more accurate or reliable measurement, additional software capability, or automation through robotics or other means. cost reductions, which reduce the manufacturing cost of our products through better overall design and/or improve the ease of serviceability. We devote a substantial proportion of our research and development budget to software development. This includes software to process the signals captured by the sensors of our instruments, application- specific software, and software that connects our solutions into customers’ existing IT systems. We closely integrate research and development with marketing, manufacturing, and product engineering. We have approximately 1,200 employees in research and development and product engineering in countries around the globe. Manufacturing We are a worldwide manufacturer, with facilities principally located in China, Switzerland, the United States, Germany, and the United Kingdom. We emphasize product quality in our manufacturing operations, and most of our products require very strict tolerances and exact specifications. We use an extensive quality control system that is integrated into each step of the manufacturing process. All major manufacturing facilities have achieved ISO 9001 certification. We believe that our manufacturing capacity is sufficient to meet our present and currently anticipated demand. We generally manufacture critical components, which are components that contain proprietary technology. When outside manufacturing is more efficient, we contract with other manufacturers for certain nonproprietary components. We use a wide range of suppliers. We believe our supply arrangements are adequate and that there are no material constraints on the sources and availability of materials. From time to time, we may rely on a single supplier for all of our requirements of a particular component. Supply arrangements for electronic components are generally made globally. Backlog; Seasonality Our manufacturing turnaround time is generally short, which permits us to manufacture orders to fill for most of our products. Backlog is generally a function of requested customer delivery dates and is typically no longer than one to two months. Our business has historically experienced a slight amount of seasonal variation, particularly the high- end laboratory instruments business. Traditionally, sales in the first quarter are slightly lower than, and sales in the fourth quarter are slightly higher than, sales in the second and third quarters. Fourth quarter sales have historically generated approximately 28% to 30% of our net sales. This trend has a somewhat greater effect on income from operations than on net sales because fixed costs are generally incurred evenly across all quarters. 9 Employees Our total workforce was 13,100 throughout the world, including employees and 1,100 of temporary personnel, as of December 31, 2014, and includes approximately 5,100 in Europe, 3,400 in North and South America, and 4,600 in Asia and other countries. We believe our employee relations are good, and we have not suffered any material employee work stoppage or strike during the last five years. Labor unions do not represent a meaningful number of our employees. Approximately 600 employees in Germany and France are represented by unions. Sustainability We believe a sustainable business is one positioned for long-term growth and for us it defines our approach to decision making, from how we manage our impact on the environment to our relationships with employees, customers, and shareholders. In 2014, we published our latest sustainability report, which measures progress and highlights accomplishments since our last report in 2011. We followed the Global Reporting Initiative G4 guidelines. Our GreenMT program is designed to help save energy and resources and at the same time realize financial benefits. We are now working on making significant reductions in our emissions by finding new ways of managing our vehicle fleets, incorporating new design features into our products, improving the energy efficiency of our buildings and processes, and looking at how we source the electricity we use in our facilities. We think these efforts will produce a favorable impact on the environment as well as potential savings in future periods. Blue Ocean Program “Blue Ocean” refers to our program to establish a new global operating model with standardized, automated and integrated processes, and high levels of global data transparency. It encompasses a new enterprise architecture, with a global, single instance ERP system. Within our IT systems, we are moving toward integrated, homogeneous applications and common data structures. We will also largely standardize our key business processes. The implementation of the systems and processes has been proceeding on a staggered basis over a multi-year period with the initial go-live rollout having occurred in 2010. We have implemented the Blue Ocean program in our Swiss, Chinese, and certain U.S. and German operations and have over half of the program completed as measured in users. We will continue to implement the program in additional locations over the coming years. Intellectual Property We hold over 4,900 patents and trademarks (including pending applications), primarily in the United States, Switzerland, Germany, the United Kingdom, Italy, France, Japan, China, South Korea, Brazil, and India. Our products generally incorporate a wide variety of technological innovations, some of which are protected by patents of various durations. Products are generally not protected as a whole by individual patents, and as a result, no one patent or group of related patents is material to our business. We have numerous trademarks, including the Mettler-Toledo name and logo, which are material to our business. We regularly protect against infringement of our intellectual property. Regulation Our products are subject to various regulatory standards and approvals by weights and measures regulatory authorities. All of our electrical components are subject to electrical safety standards. We believe that we are in compliance in all material respects with applicable regulations. Approvals are required to ensure our instruments do not impermissibly influence other instruments and are themselves not affected by other instruments. In addition, some of our products are used in “legal for trade” applications, in which prices based on weight are calculated and for which specific weights and measures approvals are required. Although there are a large number of regulatory agencies across our 10 markets, there is an increasing trend toward harmonization of standards, and weights and measures regulation is harmonized across the European Union. Our products may also be subject to special requirements depending on the end-user and market. For example, laboratory customers are typically subject to Good Laboratory Practices (GLP), industrial customers to Good Manufacturing Practices (GMP), pharmaceutical customers to U.S. Food and Drug Administration (FDA) regulations, and customers in food processing industries may be subject to Hazard Analysis and Critical Control Point (HACCP) regulations. Products used in hazardous environments may also be subject to special requirements. Environmental Matters We are subject to environmental laws and regulations in the jurisdictions in which we operate. We own or lease a number of properties and manufacturing facilities around the world. Like many of our competitors, we have incurred, and will continue to incur, capital and operating expenditures and other costs in complying with such laws and regulations. We are currently involved in, or have potential liability with respect to, the remediation of past contamination in certain of our facilities. A former subsidiary of Mettler-Toledo, LLC known as Hi-Speed Checkweigher Co., Inc. was one of two private parties ordered by the New Jersey Department of Environmental Protection, in an administrative consent order signed on June 13, 1988, to investigate and remediate certain ground water contamination at a property in Landing, New Jersey. After the other party under this order failed to fulfill its obligations, Hi-Speed became solely responsible for compliance with the order. Residual ground water contamination at this site is now within a Classification Exception Area which the Department of Environmental Protection has approved and within which the Company oversees monitoring of the decay of contaminants of concern. A concurrent Well Restriction Area also exists for the site. The Department of Environmental Protection does not view these vehicles as remedial measures, but rather as “institutional controls” that must be adequately maintained and periodically evaluated. We estimate that the costs of compliance associated with the site over the next several years will approximate $0.4 million. In addition, certain of our present and former facilities have or had been in operation for many decades and, over such time, some of these facilities may have used substances or generated and disposed of wastes that are or may be considered hazardous. It is possible that these sites, as well as disposal sites owned by third parties to which we have sent wastes, may in the future be identified and become the subject of remediation. Although we believe that we are in substantial compliance with applicable environmental requirements and, to date, we have not incurred material expenditures in connection with environmental matters, it is possible that we could become subject to additional environmental liabilities in the future that could have a material adverse effect on our financial condition, results of operations, or cash flows. Competition Our markets are highly competitive. Many of the markets in which we compete are fragmented both geographically and by application, particularly the industrial and food retailing markets. As a result, we face numerous regional or specialized competitors, many of which are well established in their markets. For example, some of our competitors are divisions of larger companies with potentially greater financial and other resources than our own. In addition, some of our competitors are domiciled in emerging markets and may have a lower cost structure than ours. We are confronted with new competitors in emerging markets which, although relatively small in size today, could become larger companies in their home markets. Given the sometimes significant growth rates of these emerging markets, and in light of their cost advantage over developed markets, emerging market competitors could become more significant 11 global competitors. Taken together, the competitive forces present in our markets can impair our operating margins in certain product lines and geographic markets. We expect our competitors to continue to improve the design and performance of their products and to introduce new products with competitive prices. Although we believe that we have technological and other competitive advantages over many of our competitors, we may not be able to realize and maintain these advantages. These advantages include our worldwide market leadership positions; our global brand and reputation; our track record of technological innovation; our comprehensive, high-quality solution offering; our global sales and service offering; our large installed base of weighing instruments; and the diversification of our revenue base by geographic region, product range, and customer. To remain competitive, we must continue to invest in research and development, sales and marketing, and customer service and support. We cannot be sure that we will have sufficient resources to continue to make these investments or that we will be successful in identifying, developing, and maintaining any competitive advantages. We believe the principal competitive factors in developed markets for purchasing decisions are the product itself, application support, service support, and price. In emerging markets, where there is greater demand for less sophisticated products, price is a more important factor than in developed markets. Competition in the U.S. laboratory market is also influenced by the presence of large distributors that sell not only our products but those of our competitors as well. Company Website and Information You can find our website on the Internet at www.mt.com. The website contains information about us and our operations. You can view and download free of charge copies of each of our filings with the SEC on Form 10-K, Form 10-Q, Form 8-K, and Schedule 14A and all amendments to those reports by accessing www.mt.com, clicking on About Us, Investor Relations, and then clicking on SEC Filings. You may also read and copy these filings at the SEC’s Public Reference Room at 450 Fifth Street, N.W., Washington, D.C. 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a website at http://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. Our website also contains copies of the following documents that you can download free of charge: • Corporate Governance Guidelines • Audit Committee Charter • Compensation Committee Charter • Nominating and Corporate Governance Committee Charter • Code of Conduct • Sustainability Report You can also obtain in print, free of charge, any of the above documents and any of our reports on Form 10-K, Form 10-Q, Form 8-K, and Schedule 14A and all amendments to those reports by sending a written request to our Investor Relations Department: Investor Relations Mettler-Toledo International Inc. 1900 Polaris Parkway Columbus, OH 43240 U.S.A. Phone: +1 614 438 4748 Fax: +1 614 438 4646 E-mail: mary.finnegan@mt.com 12 Item 1A. Risk Factors Factors Affecting Our Future Operating Results We sell primarily to companies in developed countries. Continued economic uncertainty in these countries could hurt our operating results. Most of our business is derived from companies in developed countries. Economic instability in many parts of the world, including sovereign debt levels in the European Union and the United States, continues to be a situation that we are monitoring closely. A potential financial crisis on financial institutions globally would likely have an adverse effect on the global capital markets and our business. In addition, if developed countries were to experience slow growth or recession, we could see the following effects: • • • • • • • a drop in demand for our products; companies being unable to finance their businesses; difficulty in obtaining materials and supplies; potential devaluation and/or impairment of assets; difficulty in collecting accounts receivables; an increase in accounts receivable write-offs; and greater foreign exchange rate volatility affecting our profitability and cash flow. Economic downturns or recessions adversely affect our operating results because our customers often decrease or delay capital expenditures. Customers may also purchase lower-cost products made by competitors and not resume purchasing our products even after economic conditions improve. These conditions would reduce our revenues and profitability. We are subject to certain risks associated with our international operations and have a significant concentration of business in China. We conduct business in many countries, including emerging markets in Asia, Latin America, and Eastern Europe, and these operations represent a significant portion of our sales and earnings. For example, our Chinese operations account for 17% of sales to external customers, approximately 30% of our global production, and 26% of segment profit during 2014. In addition to the currency risks discussed below, international operations pose other substantial risks and problems for us. Including the following: countries may revise or alter their respective legal and regulatory requirements; local tariffs and trade barriers; • • • difficulties in staffing and managing local operations and/or mandatory salary increases; • credit risks arising from financial difficulties facing local customers and distributors; • difficulties in protecting intellectual property; • nationalization of private enterprises which may result in the confiscation of assets, as we hold significant assets around the world in the form of property, plant, and equipment, inventory, and accounts receivable, as well as $46.3 million of cash at December 31, 2014 in our Chinese subsidiaries; restrictions on investments and/or limitations regarding foreign ownership; adverse tax consequences, including tax disputes, imposition or increase of withholding and other taxes on remittances and other payments by subsidiaries; • • • other uncertain local economic, political, and social conditions, including hyper-inflationary conditions or periods of low or no productivity growth; and credit tightening or reduction in credit availability for local customers. • 13 We must also comply with regulations regarding the conversion and repatriation of funds earned in local currencies. For example, we need government approval to convert earnings from our operations in China into other currencies and to repatriate these funds. If we cannot comply with these or other applicable regulations, we may face increased difficulties in using cash generated in China. We are required to comply with various import, export control, and economic sanctions laws, which may affect our transactions with certain customers, business partners, and other persons, including in certain cases dealings with or between our employees and subsidiaries. In certain circumstances, export control and economic sanctions regulations may prohibit the export of certain products, services, and technologies, and in other circumstances, we may be required to obtain an export license before exporting a controlled item. We do business in Russia and Crimea. Sanctions imposed on business in these regions will likely affect the economies and our business in these regions. In addition, failure to comply with any of these regulations could result in civil and criminal, monetary and non-monetary penalties, disruptions to our business, limitations on our ability to import and export products and services and damage to our reputation. Current Chinese market conditions reflect overcapacity in certain end-user segments and a reduction of credit availability for many local Chinese customers. Growth in China and other emerging markets can be expected to be volatile and the timing of recoveries can be uncertain. Currency fluctuations affect our operating profits. Our earnings are affected by changing exchange rates. We are most sensitive to changes in the exchange rates between the Swiss franc, euro, and U.S. dollar. We have more Swiss franc expenses than we do Swiss franc sales because we develop and manufacture products in Switzerland that we sell globally and have a number of corporate functions located in Switzerland. When the Swiss franc strengthens against our other trading currencies, particularly the U.S. dollar and euro, our earnings go down. We also have significantly more sales in the euro than we do expenses. When the euro weakens against the U.S. dollar and Swiss franc, our earnings also go down. In January 2015, we entered into foreign currency forward contracts that reduce our exposure from the Swiss franc strengthening against the euro through 2016. The notional amount and average forward rate of our foreign currency forward contracts is Euro 86 million and 1.21 for contracts that mature in 2015, and Euro 67 million and 1.19 for contracts that mature in 2016, respectively. In September 2011, the Swiss National Bank established an exchange rate floor of 1.20 Swiss francs per euro which was abandoned in January 2015 after we entered into the previously mentioned foreign currency forward contracts. The Swiss National Bank's abandonment of the euro exchange rate floor resulted in an immediate strengthening of the Swiss franc against the euro and U.S. dollar. Absent these forward currency forward contracts, we estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $1.1 million to $1.3 million annually. We also estimate a 1% strengthening of the Swiss franc against the U.S. dollar would reduce our earnings before tax by approximately $0.5 million to $0.7 million annually in addition to the previously mentioned strengthening of the Swiss franc against the euro impact. We also conduct business in many geographies throughout the world, including Asia Pacific, the United Kingdom, Eastern Europe, Latin America, and Canada. Fluctuations in these currency exchange rates against the U.S. dollar can also affect our operating results. The most significant of these currency exposures is the Chinese Renminbi. The impact on our earnings before tax of the Chinese Renminbi weakening 1% against the U.S. dollar is a reduction of approximately $0.7 million to $0.9 million annually. 14 In addition to the effects of exchange rate movements on operating profits, our debt levels can fluctuate due to changes in exchange rates, particularly between the U.S. dollar and the Swiss franc. Based on our outstanding debt at December 31, 2014, we estimate that a 10% weakening of the U.S. dollar against the currencies in which our debt is denominated would result in an increase of approximately $2.3 million in the reported U.S. dollar value of our debt. Concerns regarding the European debt levels and market perception concerning the instability of the euro could affect our operating profits. We conduct business in many countries that use the euro as their currency (the Eurozone). Concerns persist regarding the debt burden of certain Eurozone countries and their ability to meet future financial obligations. In addition, concerns in recent years have existed regarding the overall stability of the euro and the suitability of the euro as a single currency given the diverse economic and political circumstances in individual Eurozone countries. These concerns could lead to the re-introduction of individual currencies in one or more Eurozone countries or, in more extreme circumstances, the possible dissolution of the euro currency entirely. Should the euro dissolve entirely, the legal and contractual consequences for holders of euro-denominated obligations would be determined by laws in effect at such time. These potential developments, or market perceptions concerning these and related issues, could adversely affect the value of our euro-denominated assets and obligations. In addition, concerns over the effect of this financial crisis on financial institutions in Europe and globally could have an adverse effect on the global capital markets and, more specifically, on the ability of our Company, our customers, suppliers, and lenders to finance their respective businesses, to access liquidity at acceptable financing costs, if at all, on the availability of supplies and materials, and on the demand for our products. We are vulnerable to system failures, including those that may be related to cyber security attacks, which could harm our business. We rely on our technology infrastructure to interact with suppliers, sell our products and services, support our customers, fulfill orders, and bill, collect, and make payments. Our systems are vulnerable to damage or interruption from natural disasters, power loss, telecommunication failures, terrorist or hacker attacks, computer viruses, and other events. When we upgrade or change systems, we may suffer interruptions in service, loss of data, or reduced functionality. A significant number of our systems are not redundant, and our disaster recovery planning is not sufficient for every eventuality. Despite any precautions we may take, such problems could result in interruptions in our services, fraudulent loss of assets, or unauthorized disclosure of confidential information, which could harm our reputation and financial condition. We do not carry business interruption insurance sufficient to compensate us for losses that may result from interruptions in our services or data loss as a result of system failures. We also are in the process of implementing a program to globalize our business processes and information technology systems that includes the implementation of a Company-wide enterprise resource planning system. This has been proceeding on a staggered basis over several years with the initial go-live rollout having occurred in 2010. We have implemented the program in our Swiss, Chinese, and certain U.S. and German operations and have more than half of the program implemented, as measured in users. If the implementation is flawed, we could suffer interruptions in operations and customer-facing activities that could harm our reputation and financial condition, or cause us to lose data, experience reduced functionality, or have delays in reporting financial information. It may take us longer to implement the program than we have planned, and the project may cost us more than we have estimated, either of which would negatively impact our ability to generate cost savings or other efficiencies. In addition, the implementation will increase our reliance on a single information technology system, which would have greater consequences should we experience a system disruption. 15 We operate in highly competitive markets, and it may be difficult for us to preserve operating margins, gain market share, and maintain a technological advantage. Our markets are highly competitive. Many are fragmented both geographically and by application, particularly the industrial and food retailing markets. As a result, we face numerous regional or specialized competitors, many of which are well established in their markets. In addition, some of our competitors are divisions of larger companies with potentially greater financial and other resources than our own. Some of our competitors are domiciled or operate in emerging markets and may have a lower cost structure than ours. We are confronted with new competitors in emerging markets which, although relatively small in size today, could become larger companies in their home markets. Given the sometimes significant growth rates of these emerging markets, and in light of their cost advantage over developed markets, emerging market competitors could become more significant global competitors. Taken together, the competitive forces present in our markets could harm our operating margins. We expect our competitors to continue to improve the design and performance of their products and to introduce new products with competitive prices. Although we believe that we have certain technological and other advantages over our competitors, we may not be able to maintain these advantages. Our ability to manufacture and deliver products and services may be disrupted. We have key manufacturing facilities located in China, Europe, and the United States. Many of our products are developed and manufactured at single locations, with limited alternate facilities. In addition, a large portion of our products and spare parts are distributed through regional logistics centers, in which certain logistics activities are outsourced to third parties. If we experience any significant disruption in these facilities for any reason, such as strikes or other labor unrest, power interruptions, fire, earthquakes, or other events beyond our control, we may be unable to satisfy customer demand for our products or services and lose sales. It may be expensive to resolve these issues, even though some of these risks are covered by insurance policies. More importantly, customers may switch to competitors and may not return to us even if we resolve the interruption. Our business would suffer if we were unable to obtain supplies of material. We purchase most of our raw materials, components, and supplies from multiple suppliers. Some items are purchased from a limited or single source of supply, however, and disruption of these sources could affect our ability to manufacture products. Even where multiple sources of materials and components are available, the quality of the alternative materials, regulatory and contractual requirements to qualify materials for use in manufacturing, and the time required to establish new relationships with reliable suppliers could result in manufacturing delays and possible loss of sales. If we are unable to obtain materials or components for an extended time, this could damage our customer relationships and harm our financial condition or results of operations. Our product development efforts may not produce commercially viable products in a timely manner. If we do not introduce new products and enhancements, our products could become technologically obsolete over time, which would harm our operating results. To remain competitive, we must continue to make significant investments in research and development, sales and marketing, and customer service and support. We cannot be sure that we will have sufficient resources to continue to make these investments. In developing new products, we may be required to make substantial investments before we can determine their commercial viability. As a result, we may not be successful in developing new products and we may never realize the benefits of our research and development activities. 16 A prolonged downturn or additional consolidation in the pharmaceutical, food and beverage, and chemical industries could adversely affect our operating results. A reduction in the capital resources or government funding of our customers could reduce our sales. Our products are used extensively in the pharmaceutical, food and beverage, and chemical industries. Consolidation in the pharmaceutical and chemical industries hurt our sales in prior years. A prolonged economic downturn or additional consolidation in any of these industries could adversely affect our operating results. In addition, the capital spending policies of our customers in these and other industries are based on a variety of factors we cannot control, including the resources available for purchasing equipment, the spending priorities among various types of equipment, and policies regarding capital expenditures. Any decrease or delay in capital spending by our customers would cause our revenues to decline and could harm our profitability. A decline in government funding of research or education could reduce some customers' ability to purchase our products. Unanticipated changes in our tax rates or exposure to additional income tax liabilities could impact our profitability. We are subject to income taxes in the United States and various other foreign jurisdictions, and our domestic and international tax liabilities are subject to allocation of expenses among different jurisdictions. Our effective tax rates could be adversely affected by changes in the mix of earnings by jurisdiction, changes in tax laws or tax rates, changes in the valuation of deferred tax assets and liabilities, and material adjustments from tax audits. In particular, the carrying value of deferred tax assets, which are predominantly in the U.S., is dependent upon our ability to generate future taxable income in the U.S. In addition, the amount of income taxes we pay is subject to ongoing audits in various jurisdictions, and a material assessment by a governing tax authority could affect our profitability. Our tax expense could increase as a result of a changing application of tax law. As a result of the current uncertain financial and economic environment, governments are facing greater pressure on public finances, which could lead to their more aggressively applying existing tax laws and regulations. Governments also periodically change tax laws and regulations. Any changes in corporate income tax rates or regulations, on repatriation of dividends or capital, or on transfer pricing, as well as changes in the interpretation of existing tax laws and regulations in the jurisdictions in which we operate, could adversely affect our cash flow and increase our overall tax burden, which would negatively affect our profitability. We face risks related to sales through distributors and other third parties that we do not control, which could harm our business. We sell some products through third parties including distributors and value-added resellers. This exposes us to various risks, including competitive pressure, concentration of sales volumes, credit risks, and compliance risks. We may rely on one or a few key distributors for a product or market, and the loss of these distributors could reduce our revenue and net earnings. Distributors may also face financial difficulties, including bankruptcy, which could harm our collection of accounts receivables. Violations of the FCPA or similar anti-bribery laws by distributors or other third party intermediaries could materially impact our business. Risks related to our use of distributors may reduce sales, increase expenses, and weaken our competitive position. 17 A widespread outbreak of an illness or other health issue could negatively affect our business, making it more difficult and expensive to meet our obligations to our customers, and could result in reduced demand from our customers. In recent years, a number of countries have experienced outbreaks of the H1N1 influenza (swine flu) or, in the Asia Pacific region, outbreaks of SARS and/or avian influenza (bird flu), and more recently, Ebola outbreaks in parts of Africa. Despite the implementation of certain precautions, we are susceptible to such outbreaks. As a result of such outbreaks, businesses can be shut down and individuals can become ill or quarantined. Outbreaks of infectious diseases such as these, particularly in North America, Europe, China, or other locations significant to our operations, could adversely affect general commercial activity, which could have a material adverse effect on our financial condition, results of operations, business, or prospects. If our operations are curtailed because of health issues, we may need to seek alternate sources of supply for services and staff and these alternate sources may be more expensive. Alternate sources may not be available or may result in delays in shipments to our customers, each of which would affect our results of operations. In addition, a curtailment of our product design operations could result in delays in the development of new products. Further, if our customers’ businesses are affected by health issues, they might delay or reduce purchases from us, which could adversely affect our results of operations. We may face risks associated with future acquisitions. We may pursue acquisitions of complementary product lines, technologies, or businesses. Acquisitions involve numerous risks, including difficulties in integrating the acquired operations, technologies, and products; diversion of management’s attention from other business concerns; and potential departures of key employees of the acquired company. If we successfully identify acquisitions in the future, completing such acquisitions may result in new issuances of our stock that may be dilutive to current owners, increases in our debt and contingent liabilities, and additional amortization expense related to intangible assets. Any of these acquisition-related risks could have a material adverse effect on our profitability. Larger companies have identified life sciences and instruments as businesses they will consider entering, which could change the competitive dynamics of these markets. In addition, we may not be able to identify, successfully complete, or integrate potential acquisitions in the future. Even if we can do so, we cannot be sure that these acquisitions will have a positive impact on our business or operating results. If we cannot protect our intellectual property rights, or if we infringe or misappropriate the proprietary rights of others, our operating results could be harmed. Our success depends on our ability to obtain and enforce patents on our technology, maintain our trademarks, and protect our trade secrets. Our patents may not provide complete protection, and competitors may develop similar products that are not covered by our patents. Our patents may also be challenged by third parties and invalidated or narrowed. Competitors sometimes seek to take advantage of our trademarks or brands in ways that may create customer confusion or weaken our brand. Although we take measures to protect confidential information, improper use or disclosure of our trade secrets may still occur. We may be sued for infringing on the intellectual property rights of others. The cost of any litigation could affect our profitability regardless of the outcome, and management attention could be diverted. If we are unsuccessful in such litigation, we may have to pay damages, stop the infringing activity, and/or obtain a license. If we fail to obtain a required license, we may be unable to sell some of our products, which could result in a decline in our revenues. 18 Departures of key employees could impair our operations. We generally have employment contracts with each of our key employees. Our executive officers own shares of our common stock and/or have options to purchase additional shares. Nevertheless, such individuals could leave the Company. If any key employees stopped working for us, our operations could be harmed. Important R&D personnel may leave and join competitors, which could substantially delay or hinder ongoing development projects. We have no key man life insurance policies with respect to any of our senior executives. We may be adversely affected by environmental laws and regulations. We are subject to various environmental laws and regulations and incur expenditures in complying with environmental laws and regulations. We are currently involved in, or have potential liability with respect to, the remediation of past contamination in various facilities. In addition, some of our facilities are or have been in operation for many decades and may have used substances or generated and disposed of wastes that are hazardous or may be considered hazardous in the future. These sites and disposal sites owned by others to which we sent waste may in the future be identified as contaminated and require remediation. Accordingly, it is possible that we could become subject to additional environmental liabilities in the future that may harm our results of operations or financial condition. We may be adversely affected by regulations relating to conflict minerals. In August 2012, the SEC adopted disclosures and reporting requirements for companies whose products contain certain minerals and their derivatives, namely tin, tantalum, tungsten, or gold, known as conflict minerals. Companies must report annually whether or not such minerals originate from the Democratic Republic of Congo (DRC) and adjoining countries and in some cases to perform extensive due diligence on their supply chains for such minerals. The implementation of these requirements could adversely affect the sourcing, availability, and pricing of materials used in the manufacturing of our products. In addition, we will incur additional costs to comply with the disclosure requirements, including cost related to determining the source of any of the relevant minerals used in our products. Since our supply chain is complex, the due diligence procedures that we implement may not enable us to ascertain with sufficient certainty the origins for these minerals or determine that these minerals are DRC conflict free, which may harm our reputation. We may also face difficulties in satisfying customers who may require that our products be certified as DRC conflict free, which could harm our relationships with these customers and/or lead to a loss of revenue. These requirements also could have the effect of limiting the pool of suppliers from which we source these minerals, and we may be unable to obtain conflict-free minerals at prices similar to the past, which could increase our costs and adversely affect our manufacturing operations and our profitability. We may be adversely affected by failure to comply with regulations of governmental agencies or by the adoption of new regulations. Our products are subject to regulation by governmental agencies. These regulations govern a wide variety of activities relating to our products, from design and development, product safety, labeling, manufacturing, promotion, sales, and distribution. If we fail to comply with these regulations, or if new regulations are adopted that substantially change existing practice or impose new burdens, we may have to recall products and cease their manufacture and distribution. In addition, we could be subject to fines or criminal prosecution. 19 We may experience impairments of goodwill or other intangible assets. As of December 31, 2014, our consolidated balance sheet included goodwill of $444.1 million and other intangible assets of $112.8 million. Our business acquisitions typically result in goodwill and other intangible assets, which affect the amount of future period amortization expense and possible impairment expense. We make estimates and assumptions in valuing such intangible assets that affect our consolidated financial statements. In accordance with U.S. GAAP, our goodwill and indefinite-lived intangible assets are not amortized, but are evaluated for impairment annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that an asset might be impaired. The evaluation is based on valuation models that estimate fair value. In preparing the valuation models, we consider a number of factors, including operating results, business plans, economic conditions, future cash flows, and transactions and market data. There are inherent uncertainties related to these factors and our judgment in applying them to the impairment analyses. The significant estimates and assumptions within our fair value models include sales growth, controllable cost growth, perpetual growth, effective tax rates, and discount rates. Our assessments to date have indicated that there has been no impairment of these assets. Should any of these estimates or assumptions change, or should we incur lower-than-expected operating performance or cash flows, including from a prolonged economic slowdown, we may experience a triggering event that requires a new fair value assessment for our reporting units, possibly prior to the required annual assessment. These types of events and resulting analysis could result in impairment charges for goodwill and other indefinite-lived intangible assets if the fair value estimate declines below the carrying value. Our amortization expense related to intangible assets with finite lives may materially change should our estimates of their useful lives change. We have debt and we may incur substantially more debt, which could affect our ability to meet our debt obligations and may otherwise restrict our activities. We have debt and we may incur substantial additional debt in the future. As of December 31, 2014, we had total indebtedness of approximately $366.7 million, net of cash of $85.3 million. Our debt instruments allow us to incur substantial additional indebtedness. The existence and magnitude of our debt could have important consequences. For example, it could make it more difficult for us to satisfy our obligations under our debt instruments; require us to dedicate a substantial portion of our cash flow to payments on our indebtedness, which would reduce the amount of cash flow available to fund working capital, capital expenditures, product development, and other corporate requirements; increase our vulnerability to general adverse economic and industry conditions, including changes in raw material costs; limit our ability to respond to business opportunities; limit our ability to borrow additional funds, which may be necessary; and subject us to financial and other restrictive covenants, which, if we fail to comply with these covenants and our failure is not waived or cured, could result in an event of default under our debt instruments. The agreements governing our debt impose restrictions on our business. The note purchase agreements governing our senior notes and the agreements governing our credit facility contain covenants imposing various restrictions on our business. These restrictions may affect our ability to operate our business and may limit our ability to take advantage of potential business opportunities. The restrictions these covenants place on us include limitations on our ability to incur liens and consolidate, merge, sell, or lease all or substantially all of our assets. Our credit facility and the note purchase agreements governing our senior notes also require us to meet certain financial ratios. 20 Our ability to comply with these agreements may be affected by events beyond our control, including economic, financial, and industry conditions. The breach of any covenants or restrictions could result in a default under the note purchase agreements governing the senior notes and/or under our credit facility. An event of default under the agreements governing our debt would permit holders of our debt to declare all amounts owed to them under such agreements to be immediately due and payable. Acceleration of our other indebtedness may cause us to be unable to make interest payments on the senior notes and repay the principal amount of the senior notes. The lenders under our credit agreement may be unable to meet their funding commitments, reducing the amount of our borrowing capacity. We have a revolving credit facility outstanding under which the Company and certain of its subsidiaries may borrow up to $800 million. Our credit facility is provided by a group of 13 financial institutions, which individually have between 2% and 14% of the total funding commitment. At December 31, 2014, we had borrowings of $110.8 million outstanding under our credit facility. Our ability to borrow further funds under our credit facility is subject to the various lenders’ financial condition and ability to make funds available. Even though the financial institutions are contractually obligated to lend funds, if one or more of the lenders encounters financial difficulties or goes bankrupt, such lenders may be unable to meet their obligations. This could result in us being unable to borrow the full $800 million amount available. We make forward-looking statements, and actual events or results may differ materially from these statements because assumptions we have made prove incorrect due to market conditions in our industries or other factors. We provide forward-looking statements both in our filings with the SEC and orally in connection with our quarterly earnings calls, including guidance on anticipated earnings per share. You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties. Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements. See in particular “Factors Affecting Our Future Operating Results” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” In providing guidance on our future earnings, we evaluate our budgets, strategic plans, and other factors relating to our business. We make assumptions about external factors, including the following: the outlook for our end markets and the global economy; the impact of external factors on our competition; the financial position of our customers; the estimated costs of purchasing materials; • • • • • developments in personnel costs; and • rates for currency exchange, particularly between the Swiss franc and the euro. Some of these assumptions may prove to be incorrect over time. For example, although no single customer accounts for more than 1% of our revenues, if a number of our customers experienced significant deteriorations in their financial positions concurrently, it could have an impact on our results of operations. 21 Some of our key internal assumptions include the following: • our ability to implement our business strategy; • the effectiveness of our sales and marketing programs such as our Spinnaker and market penetration initiatives; • our ability to develop and deliver innovative products and services; the continued growth of our sales in emerging markets; • • our ability to implement price increases as forecasted; and • the effectiveness of our cost saving initiatives. These internal assumptions may also prove to be incorrect over time. For example, with respect to our ability to realize our planned price increases without disturbing our customer base in core markets, in certain markets, such as emerging markets, price tends to be a more significant factor in customers’ decisions to purchase our products. Furthermore, we can have no assurance that our cost reduction programs will generate adequate cost savings. Additionally, it may become necessary to take additional restructuring actions resulting in additional restructuring costs. We believe our current assumptions are reasonable and prudent for planning purposes. However, should any of these assumptions prove to be incorrect, or should we incur lower-than-expected operating performance or cash flows, we may experience results different than our projections. Our ability to generate cash depends in part on factors beyond our control. Our ability to make payments on our debt and to fund planned capital expenditures and research and development efforts depends on our ability to generate cash in the future. This is subject to factors beyond our control, including general economic, financial, competitive, legislative, regulatory, and other factors described in this section. We cannot ensure that our business will generate sufficient cash flows from operations or that future borrowings will be available to us under our credit facility in an amount sufficient to enable us to pay our debt or to fund our other liquidity needs. We may need to refinance all or a portion of our indebtedness on or before maturity. We cannot ensure that we will be able to refinance any of our debt, including our credit facility and the senior notes, on commercially reasonable terms or at all. 22 Item 1B. Unresolved Staff Comments None. Item 2. Properties Our principal executive offices are located in Columbus, Ohio and Greifensee, Switzerland. The following table lists our principal facilities, indicating the location and whether the facility is owned or leased. The properties listed below serve primarily as manufacturing facilities, or shared service centers and also typically have a certain amount of space for service, sales and marketing, and administrative activities. The facilities in Giessen, Germany and Viroflay, France are used primarily for sales and marketing. We believe our facilities are adequate for our current and reasonably anticipated future needs. Location Europe: Greifensee/Nanikon, Switzerland . . . . . . . . . . . . . . . . . . . . . . . Uznach, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Urdorf, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Schwerzenbach, Switzerland. . . . . . . . . . . . . . . . . . . . . . . . . . . Cambridge, England . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Manchester, England . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Viroflay, France (two facilities). . . . . . . . . . . . . . . . . . . . . . . . . Albstadt, Germany. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Giessen, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Warsaw, Poland. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Americas: Columbus, Ohio. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Worthington, Ohio (two facilities). . . . . . . . . . . . . . . . . . . . . . . Oakland, California . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Billerica, Massachusetts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ithaca, New York. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tampa, Florida. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other: Shanghai, China (two facilities) . . . . . . . . . . . . . . . . . . . . . . . . Changzhou, China (two facilities). . . . . . . . . . . . . . . . . . . . . . . ChengDu, China . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Owned/Leased Business Segment Owned Owned Owned Leased Owned Leased Building Owned; Building Leased Owned Owned Building Leased Leased Owned Leased Leased Owned Leased Buildings Owned; Land Leased Buildings Owned; Land Leased Buildings Owned; Land Leased Swiss Operations Swiss Operations Swiss Operations Swiss Operations Western European Operations Western European Operations Western European Operations Western European Operations Western European Operations Other Operations U.S. Operations U.S. Operations U.S. Operations U.S. Operations U.S. Operations U.S. Operations Chinese Operations Chinese Operations Chinese Operations Mumbai, India (two facilities). . . . . . . . . . . . . . . . . . . . . . . . . . Buildings Leased Other Operations Item 3. Legal Proceedings We are not currently involved in any legal proceeding that we believe could have a material adverse effect upon our financial condition, results of operations, or cash flows. See the disclosure in Item 1 above under “Environmental Matters.” Executive Officers of the Registrant See Part III, Item 10 of this annual report for information about our executive officers. 23 PART II Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities Market Information for Common Stock Our common stock is traded on the New York Stock Exchange under the symbol “MTD.” The following table sets forth on a per share basis the high and low sales prices for consolidated trading in our common stock as reported on the New York Stock Exchange Composite Tape for the quarters indicated. Common Stock Price Range High Low 2014 Fourth Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 305.89 Third Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 272.84 Second Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 253.18 First Quarter. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 255.85 2013 Fourth Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 253.27 Third Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 242.56 Second Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 228.00 First Quarter. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 221.56 $ $ $ $ $ $ $ $ 233.85 249.99 223.80 231.19 233.71 205.55 197.91 196.72 Holders At January 31, 2015, there were 61 holders of record of common stock and 28,127,235 shares of common stock outstanding. We estimate we have approximately 34,757 beneficial owners of common stock. Dividend Policy Historically, we have not paid dividends on our common stock. However, we will evaluate this policy on a periodic basis taking into account our results of operations, financial condition, capital requirements, including potential acquisitions, our share repurchase program, the taxation of dividends to our shareholders, and other factors deemed relevant by our Board of Directors. 24 Share Performance Graph The following graph compares the cumulative total returns (assuming reinvestment of dividends) on $100 invested on December 31, 2009 through December 31, 2014 in our common stock, the Standard & Poor’s 500 Composite Stock Index (S&P 500 Index) and the SIC Code 3826 Index — Laboratory Analytical Instruments. Comparison of Cumulative Total Return Among Mettler-Toledo International Inc., the S&P 500 Index and SIC Code 3826 Index — Laboratory Analytical Instruments Mettler-Toledo S&P 500 Index SIC Code 3826 Index 12-31-09 12-31-10 12-31-11 12-31-12 12-31-13 12-31-14 $100 $100 $100 $144 $115 $128 $141 $117 $105 $184 $136 $138 $231 $180 $210 $288 $205 $241 25 Purchases of Equity Securities by the Issuer and Affiliated Purchasers Issuer Purchases of Equity Securities Period October 1 to October 31, 2014 . . . . . November 1 to November 30, 2014 . December 1 to December 31, 2014 . Total . . . . . . . . . . . . . . . . . . . . . . . . . Total Number of Shares Purchased 149,554 129,835 151,895 431,284 Average Price Paid per Share $ $ 246.60 276.81 294.25 272.48 Total Number of Shares Purchased as Part of Publicly Announced Program Approximate Dollar Value (in thousands) of Shares that may yet be Purchased under the Program 149,554 129,835 151,895 431,284 $ $ 559,017 523,075 478,376 478,376 We have a $3 billion share repurchase program, of which there was $478.4 million remaining to be repurchased under the program as of December 31, 2014. The share repurchases are expected to be funded from existing cash balances, borrowings, and cash generated from operating activities. Repurchases will be made through open market transactions, and the amount and timing of repurchases will depend on business and market conditions, stock price, trading restrictions, the level of acquisition activity, and other factors. We have purchased 23.1 million common shares since the inception of the program in 2004 through December 31, 2014, at a total cost of $2.5 billion. During the years ended December 31, 2014 and 2013, we spent $414.0 million and $295.0 million on the repurchase of 1,617,499 shares and 1,321,577 shares at an average price per share of $255.93 and $223.18, respectively. 26 Item 6. Selected Financial Data The selected historical financial information set forth below as of and for the years then ended December 31 is derived from our audited consolidated financial statements. The financial information presented below, in thousands except share data, was prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). 2014 2013 2012 2011 2010 Statement of Operations Data: 1,358,750 Net sales. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2,485,983 1,127,233 Cost of sales. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Research and development . . . . . . . . . . . . . . . . . . . Selling, general and administrative . . . . . . . . . . . . . Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . Restructuring charges(a). . . . . . . . . . . . . . . . . . . . . . . . Other charges (income), net(b) . . . . . . . . . . . . . . . . . . Earnings before taxes . . . . . . . . . . . . . . . . . . . . . . . Provision for taxes(c) . . . . . . . . . . . . . . . . . . . . . . . . . . Net earnings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2,230 445,004 728,582 106,763 338,241 123,297 29,185 24,537 5,915 Basic earnings per common share: Net earnings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Weighted average number of common shares. . . . . 11.71 28,890,771 $ 2,378,972 $ 2,341,528 $ 2,309,328 $ 1,968,178 1,097,041 1,100,473 1,091,054 930,982 1,281,931 1,241,055 1,218,274 1,037,196 116,346 692,693 24,539 22,711 19,830 3,103 402,709 96,615 306,094 10.22 $ $ 112,530 684,026 21,357 22,764 16,687 1,090 382,601 91,754 290,847 9.37 $ $ 116,139 703,632 17,808 23,226 5,912 2,380 349,177 79,684 269,493 8.45 $ $ 97,028 588,726 14,842 20,057 4,866 4,164 307,513 75,365 232,148 6.98 $ $ 29,945,954 31,044,532 31,897,779 33,280,463 Diluted earnings per common share: Net earnings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Weighted average number of common and common equivalent shares . . . . . . . . . . . . . . . . . . . 11.44 $ 9.96 $ 9.14 $ 8.21 $ 6.80 29,571,308 30,728,482 31,824,077 32,839,365 34,140,097 Balance Sheet Data: Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . $ Working capital(d) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other non-current liabilities(e) . . . . . . . . . . . . . . . . . . . Shareholders’ equity(f) . . . . . . . . . . . . . . . . . . . . . . . . . . 85,263 $ 111,874 $ 101,702 $ 235,601 $ 447,577 201,441 254,992 242,141 201,718 166,034 2,009,110 2,152,819 2,022,288 2,114,910 2,199,544 335,790 218,108 719,595 395,960 193,170 935,052 347,131 240,886 827,219 476,715 209,945 781,137 670,301 174,469 771,584 _________________________ (a) Restructuring charges primarily relate to our global cost reduction programs. See Note 13 to the audited consolidated financial statements. (b) Other charges (income), net consists primarily of interest income, (gains) losses from foreign currency transactions, and other items. Other charges (income), net in 2010 also includes a $4.4 million ($3.8 million after-tax) charge associated with the sale of our retail software business for in-store item and inventory management solutions. This amount was partially offset by a benefit from unrealized contingent consideration from a previous acquisition totaling $1.2 million ($1.2 million after-tax). (c) The provision for taxes for 2011 and 2010 includes discrete tax items resulting in a net tax benefit of $3.8 million and $5.2 million, respectively, primarily related to the favorable resolution of certain prior year tax matters. (d) Working capital represents total current assets net of cash, less total current liabilities net of short-term borrowings and current maturities of long-term debt. (e) Other non-current liabilities consist of pension and other post-retirement liabilities, plus certain other non-current liabilities. See Note 11 to the audited consolidated financial statements. (f) No dividends were paid during the five-year period ended December 31, 2014. 27 Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis of our financial condition and results of operations should be read together with our audited consolidated financial statements. Changes in local currencies exclude the effect of currency exchange rate fluctuations. Local currency amounts are determined by translating current and previous year consolidated financial information at an index utilizing historical currency exchange rates. We believe local currency information provides a helpful assessment of business performance and a useful measure of results between periods. We do not, nor do we suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We present non-GAAP financial measures in reporting our financial results to provide investors with an additional analytical tool to evaluate our operating results. Overview We operate a global business with sales that are diversified by geographic region, product range, and customer. We hold leading positions worldwide in many of our markets and attribute this leadership to several factors, including the strength of our brand name and reputation, our comprehensive offering of innovative instruments and solutions, and the breadth and quality of our global sales and service network. Net sales in U.S. dollars increased by 4% in 2014 and 2% in 2013. Excluding the effect of currency exchange rate fluctuations, or in local currencies, net sales increased 5% in 2014 and 1% in 2013. Net sales growth during 2014 benefited from improved market conditions, especially in the United States. We expect to continue to benefit from our strong global leadership positions, diversified customer base, robust product offering, investment in emerging markets, significant installed base, and the impact of our global sales and marketing programs. Examples of these programs include identifying and investing in growth and market penetration opportunities, improving our lead generation and lead nurturing processes, and more effectively pricing our products and services. We remain cautious about our sales growth outlook as global market conditions remain uncertain, especially in certain emerging markets (including China), as well as parts of Europe. With respect to our end-user markets, we experienced increased results during 2014 versus the prior year in our laboratory-related markets, such as pharmaceutical and biotech customers, as well as the laboratories of chemical companies and food and beverage companies. Demand from these markets was generally strong during 2014. We also experienced increased demand from universities and government- funded research institutions. Our industrial markets, especially product inspection, were favorably impacted by our customer's focus on brand protection and food safety. Core-industrial products also experienced improved market conditions in the Americas and Europe, but were adversely impacted in 2014 by a decline in our Chinese industrial-related sales. Emerging market economies have historically been an important source of growth based upon the expansion of their domestic economies, as well as increased exports as companies have moved production to low-cost countries. Overall, Chinese market conditions for our industrial-related products were weak during 2014 and 2013 related to overcapacity in certain end-user segments and a reduction of credit availability for many local Chinese customers. Growth in China and other emerging markets can be expected to be volatile and the timing of recoveries can be uncertain. Our industrial- related products are especially sensitive to changes in economic growth. Our food retailing markets experienced modest growth during 2014, primarily driven by strong project activity in Europe, offset in part by reduced sales in the Americas due to the timing of project 28 activity. Traditionally the spending levels in this sector have experienced more volatility than our other customer sectors due to the timing of customer project activity and new regulations. Similar to our industrial business, emerging markets have also historically provided growth as the expansion of local emerging market economies creates a significant number of new retail stores each year. In 2015, we expect to continue to pursue the overall business growth strategies which we have followed in recent years: Gaining Market Share. Our global sales and marketing initiative, “Spinnaker,” continues to be an important growth strategy. For example, we are in the process of adding approximately 200 field sales and service resources to pursue under-penetrated market opportunities. We also aim to gain market share by implementing sophisticated sales and marketing programs and leveraging our extensive customer databases. While this initiative is broad-based, efforts to improve these processes include increased segment marketing and leads generation and nurturing activities, the implementation of more effective pricing and value-based selling strategies and processes, improved sales force training and effectiveness, cross-selling, and other sales and marketing topics. Our comprehensive service offerings, and our initiatives to globalize and harmonize these offerings, help us further penetrate developed markets. We estimate that we have the largest installed base of weighing instruments in the world, and we continue to invest in sales and marketing activities aimed at increasing the proportion of our installed base that is under service contract. In addition to traditional repair and maintenance, our service offerings continue to expand into value-added services for a range of market needs, including regulatory compliance. Expanding Emerging Markets. Emerging markets, comprising Asia (excluding Japan), Eastern Europe, Latin America, the Middle East, and Africa, account for approximately 36% of our total net sales. We have a two-pronged strategy in emerging markets: first, to capitalize on growth opportunities in these markets and second, to leverage our low-cost manufacturing operations in China. We have over a 25-year track record in China, and our sales in Asia have grown more than 16% on a compound annual growth basis in local currencies since 1999. We have broadened our product offering to the Asian markets and benefit as multinational customers shift production to China. We are pleased with our accomplishments in China and in recent years have expanded our territory coverage into second-tier cities with new branch offices, additional dealers, and more service professionals. India has also been a source of emerging market sales growth in past years due to increased life science research activities. Overall, market conditions in emerging markets improved during 2014 but remain below our long-term expectations. We experienced a 3% increase in emerging market local currency sales during 2014 versus the prior year, offset in part by reduced sales volume in Russia. Chinese market conditions for our industrial products also continued to be weak in 2014 related to overcapacity in certain end-user segments and a reduction of credit availability for many local Chinese customers. Growth in China and other emerging markets can be expected to be volatile and the timing of recoveries can be uncertain. Within China, we are redeploying resources and sales and marketing efforts to the faster-growing segments of pharma, food safety, and environment. We believe the long-term growth of these segments will be favorably impacted by the Chinese government's emphasis on science, high-value industries, and product quality. We expect our laboratory, process analytics, and product inspection businesses will particularly benefit from these segments. Extending Our Technology Lead. We continue to focus on product innovation. In the last three years, we spent approximately 5% of net sales on research and development. We seek to drive shorter product life cycles, as well as improve our product offerings and their capabilities with additional integrated technologies and software. In addition, we aim to create value for our customers by having an intimate knowledge of their processes via our significant installed product base. 29 Maintaining Cost Leadership. We continue to strive to improve our margins by optimizing our cost structure. For example, we have focused on reallocating resources and better aligning our cost structure to support our investments in market penetration initiatives, higher growth areas, and opportunities for margin improvement. We have also initiated various restructuring programs over the past few years in response to weak market conditions. As previously mentioned, shifting production to China has also been an important component of our cost savings initiatives. We have also implemented global procurement and supply chain management programs over the last several years aimed at lowering supply costs. Our cost leadership initiatives are also focused on continuously improving our invested capital efficiency, such as reducing our working capital levels and ensuring appropriate returns on our expenditures. Pursuing Strategic Acquisitions. We seek to pursue acquisitions that may leverage our global sales and service network, respected brand, extensive distribution channels, and technological leadership. We have identified life sciences, product inspection, and process analytics as three key areas for acquisitions. We also continue to pursue “bolt-on” acquisitions. Results of Operations — Consolidated Net sales Net sales were $2,486.0 million for the year ended December 31, 2014, compared to $2,379.0 million in 2013 and $2,341.5 million in 2012. This represents increases of 4% in 2014 and 2% in 2013 in U.S. dollars and 5% and 1% in local currencies, respectively. In 2014, our net sales by geographic destination increased in U.S. dollars by 5% in both the Americas and Europe and 3% in Asia/Rest of World. In local currencies, our net sales by geographic destination increased in 2014 by 6% in the Americas, 5% in Europe, and 4% in Asia/Rest of World. A discussion of sales by operating segment is included below. Net sales in local currencies for Asia/Rest of World for the year ended December 31, 2014 were reduced by approximately 1%, due to the exit of certain industrial- related businesses in China. As previously mentioned, global market conditions remain uncertain and accordingly, we are cautious regarding our sales growth outlook. As described in Note 16 to our audited consolidated financial statements, our net sales comprise product sales of precision instruments and related services. Service revenues are primarily derived from repair and other services, including regulatory compliance qualification, calibration, certification, preventative maintenance, and spare parts. Net sales of products increased 4% in both U.S. dollars and local currencies during 2014 and increased by 1% in U.S. dollars and were flat in local currencies in 2013. Service revenue (including spare parts) increased by 7% in U.S. dollars and 8% in local currencies in 2014, and 6% and 5% in U.S. dollars and local currencies, respectively, in 2013. Net sales of our laboratory-related products, which represented approximately 47% of our total net sales in 2014, increased by 6% in both U.S. dollars and local currencies during 2014. The increase in net sales of our laboratory-related products is principally driven by increased volume and favorable price realization in most categories. Net sales of our industrial-related products, which represented approximately 44% of our total net sales in 2014, increased 4% in both U.S. dollars and local currencies during 2014. The increase in net sales of our industrial-related products includes increased volume and favorable price realization in most product categories, particularly in product inspection. Net sales in 2014 were offset in part by the exit of certain industrial-related businesses in China, which decreased industrial-related sales in local currency by 1%. Overall Chinese market conditions for our industrial-related products remain weak. Growth in China can be expected to be volatile and the timing of recovery is uncertain. 30 Net sales of our food retailing products, which represented approximately 9% of our total net sales in 2014, increased by 2% in both U.S. dollars and local currencies during 2014. The increase in net sales in local currencies of our food retailing products during 2014 is driven by increased project activity in Europe, offset in part by reduced sales in the Americas due to the timing of project activity. Gross profit Gross profit as a percentage of net sales was 54.7% for 2014, compared to 53.9% for 2013 and 53.0% for 2012. Gross profit as a percentage of net sales for products was 58.1% for 2014, compared to 57.3% for 2013 and 56.2% for 2012. Gross profit as a percentage of net sales for services (including spare parts) was 42.8% for 2014, compared to 41.7% for 2013 and 40.9% for 2012. The increase in gross profit as a percentage of net sales for 2014 primarily includes favorable price realization and reduced material costs. Research and development and selling, general, and administrative expenses Research and development expenses as a percentage of net sales were 5.0% for 2014, 4.9% for 2013, and 4.8% for 2012. Research and development expenses in U.S. dollars increased by 6% in 2014 and 3% in 2013, and in local currencies increased 5% in 2014 and 2% in 2013. The increase in our research and development spending levels reflects the timing of research and development project activity. Selling, general, and administrative expenses as a percentage of net sales increased to 29.3% for 2014, compared to 29.1% for 2013 and 29.2% for 2012. Selling, general, and administrative expenses increased by 5% in 2014 in both U.S. dollars and local currencies and increased by 1% in both U.S. dollars and local currencies in 2013. The increase includes higher cash incentive compensation and increased investments in our field sales organization as compared to the prior year, partially offset by lower employee benefit costs. Amortization expense Amortization expense was $29.2 million and $24.5 million for 2014 and 2013, respectively. The increase in amortization expense is primarily related to recent investment in information technology, including the Company's Blue Ocean program. Restructuring charges During the past few years, we initiated additional cost reduction measures in response to global economic conditions. For the year ended December 31, 2014, we have incurred $5.9 million of restructuring expenses which primarily comprise employee-related costs. See Note 13 to our audited consolidated financial statements for a summary of restructuring activity during 2014. Other charges (income), net Other charges (income), net consisted of net charges of $2.2 million in 2014, compared to net charges of $3.1 million and $1.1 million in 2013 and 2012, respectively. Other charges (income), net consists primarily of (gains) losses from foreign currency transactions, interest income, and other items. 31 Interest expense and taxes Interest expense was $24.5 million for 2014, compared to $22.7 million for 2013 and $22.8 million for 2012. Our annual effective tax rate was 24% for 2014, 2013, and 2012. Our consolidated income tax rate is lower than the U.S. statutory rate primarily because of benefits from lower-taxed non-U.S. operations. The most significant of these lower-taxed operations are in Switzerland and China. Results of Operations — by Operating Segment The following is a discussion of the financial results of our operating segments. We currently have five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. A more detailed description of these segments is outlined in Note 16 to our audited consolidated financial statements. U.S. Operations (amounts in thousands) 2014 2013 2012 Increase (Decrease) in % 2014 vs. 2013 Increase (Decrease) in % 2013 vs. 2012 Net sales . . . . . . . . . . . . . . . . . . . $ 846,385 Net sales to external customers . $ 755,922 Segment profit . . . . . . . . . . . . . . $ 134,045 $ 801,853 $ 778,120 $ 718,671 $ 697,956 $ 137,837 $ 138,894 6% 5% (3)% 3% 3% (1)% The increase in total net sales and net sales to external customers in 2014 reflects strong growth in most of our product categories, particularly laboratory-related products, due to increased sales volume and favorable price realization, offset in part by reduced net sales in food retailing due to the timing of project activity. Segment profit decreased by $3.8 million in our U.S. Operations segment during 2014, compared to a decrease of $1.1 million during 2013. The decrease in segment profit primarily related to a reduction in inter-segment royalty income, increased sales and service investments, and higher cash incentive expense, offset in part by increased net sales. Swiss Operations (amounts in thousands) 2014 2013 2012 Increase (Decrease) in %(1) 2014 vs. 2013 Net sales . . . . . . . . . . . . . . . . . . . $ 598,402 Net sales to external customers . $ 137,231 Segment profit . . . . . . . . . . . . . . $ 170,764 $ 568,144 $ 530,847 $ 132,240 $ 124,362 $ 147,990 $ 127,011 5% 4% 15% _______________________________________ (1) Represents U.S. dollar growth for net sales and segment profit. Increase (Decrease) in %(1) 2013 vs. 2012 7% 6% 17% Total net sales in U.S. dollars increased by 5% in 2014 and 7% in 2013, and in local currencies increased by 4% in 2014 and 5% in 2013. Net sales to external customers in U.S. dollars increased by 4% in 2014 and 6% in 2013, and in local currencies increased by 3% in 2014 and 5% in 2013. The increase in local currency net sales to external customers includes particularly strong volume growth in analytical instruments and core-industrial products. 32 Segment profit increased by $22.8 million in our Swiss Operations segment during 2014, compared to an increase of $21.0 million during 2013. Segment profit includes the impact of increased inter-segment royalty income and net sales, partially offset by unfavorable currency and increased cash incentive compensation. Western European Operations (amounts in thousands) 2014 2013 2012 Increase (Decrease) in %(1) 2014 vs. 2013 Net sales . . . . . . . . . . . . . . . . . . . $ 837,667 Net sales to external customers. . $ 713,318 Segment profit . . . . . . . . . . . . . . $ 120,659 $ 786,327 $ 746,313 $ 674,278 $ 644,361 $ 111,951 $ 95,523 7% 6% 8% _______________________________________ (1) Represents U.S. dollar growth for net sales and segment profit. Increase (Decrease) in %(1) 2013 vs. 2012 5% 5% 17% Total net sales in U.S. dollars increased by 7% in 2014 and 5% in 2013, and in local currencies increased by 6% in 2014 and 3% in 2013. Net sales to external customers in U.S. dollars increased by 6% in 2014 and 5% in 2013, and in local currencies increased by 6% in 2014 and 2% in 2013. The increase in total net sales and net sales to external customers includes volume increases and favorable price realization across most product categories. Segment profit increased by $8.7 million in our Western European Operations segment during 2014, compared to an increase of $16.4 million in 2013. Segment profit benefited from increased net sales, offset in part by increased sales and service investments, higher cash incentive expense, and unfavorable currency. Chinese Operations (amounts in thousands) 2014 2013 2012 Increase (Decrease) in %(1) 2014 vs. 2013 Net sales . . . . . . . . . . . . . . . . . . . $ 571,164 Net sales to external customers. . $ 415,474 Segment profit . . . . . . . . . . . . . . $ 132,521 $ 556,215 $ 555,924 $ 407,131 $ 432,255 $ 122,214 $ 125,217 3% 2% 8% _______________________________________ (1) Represents U.S. dollar growth for net sales and segment profit. Increase (Decrease) in %(1) 2013 vs. 2012 —% (6)% (2)% Total net sales in U.S. dollars increased 3% in 2014 and were flat in 2013, and in local currencies increased by 2% in 2014 and decreased by 2% in 2013. Net sales to external customers in U.S. dollars increased by 2% and decreased by 6% in 2014 and 2013, respectively, and in local currencies increased by 1% in 2014 and decreased by 8% in 2013. The increase in net sales to external customers includes strong growth in most laboratory-related products, offset in part by a decline in core-industrial products. The exit of certain industrial-related businesses decreased local currency net sales to external customers by approximately 2% in 2014. Overall Chinese market conditions for our industrial-related products remain weak. Growth in China can be expected to be volatile and the timing of a recovery is uncertain. Segment profit increased by $10.3 million in our Chinese Operations segment during 2014, compared to a decrease of $3.0 million in 2013. The increase in segment profit includes increased net sales, favorable business mix, and increased price realization, offset in part by investments in sales and service. 33 Other (amounts in thousands) 2014 2013 2012 Increase (Decrease) in % (1) 2014 vs. 2013 Net sales . . . . . . . . . . . . . . . . . . . $ 471,565 Net sales to external customers. . $ 464,038 52,461 Segment profit . . . . . . . . . . . . . . $ $ 452,960 $ 447,727 $ 446,652 $ 442,594 $ 49,673 $ 48,857 4% 4% 6% _______________________________________ (1) Represents U.S. dollar growth for net sales and segment profit. Increase (Decrease) in % (1) 2013 vs. 2012 1% 1% 2% Total net sales and net sales to external customers in U.S. dollars increased by 4% in 2014 and 1% in 2013, and in local currencies increased by 8% and 5% in 2014 and 2013, respectively. The increase in total net sales and net sales to external customers reflects increased sales volume and favorable price realization in most product categories, particularly product inspection and core-industrial products. Segment profit increased by $2.8 million in our Other segment during 2014, compared to an increase of $0.8 million during 2013. The increase in segment profit includes sales volume growth and favorable price realization, partially offset by unfavorable currency and increased sales and marketing investments. Liquidity and Capital Resources Liquidity is our ability to generate sufficient cash flows from operating activities to meet our obligations and commitments. In addition, liquidity includes the ability to obtain appropriate financing. Currently, our financing requirements are primarily driven by working capital requirements, capital expenditures, share repurchases, and acquisitions. As previously mentioned, global market conditions remain uncertain, and our ability to generate cash flows could be reduced by a prolonged slowdown in global market conditions. Cash provided by operating activities totaled $418.9 million in 2014, compared to $345.9 million in 2013 and $327.7 million in 2012. The increase in 2014 is primarily due to a reduction in working capital, particularly accounts receivable, offset in part by the timing of tax and higher cash incentive payments. Capital expenditures are made primarily for investments in information systems and technology, machinery, equipment, and the purchase and expansion of facilities. Our capital expenditures totaled $89.4 million in 2014, $82.3 million in 2013, and $95.6 million in 2012. Cash flows used in financing activities during 2014 included proceeds of $125 million from the issuance of our 3.84% Senior Notes. As further described below, in accordance with our share repurchase plan, we repurchased 1,617,499 shares and 1,321,577 shares in the amount of $414.0 million and $295.0 million during 2014 and 2013, respectively. We continue to explore potential acquisitions. In connection with any acquisition, we may incur additional indebtedness. We plan to repatriate earnings from China, Switzerland, Germany, the United Kingdom, and certain other countries in future years and expect the only additional cost associated with the repatriation of such foreign earnings will be withholding taxes. All other undistributed earnings are considered to be permanently reinvested. As of December 31, 2014, we had an immaterial amount of cash and cash equivalents in foreign subsidiaries where undistributed earnings are considered permanently reinvested. Accordingly, we believe the tax impact associated with repatriating our undistributed foreign earnings will not have a material effect on our liquidity. 34 6.30% Senior Notes In 2009, we issued and sold $100 million of 6.30% Senior Notes due June 25, 2015 in a private placement. The 6.30% Senior Notes are senior unsecured obligations of the Company. Interest on the 6.30% Senior Notes is payable semi-annually in June and December. We may at any time prepay the 6.30% Senior Notes, in whole or in part (but in an amount not less than 10% of the original aggregate principal amount), at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, plus a “make-whole” prepayment premium. In the event of a change in control of the Company (as defined in the note purchase agreement), we may be required to offer to prepay the 6.30% Senior Notes in whole at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest. The 6.30% Senior Notes contain customary affirmative and negative covenants including, among others, limitations on the Company and its subsidiaries with respect to incurrence of liens and priority indebtedness, disposition of assets, mergers, and transactions with affiliates. The note purchase agreement also requires us to maintain a consolidated interest coverage ratio of not less than 3.5 to 1.0 and a consolidated leverage ratio of not more than 3.5 to 1.0. The agreement contains customary events of default with customary grace periods, as applicable. We were in compliance with these covenants at December 31, 2014. Issuance costs approximating $0.7 million will be amortized to interest expense over the six-year term of the 6.30% Senior Notes. 3.67% Senior Notes In 2012, we issued and sold $50 million of 3.67% Senior Notes due December 17, 2022 in a private placement. The 3.67% Senior Notes are senior unsecured obligations of the Company. Interest is payable semi-annually in June and December. The 3.67% Senior Notes contain customary affirmative and negative covenants, change in control and prepayment provisions, that are substantially similar to those contained in the previously issued debt of the Company as described above. The 3.67% Senior Notes also contain customary events of default with customary grace periods, as applicable. We were in compliance with these covenants at December 31, 2014. Issuance costs approximating $0.4 million will be amortized to interest expense over the ten-year term of the 3.67% Senior Notes. 4.10% Senior Notes In 2013, we issued and sold $50 million of 4.10% Senior Notes due September 19, 2023 in a private placement. The 4.10% Senior Notes are senior unsecured obligations of the Company. Interest on the 4.10% Senior Notes is payable semi-annually in March and September of each year, beginning in March 2014. The 4.10% Senior Notes contain customary affirmative and negative covenants, change in control and prepayment provisions, that are substantially similar to those contained in the previously issued debt of the Company as described above. The 4.10% Senior Notes also contain customary events of default with customary grace periods, as applicable. We were in compliance with these covenants at December 31, 2014. 35 Issuance costs approximating $0.4 million will be amortized to interest expense over the ten-year term of the 4.10% Senior Notes. 3.84% Senior Notes and 4.24% Senior Notes In the second quarter of 2014, the Company entered into an agreement to issue and sell $250 million of ten-year Senior Notes in a private placement. The Company issued $125 million with a fixed interest rate of 3.84% ("3.84% Senior Notes") in September 2014 and will issue $125 million with a fixed interest rate of 4.24% ("4.24% Senior Notes") in June 2015. The Senior Notes are senior unsecured obligations of the Company. Interest on the 3.84% Senior Notes is payable semi-annually in March and September each year, beginning in March 2015. Interest on the 4.24% Senior Notes is payable semi-annually in June and December of each year, beginning in December 2015. The 3.84% Senior Notes and 4.24% Senior Notes contain customary affirmative and negative covenants, change in control and prepayment provisions, that are substantially similar to those contained in the previously issued debt of the Company as described above. The 3.84% Senior Notes and 4.24% Senior Notes also contain customary events of default with customary grace periods, as applicable. The Company was in compliance with these covenants at December 31, 2014. Issuance costs approximating $0.9 million will be amortized to interest expense over the ten-year term of the Senior Notes. Credit Agreement In 2013, we entered into an $800 million Amended Credit Agreement (the "Credit Agreement"), which replaced our $880 million Amended and Restated Credit Agreement (the "Prior Credit Agreement"). The Credit Agreement is provided by a group of financial institutions (similar to our Prior Credit Agreement) and has a maturity date of November 26, 2018. It is a revolving credit facility and is not subject to any scheduled principal payments prior to maturity. The obligations under the Credit Agreement are unsecured. Borrowings under the Credit Agreement bear interest at current market rates plus a margin based on our consolidated leverage ratio, which was, as of December 31, 2014, set at LIBOR plus 75 basis points. We must also pay facility fees that are tied to our leverage ratio. The Credit Agreement contains covenants that are substantially similar to those contained in our previously issued debt as described above, with which we were in compliance as of December 31, 2014. The Credit Agreement also places certain limitations on us, including limiting our ability to incur liens or indebtedness at a subsidiary level. In addition, the Credit Agreement has several events of default. We incurred approximately $0.4 million of debt extinguishment costs during 2013 related to the Prior Credit Agreement. We capitalized $1.1 million in financing fees during 2013 associated with the Credit Agreement which will be amortized to interest expense through 2018. As of December 31, 2014, approximately $684.8 million was available under the facility. 36 Our short-term borrowings and long-term debt consisted of the following at December 31, 2014: U.S. Dollar $100 million Senior Notes, interest at 6.30%, due June 25, 2015. . . . . . . . . . $ 100,000 $50 million Senior Notes, interest at 3.67%, due December 17, 2022 . . . . . . 50,000 $50 million Senior Notes, interest at 4.10%, due September 19, 2023. . . . . . $125 million Senior Notes, interest at 3.84%, due September 19, 2024. . . . . $800 million Credit Agreement, interest at LIBOR plus 75 basis points . . . . Other local arrangements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 431,238 Total debt. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (100,377) Less: current portion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 330,861 125,000 105,861 50,000 377 Other Principal Trading Currencies Total — $ 100,000 — — — 4,929 15,787 50,000 50,000 125,000 110,790 16,164 20,716 (15,787) 4,929 451,954 (116,164) $ 335,790 $ $ Changes in exchange rates between the currencies in which we generate cash flow and the currencies in which our borrowings are denominated affect our liquidity. In addition, because we borrow in a variety of currencies, our debt balances fluctuate due to changes in exchange rates. Further, we do not have any downgrade triggers relating to ratings from rating agencies that would accelerate the maturity dates of our debt. We currently believe that cash flows from operating activities, together with liquidity available under our Credit Agreement and local working capital facilities, will be sufficient to fund currently anticipated working capital needs and capital spending requirements for at least the foreseeable future. Contractual Obligations The following summarizes certain of our contractual obligations at December 31, 2014 and the effect such obligations are expected to have on our liquidity and cash flows in future periods. We do not have significant outstanding letters of credit or other financial commitments. Total Less than 1 Year 1-3 Years 3-5 Years After 5 Years Payments Due by Period Short and long-term debt . . . . . . . . . . . . . . . . . . . . $ 576,954 Interest on debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143,797 Non-cancelable operating leases. . . . . . . . . . . . . . . Pension and post-retirement funding(1) . . . . . . . . . . . 77,013 Purchase obligations . . . . . . . . . . . . . . . . . . . . . . . . Total(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 921,592 _______________________________________ 103,536 20,292 $ 116,164 $ — $ 110,790 $ 350,000 18,240 30,745 20,292 75,579 31,281 40,360 — 1,434 29,404 18,836 — — 64,872 13,595 — — $ 261,020 $ 73,075 $ 159,030 $ 428,467 (1) In addition to the above table, we also have liabilities for pension and post-retirement funding and income taxes. However, we cannot determine the timing or the amounts for periods beyond 2014 income taxes and beyond 2015 for pension and post-retirement funding. We have purchase commitments for materials, supplies, services, and fixed assets in the normal course of business. Due to the proprietary nature of many of our materials and processes, certain supply contracts contain penalty provisions. We do not expect potential payments under these provisions to materially affect results of operations or financial condition. This conclusion is based upon reasonably likely outcomes derived by reference to historical experience and current business plans. 37 Share Repurchase Program We have a $3 billion share repurchase program, of which there was $478.4 million remaining to be repurchased under the program as of December 31, 2014. The share repurchases are expected to be funded from existing cash balances, borrowings, and cash generated from operating activities. Repurchases will be made through open market transactions, and the amount and timing of repurchases will depend on business and market conditions, stock price, trading restrictions, the level of acquisition activity, and other factors. We have purchased 23.1 million shares since the inception of the program in 2004 through December 31, 2014. During the years ended December 31, 2014 and 2013, we spent $414.0 million and $295.0 million on the repurchase of 1,617,499 shares and 1,321,577 shares at an average price per share of $255.93 and $223.18, respectively. We reissued 373,431 and 398,646 shares held in treasury for the exercise of stock options and restricted stock units during 2014 and 2013, respectively. Off-Balance Sheet Arrangements Currently, we have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material. Effect of Currency on Results of Operations Currency fluctuations affect our operating profits. Our earnings are affected by changing exchange rates. We are most sensitive to changes in the exchange rates between the Swiss franc, euro, and U.S. dollar. We have more Swiss franc expenses than we do Swiss franc sales because we develop and manufacture products in Switzerland that we sell globally, and have a number of corporate functions located in Switzerland. When the Swiss franc strengthens against our other trading currencies, particularly the U.S. dollar and euro, our earnings go down. We also have significantly more sales in the euro than we do expenses. When the euro weakens against the U.S. dollar and Swiss franc, our earnings also go down. In January 2015, we entered into foreign currency forward contracts that reduce our exposure from the Swiss franc strengthening against the euro through 2016. The notional amount and average forward rate of our foreign currency forward contracts is Euro 86 million and 1.21 for contracts that mature in 2015, and Euro 67 million and 1.19 for contracts that mature in 2016, respectively. In September 2011, the Swiss National Bank established an exchange rate floor of 1.20 Swiss francs per euro which was abandoned in January 2015 after we entered into the previously mentioned foreign currency forward contracts. The Swiss National Bank's abandonment of the euro exchange rate floor resulted in an immediate strengthening of the Swiss franc against the euro and U.S. dollar. Absent these forward currency forward contracts, we estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $1.1 million to $1.3 million annually. We also estimate a 1% strengthening of the Swiss franc against the U.S. dollar would reduce our earnings before tax by approximately $0.5 million to $0.7 million annually in addition to the previously mentioned strengthening of the Swiss franc against the euro impact. We also conduct business in many geographies throughout the world, including Asia Pacific, the United Kingdom, Eastern Europe, Latin America, and Canada. Fluctuations in these currency exchange rates against the U.S. dollar can also affect our operating results. The most significant of these currency exposures is the Chinese Renminbi. The impact on our earnings before tax of the Chinese Renminbi weakening 1% against the U.S. dollar is a reduction of approximately $0.7 million to $0.9 million annually. 38 In addition to the effects of exchange rate movements on operating profits, our debt levels can fluctuate due to changes in exchange rates, particularly between the U.S. dollar and the Swiss franc. Based on our outstanding debt at December 31, 2014, we estimate that a 10% weakening of the U.S. dollar against the currencies in which our debt is denominated would result in an increase of approximately $2.3 million in the reported U.S. dollar value of our debt. Taxes We are subject to taxation in many jurisdictions throughout the world. Our effective tax rate and tax liability will be affected by a number of factors, such as the amount of taxable income in particular jurisdictions, the tax rates in such jurisdictions, tax treaties between jurisdictions, the extent to which we transfer funds between jurisdictions, earnings repatriations between jurisdictions, and changes in law. Generally, the tax liability for each taxpayer within the group is determined either (i) on a non- consolidated/non-combined basis or (ii) on a consolidated/combined basis only with other eligible entities subject to tax in the same jurisdiction, in either case without regard to the taxable losses of non- consolidated/non-combined affiliated legal entities. Environmental Matters We are subject to environmental laws and regulations in the jurisdictions in which we operate. We own or lease a number of properties and manufacturing facilities around the world. Like many of our competitors, we have incurred, and will continue to incur, capital and operating expenditures and other costs in complying with such laws and regulations. We are currently involved in, or have potential liability with respect to, the remediation of past contamination in certain of our facilities. A former subsidiary of Mettler-Toledo, LLC known as Hi-Speed Checkweigher Co., Inc. was one of two private parties ordered by the New Jersey Department of Environmental Protection, in an administrative consent order signed on June 13, 1988, to investigate and remediate certain ground water contamination at a property in Landing, New Jersey. After the other party under this order failed to fulfill its obligations, Hi-Speed became solely responsible for compliance with the order. Residual ground water contamination at this site is now within a Classification Exception Area which the Department of Environmental Protection has approved and within which the company oversees monitoring of the decay of contaminants of concern. A concurrent Well Restriction Area also exists for the site. The Department of Environmental Protection does not view these vehicles as remedial measures, but rather as “institutional controls” that must be adequately maintained and periodically evaluated. We estimate that the costs of compliance associated with the site over the next several years will approximate $0.4 million. In addition, certain of our present and former facilities have or had been in operation for many decades and, over such time, some of these facilities may have used substances or generated and disposed of wastes which are or may be considered hazardous. It is possible that these sites, as well as disposal sites owned by third parties to which we have sent wastes, may in the future be identified and become the subject of remediation. Although we believe that we are in substantial compliance with applicable environmental requirements and, to date, we have not incurred material expenditures in connection with environmental matters, it is possible that we could become subject to additional environmental liabilities in the future that could have a material adverse effect on our financial condition, results of operations or cash flows. 39 Inflation Inflation can affect the costs of goods and services that we use, including raw materials to manufacture our products. The competitive environment in which we operate limits somewhat our ability to recover higher costs through increased selling prices. Moreover, there may be differences in inflation rates between countries in which we incur the major portion of our costs and other countries in which we sell products, which may limit our ability to recover increased costs. We remain committed to operations in China and Eastern Europe, which have experienced inflationary conditions. To date, inflationary conditions have not had a material effect on our operating results. However, as our presence in China and Eastern Europe increases, these inflationary conditions could have a greater impact on our operating results. Quantitative and Qualitative Disclosures about Market Risk We have only limited involvement with derivative financial instruments and do not use them for trading purposes. We have entered into foreign currency forward contracts to economically hedge short-term intercompany balances with our international businesses on a monthly basis and to hedge certain forecasted intercompany sales. Such contracts limit our exposure to both favorable and unfavorable currency fluctuations. The net fair value of these contracts was a $0.2 million net loss at December 31, 2014. A sensitivity analysis to changes on these foreign currency-denominated contracts indicates that if the primary currency (primarily U.S. dollar, Swiss franc, and the euro) declined by 10%, the fair value of these instruments would increase by $6.2 million at December 31, 2014. Any resulting changes in fair value would be offset by changes in the underlying hedged balance sheet position. The sensitivity analysis assumes a parallel shift in foreign currency exchange rates. The assumption that exchange rates change in parallel fashion may overstate the impact of changing exchange rates on assets and liabilities denominated in a foreign currency. We also have other currency risks as described under “Effect of Currency on Results of Operations.” We have entered into certain interest rate swap agreements. These contracts are more fully described in Note 5 to our audited consolidated financial statements. The fair value of these contracts was a net loss of $3.8 million at December 31, 2014. Based on our agreements outstanding at December 31, 2014, a 100- basis-point increase in interest rates would result in an increase in the net aggregate market value of these instruments of $3.2 million. Conversely, a 100-basis-point decrease in interest rates would result in a $3.4 million decrease in the net aggregate market value of these instruments at December 31, 2014. Any change in fair value would not affect our consolidated statement of operations unless such agreements and the debt they hedge were prematurely settled. Critical Accounting Policies Management’s discussion and analysis of our financial condition and results of operations is based upon our audited consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to pensions and other post-retirement benefits, trade accounts receivable, inventories, intangible assets, income taxes, and revenue. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily 40 apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our audited consolidated financial statements. For a detailed discussion on the application of these and other accounting policies, see Note 2 to our audited consolidated financial statements. Employee benefit plans The net periodic pension cost for 2014 and projected benefit obligation as of December 31, 2014 were $3.5 million and $164.4 million, respectively, for our U.S. pension plan. The net periodic benefit for 2014 and projected benefit obligation as of December 31, 2014 were $0.4 million and $863.6 million, respectively, for our international pension plans. The net periodic post-retirement benefit for 2014 and expected post-retirement benefit obligation as of December 31, 2014 for our U.S. post-retirement medical benefit plan were $1.8 million and $3.8 million, respectively. Pension and post-retirement benefit plan expense and obligations are developed from assumptions utilized in actuarial valuations. The most significant of these assumptions include the discount rate and expected return on plan assets. In accordance with U.S. GAAP, actual results that differ from the assumptions are accumulated and deferred over future periods. While management believes the assumptions used are appropriate, differences in actual experience or changes in assumptions may affect our plan obligations and future expense. The expected rates of return on the various defined benefit pension plans’ assets are based on the asset allocation of each plan and the long-term projected return of those assets, which represent a diversified mix of U.S. and international corporate equities and government and corporate debt securities. In 2002, we froze our U.S. defined benefit pension plan and discontinued our retiree medical program for certain current and all future employees. Consequently, no significant future service costs will be incurred on these plans. For 2014, the weighted average return on assets assumption was 7.5% for the U.S. plan and 4.8% for the international plans. A change in the rate of return of 1% would impact annual benefit plan expense by approximately $6.7 million after tax. The discount rates for defined benefit and post-retirement plans are set by benchmarking against high-quality corporate bonds. For 2014, the average discount rate assumption was 4.0% for the U.S. plan and 1.7% for the international plans, representing a weighted average of local rates in countries where such plans exist. A change in the discount rate of 1% would impact annual benefit plan expense by approximately $10.6 million after tax. We made voluntary incremental funding payments of $18.0 million and $17.6 million in 2014 and 2013, respectively, to increase the funded status of our pension plans. In the future, we may make additional mandatory or discretionary contributions to our plans. Equity-based compensation We also have an equity incentive plan that provides for the grant of stock options, restricted stock, restricted stock units, and other equity-based awards which are accounted for and recognized in the consolidated statement of operations based on the grant-date fair value of the award. This methodology yields an estimate of fair value based in part on a number of management estimates, the most significant of which include future volatility and estimated option lives. Changes in these assumptions could significantly impact the estimated fair value of stock options. 41 Trade accounts receivable As of December 31, 2014, trade accounts receivable were $435.6 million, net of a $16.0 million allowance for doubtful accounts. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts represents our best estimate of probable credit losses in our existing trade accounts receivable. We determine the allowance based upon a review of both specific accounts for collection and the age of the accounts receivable portfolio. Inventories As of December 31, 2014, inventories were $204.5 million. We record our inventory at the lower of cost or net realizable value. Cost, which includes direct materials, labor and overhead, is generally determined using the first in, first out (FIFO) method. The estimated net realizable value is based on assumptions for future demand and related pricing. Adjustments to the cost basis of our inventory are made for excess and obsolete items based on usage, orders and technological obsolescence. If actual market conditions are less favorable than those projected by management, reductions in the value of inventory may be required. Goodwill and other intangible assets As of December 31, 2014, our consolidated balance sheet included goodwill of $444.1 million and other intangible assets of $112.8 million. Our business acquisitions typically result in goodwill and other intangible assets, which affect the amount of future period amortization expense and possible impairment expense. The determination of the value of such intangible assets requires management to make estimates and assumptions that affect our consolidated financial statements. In accordance with U.S. GAAP, our goodwill and indefinite-lived intangible assets are not amortized, but are evaluated for impairment annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that an asset might be impaired. The annual evaluation for goodwill and indefinite- lived intangible assets are generally based on an assessment of qualitative and quantitative factors to determine whether it is more likely than not that the fair value of the asset is less than its carrying amount. Both the qualitative and quantitative evaluations consider operating results, business plans, economic conditions, and market data, among other factors. There are inherent uncertainties related to these factors and our judgment in applying them to the impairment analyses. Our assessments to date have indicated that there has been no impairment of these assets and the estimated fair values of goodwill and indefinite- lived intangible assets significantly exceeds the carrying values. Should any of these estimates or assumptions change, or should we incur lower than expected operating performance or cash flows, including from a prolonged economic slowdown, we may experience a triggering event that requires a new fair value assessment for our reporting units, possibly prior to the required annual assessment. These types of events and resulting analysis could result in impairment charges for goodwill and other indefinite-lived intangible assets if the fair value estimate declines below the carrying value. Our amortization expense related to intangible assets with finite lives may materially change should our estimates of their useful lives change. 42 Income taxes Income tax expense, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect management’s assessment of estimated future taxes to be paid on items in the consolidated financial statements. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. While we have considered future taxable income and ongoing prudent and feasible tax planning strategies in assessing the need for the valuation allowance, in the event we were to determine that we would be able to realize our deferred tax assets in the future in excess of the net recorded amount, an adjustment to the deferred tax asset would increase income or equity in the period such determination was made. Likewise, should we determine that we would not be able to realize all or part of the net deferred tax asset in the future, an adjustment to the deferred tax asset would be charged to income in the period such determination was made. We plan to repatriate earnings from China, Switzerland, Germany, the United Kingdom, and certain other countries in future years and expect the only additional cost associated with the repatriation of such earnings outside the United States will be withholding taxes. All other undistributed earnings are considered permanently reinvested. The significant assumptions and estimates described in the preceding paragraphs are important contributors to our ultimate effective tax rate for each year in addition to our income mix from geographical regions. If any of our assumptions or estimates were to change, or should our income mix from our geographical regions change, our effective tax rate could be materially affected. Based on earnings before taxes of $445.0 million for the year ended December 31, 2014, each increase of $4.5 million in tax expense would increase our effective tax rate by 1%. Revenue recognition Revenue is recognized when title to a product has transferred and any significant customer obligations have been fulfilled. Standard shipping terms are generally FOB shipping point in most countries and, accordingly, title and risk of loss transfers upon shipment. In countries where title cannot legally transfer before delivery, the Company defers revenue recognition until delivery has occurred. The Company generally maintains the right to accept or reject a product return in its terms and conditions and also maintains appropriate accruals for outstanding credits. Shipping and handling costs charged to customers are included in total net sales and the associated expense is recorded in cost of sales for all periods presented. Other than a few small software applications, the Company does not sell software products without the related hardware instrument as the software is embedded in the instrument. The Company’s products typically require no significant production, modification or customization of the hardware or software that is essential to the functionality of the products. To the extent the Company’s solutions have a post-shipment obligation, such as customer acceptance, revenue is deferred until the obligation has been completed. The Company defers product revenue where installation is required, unless such installation is deemed perfunctory. The Company also sometimes enters into certain arrangements that require the separate delivery of multiple goods and/or services. These deliverables are accounted for separately if the deliverables have stand-alone value and the performance of undelivered items is probable and within the Company's control. The allocation of revenue between the separate deliverables is typically based on the relative selling price at the time of the sale in accordance with a number of factors including service technician billing rates, time to install, and geographic location. Further, certain products are also sold through indirect distribution channels whereby the distributor assumes any further obligations to the customer upon title transfer. Revenue is recognized on these products upon transfer of title and risk of loss to distributors. Distributor discounts are offset against revenue at the time such revenue is recognized. 43 Service revenue not under contract is recognized upon the completion of the service performed. Spare parts sold on a stand-alone basis are recognized upon title and risk of loss transfer which is generally at the time of shipment. Revenues from service contracts are recognized ratably over the contract period. These contracts represent an obligation to perform repair and other services including regulatory compliance qualification, calibration, certification, and preventative maintenance on a customer’s pre-defined equipment over the contract period. Service contracts are separately priced and payment is typically received from the customer at the beginning of the contract period. New Accounting Pronouncements See Note 2 to the audited consolidated financial statements. Item 7A. Quantitative and Qualitative Disclosures about Market Risk Discussion of this item is included in Management’s Discussion and Analysis of Financial Condition and Results of Operations. 44 Item 8. Financial Statements and Supplementary Data The financial statements required by this item are set forth starting on page F-1 and the related financial schedule is set forth on page S-1. Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure None. Item 9A. Controls and Procedures Conclusions Regarding the Effectiveness of Disclosure Controls and Procedures and Changes in Internal Control over Financial Reporting Under the supervision and with the participation of our management, including the Chief Executive Officer, Principal Financial Officer, and Principal Accounting Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer, Principal Financial Officer, and Principal Accounting Officer have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting during the quarter ended December 31, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Management’s Report on Internal Control over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the Company’s financial statements for external reporting purposes in accordance with accounting principles generally accepted in the United States of America. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2014. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework (2013). Based on our assessment, we concluded that, as of December 31, 2014, the Company’s internal control over financial reporting is effective. PricewaterhouseCoopers LLP, an independent registered public accounting firm that audited the financial statements included in this Report on Form 10-K, has issued an attestation in their report on our internal control over financial reporting which appears on page F-2. Item 9B. Other Information None. 45 PART III Item 10. Directors, Executive Officers, and Corporate Governance The executive officers of the Company are set forth below. Officers are appointed by the Board of Directors and serve at the discretion of the Board. Name Olivier A. Filliol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Age 48 William P. Donnelly . . . . . . . . . . . . . . . . . . . . . . . . . . Thomas Caratsch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Christian Magloth . . . . . . . . . . . . . . . . . . . . . . . . . . . . Michael Heidingsfelder . . . . . . . . . . . . . . . . . . . . . . . . Simon Kirk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Marc de La Guéronnière . . . . . . . . . . . . . . . . . . . . . . . Waldemar Rauch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53 56 49 54 55 51 52 President and Chief Executive Officer Position Executive Vice President Head of Laboratory Head of Human Resources Head of Industrial Head of Product Inspection Head of European and North American Market Organizations Head of Process Analytics Olivier A. Filliol has been a director since January 2009. He has been President and Chief Executive Officer of the Company since January 1, 2008. Mr. Filliol served as Head of Global Sales, Service, and Marketing of the Company from April 2004 to December 2007, and Head of Process Analytics of the Company from June 1999 to December 2007. From June 1998 to June 1999, he served as General Manager of the Company’s U.S. checkweighing operations. Prior to joining the Company, he was a Strategy Consultant with the international consulting firm Bain & Company, working in the Geneva, Paris, and Sydney offices. William P. Donnelly joined the Company in 1997 and has been Executive Vice President since January 2014. He previously served as Chief Financial Officer of the Company since 1997, except for a two-year period when he ran the Company’s Product Inspection and Pipette businesses. Mr. Donnelly is responsible for Investor Relations, Finance, Supply Chain Management, Information Technology, and the Company’s Blue Ocean Program. Thomas Caratsch has been Head of Laboratory of the Company since January 2008. From October 2007 to December 2007, he served as the Head of Business Development. Prior to joining the Company in October 2007, he held various management positions with Hoffmann La Roche from 1987 to March 2007, including General Manager of Roche Instrument Center AG / Tegimenta AG and Head of Disetronic Medical Systems AG from January 2003 to August 2006. Christian Magloth joined the Company in October 2010 and has been Head of Human Resources since December 2010. Prior to joining the Company, he served as Head of Human Resources of Straumann, a leading global medical devices company listed on the Swiss stock exchange, from April 2006 to September 2010. He previously served as Head of Human Resources at Hero Group, an international consumer foods company, and in various management positions at Hilti, a leading global construction supply company. Michael Heidingsfelder joined the Company in April 2012 as Head of Industrial Division. Prior to joining the Company, Mr. Heidingsfelder held various management positions within the Freudenberg Group from 2004 to March 2012 in Europe, Asia, and the Americas, including Chief Operating Officer, Americas, and General Manager, China. Previously, he was a Partner of Roland Berger Strategy Consultants in the U.S. and Europe. 46 Simon Kirk joined the Company in January 2012 as Head of Product Inspection. Previously he worked at Schindler where he served since 2008 as Chief Executive Officer of Jardine Schindler Group, a joint venture responsible for all of Schindler's operations in Southeast Asia. From 2004 until 2008, he was Vice President responsible for Eastern Europe at Schindler. He has also held various management positions at Eaton Corporation, Owens Corning, Imperial Chemical Industries, and British Railways Board. Marc de La Guéronnière has been Head of European Market Organizations of the Company since January 2008 and Head of North American Market Organizations since April 2014. He was Head of Region South and General Manager of the Company’s market organization in Spain from January 2006 to January 2008. He joined the Company in 2001 as the Industrial Business Area Manager for our market organization in France. Prior to joining the Company, Mr. de La Guéronnière held various management positions in Europe and the United States with ABB-Elsag Bailey and Danaher-Zellweger. Waldemar Rauch joined the Company in September 2000 as Head of our Ingold business. He has served as Operating Manager since March 2004, was named Head of Process Analytics Division in January 2008, and joined the Group Management Committee in July 2011. Prior to joining the Company, he worked in R&D at Siemens in Germany and held various technical management positions with Atomika Instruments in Germany as well as with Endress + Hauser Flowtec, a leading Swiss supplier of industrial measurement and automation equipment. Certifications Our Chief Executive Officer, Principal Financial Officer, and Principal Accounting Officer also provide certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 in connection with our quarterly and annual financial statement filings with the Securities and Exchange Commission. The certifications relating to this annual report are attached as Exhibits 31.1, 31.2, and 31.3. The remaining information called for by this item is incorporated by reference from the discussion in the sections “Proposal One: Election of Directors,” “Board of Directors — General Information,” “Board of Directors — Operation,” and “Additional Information — Section 16(a) Beneficial Ownership Reporting Compliance” in the 2015 Proxy Statement. Item 11. Executive Compensation The information appearing in the sections captioned “Board of Directors — General Information — Director Compensation,” “Compensation Discussion and Analysis,” “Compensation Committee Report,” and “Additional Information — Compensation Committee Interlocks and Insider Participation” in the 2015 Proxy Statement is incorporated by reference herein. Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters The information appearing in the section “Share Ownership” in the 2015 Proxy Statement is incorporated by reference herein. Information appearing in “Securities Authorized for Issuance under Equity Compensation Plans as of December 31, 2014” is included within Note 10 to the financial statements. 47 Item 13. Certain Relationships and Related Transactions and Director Independence Certain Relationships and Related Transactions — None. Director Independence — The information in the section “Board of Directors — General Information — Independence of the Board” in the 2015 Proxy Statement is incorporated by reference herein. Item 14. Principal Accounting Fees and Services Information appearing in the section “Audit Committee Report” in the 2015 Proxy Statement is hereby incorporated by reference. PART IV Item 15. Exhibits and Financial Statement Schedules (a) Exhibits, Financial Statements, and Schedules: 1. Financial Statements. See Index to Consolidated Financial Statements included on page F-1. 2. Financial Statement Schedule. See Schedule II, which is included on page S-1. 3. List of Exhibits. See Exhibit Index included on page E-1. 48 Pursuant to the requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SIGNATURES Date: February 6, 2015 Mettler-Toledo International Inc. (Registrant) By: /s/ Olivier A. Filliol Olivier A. Filliol President and Chief Executive Officer Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant as of the date set out above and in the capacities indicated. Signature Title /s/ Olivier A. Filliol Olivier A. Filliol /s/ William P. Donnelly William P. Donnelly /s/ Shawn P. Vadala Shawn P. Vadala /s/ Olivier A. Filliol Olivier A. Filliol /s/ Wah-Hui Chu Wah-Hui Chu /s/ Francis A. Contino Francis A. Contino /s/ Michael A. Kelly Michael A. Kelly /s/ Martin Madaus Martin Madaus /s/ Hans Ulrich Maerki Hans Ulrich Maerki /s/ George M. Milne George M. Milne /s/ Thomas P. Salice Thomas P. Salice /s/ Robert F. Spoerry Robert F. Spoerry President and Chief Executive Officer Executive Vice President (Principal Financial Officer) Chief Financial Officer (Principal Accounting Officer) Director Director Director Director Director Director Director Director Director 49 EXHIBIT INDEX Description Amended and Restated Certificate of Incorporation of the Company(1) Amended By-laws of the Company, effective as of July 23, 2009(2) Exhibit No. 3.1 3.2 10.1 Credit Agreement among Mettler-Toledo International Inc., certain of its subsidiaries, JPMorgan Chase Bank, N.A., J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated, and certain other financial institutions, dated as of November 26, 2013(3) 10.11 Note Purchase Agreement dated as of June 25, 2009 by and among Mettler-Toledo International Inc. and Connecticut General Life Insurance Company, The Lincoln National Life Insurance Company, Lincoln Life & Annuity Company of New York, Massachusetts Mutual Life Insurance Company, C.M. Life Insurance Company, MassMutual Asia Limited, American Investors Life Insurance Company, Aviva Life and Annuity Company, Bankers Life and Casualty Company, Conseco Life Insurance Company, Conseco Health Insurance Company and Colonial Penn Life Insurance Company(4) 10.12 Note Purchase Agreement dated as of October 10, 2012 by and among Mettler-Toledo International Inc., Massachusetts Mutual Life Insurance Company, C.M. Life Insurance Company, MassMutual Asia Limited, The Lincoln National Life Insurance Company, Lincoln Life & Annuity Company of New York and Aviva Life and Annuity Company Royal Neighbors of America.(5) 10.13 Note Purchase Supplement dated July 29, 2013 by and among Mettler-Toledo International Inc., Aviva Life and Annuity Company and Teachers Insurance and Annuity Association of America to a Note Purchase Agreement dated October 10, 2012 by and among Mettler-Toledo International Inc., Massachusetts Mutual Life Insurance Company, C.M. Life Insurance Company, MassMutual Asia Limited, The Lincoln National Life Insurance Company, Lincoln Life & Annuity Company of New York and Aviva Life and Annuity Company Royal Neighbors of America(6) 10.14 Note Purchase Agreement dated as of June 27, 2014 by and among Mettler-Toledo International Inc., Babson Capital Management LLC, Cigna Investments, Inc. and Teachers Insurance and Annuity Association of America. (7) 10.20 Mettler-Toledo International Inc. 2004 Equity Incentive Plan(8) 10.21 Mettler-Toledo International Inc. 2007 Share Plan, effective February 7, 2008(9) 10.22 Mettler-Toledo International Inc. 2013 Equity Incentive Plan(10) 10.31 Regulations of the POBS PLUS — Incentive Scheme for Senior Management of Mettler Toledo, effective as of November, 2006(11) 10.32 Regulations of the POBS PLUS — Incentive Scheme for Members of the Group Management of Mettler Toledo, effective as of January, 2009(11) 10.50 Employment Agreement between Thomas Caratsch and Mettler-Toledo International Inc., dated as of December 4, 2007(9) 10.51 Employment Agreement between Marc de La Guéronnière and Mettler-Toledo International Inc., dated as of January 27, 2011(12) 10.52 Employment Agreement between William Donnelly and Mettler-Toledo GmbH, dated as of November 10, 1997(1) 10.53 Employment Agreement between Olivier Filliol and Mettler-Toledo International Inc., dated as of November 1, 2007(13) 10.54 Employment Agreement between Michael Heidingsfelder and Mettler-Toledo International Inc., dated as of November 30, 2011 (16) 10.55 Employment Agreement between Simon Kirk and Mettler-Toledo International Inc., dated as of November 28, 2011(16) 10.56 Employment Agreement between Christian Magloth and Mettler-Toledo International Inc., dated as of March 22, 2010(12) 10.57 Employment Agreement between Waldemar Rauch and Mettler-Toledo International Inc., dated as of June 10, 2011(15) 10.58 Employment Agreement between Robert Spoerry and Mettler-Toledo International Inc., dated as of November 1, 2007(13) 10.59 Form of Tax Equalization Agreement between Messrs. Caratsch, Filliol, Spoerry, and Kirk and Mettler-Toledo International Inc., dated October 10, 2007(9) Subsidiaries of the Company 21 23.1* Consent of PricewaterhouseCoopers LLP E-1 Exhibit No. 31.1* 31.2* 31.3* 32* Description Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Certification of the Executive Vice President Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 101.INS XBRL Instance Document 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.LAB XBRL Taxonomy Extension Label Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document 101.DEF XBRL Taxonomy Extension Definition Linkbase Document _______________________________________ (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) * Incorporated by reference to the Company’s Report on Form 10-K dated March 13, 1998 Incorporated by reference to the Company’s Report on Form 8-K dated July 24, 2009 Incorporated by reference to the Company’s Report on Form 8-K dated November 26, 2013 Incorporated by reference to the Company’s Report on Form 8-K dated June 25, 2009 Incorporated by reference to the Company's Report on Form 8-K dated October 16, 2012 Incorporated by reference to the Company's Report on Form 8-K dated July 29, 2013 Incorporated by reference to the Company's Report on Form 8-K dated July 2, 2014 Incorporated by reference to the Company’s Form DEF 14-A filed March 29, 2004 Incorporated by reference to the Company’s Report on Form 10-K dated February 15, 2008 Incorporated by reference to the Company's Registration Statement on Form S-8 dated July 26, 2013 (Reg. No. 333-190181) Incorporated by reference to the Company’s Report on Form 10-K dated February 13, 2009 Incorporated by reference to the Company's Report on Form 10-K dated February 16, 2010 Incorporated by reference to the Company’s Report on Form 8-K dated November 1, 2007 Incorporated by reference to the Company’s Report on Form 10-K dated March 4, 2002 Incorporated by reference to the Company's Report on Form 10-K dated February 13, 2012 Incorporated by reference to the Company's Report on Form 10-K dated February 8, 2013 Filed herewith E-2 METTLER-TOLEDO INTERNATIONAL INC. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Report of Independent Registered Public Accounting Firm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F-2 Consolidated Statements of Operations for the years ended December 31, 2014, 2013 and 2012 . . . . . . . . . . . . . . . . . . . . F-3 Consolidated Statements of Comprehensive Income for the years ended December 31, 2014, 2013 and 2012. . . . . . . . . . F-4 Consolidated Balance Sheets as of December 31, 2014 and 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F-5 Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2014, 2013 and 2012. . . . . . . . . . . . F-6 Consolidated Statements of Cash Flows for the years ended December 31, 2014, 2013 and 2012 . . . . . . . . . . . . . . . . . . . F-7 Notes to the Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F-8 Page F - 1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Shareholders of Mettler-Toledo International Inc. In our opinion, the consolidated financial statements listed in the index appearing on page F-1 present fairly, in all material respects, the financial position of Mettler-Toledo International Inc. at December 31, 2014 and December 31, 2013, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2014 in conformity with accounting principles generally accepted in the United States of America. In addition, in our opinion, the financial statement schedule appearing on page S-1 presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for these financial statements and financial statement schedule, for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on these financial statements, on the financial statement schedule, and on the Company’s internal control over financial reporting based on our integrated audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. /s/ PricewaterhouseCoopers LLP PricewaterhouseCoopers LLP Columbus, Ohio February 6, 2015 F - 2 METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS For the years ended December 31 (In thousands, except share data) Net sales Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Service . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cost of sales Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Service . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Research and development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Selling, general, and administrative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Restructuring charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other charges (income), net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Earnings before taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision for taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2014 2013 2012 1,930,497 $ 1,860,893 $ 1,852,192 555,486 2,485,983 518,079 2,378,972 489,336 2,341,528 809,537 317,696 795,225 301,816 811,204 289,269 1,358,750 1,281,931 1,241,055 123,297 728,582 29,185 24,537 5,915 2,230 445,004 106,763 116,346 692,693 24,539 22,711 19,830 3,103 402,709 96,615 112,530 684,026 21,357 22,764 16,687 1,090 382,601 91,754 Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 338,241 $ 306,094 $ 290,847 Basic earnings per common share: Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Weighted average number of common shares . . . . . . . . . . . . . . . . . . . . . . . 11.71 $ 10.22 $ 9.37 28,890,771 29,945,954 31,044,532 Diluted earnings per common share: Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Weighted average number of common and common equivalent shares. . . . 11.44 $ 9.96 $ 9.14 29,571,308 30,728,482 31,824,077 The accompanying notes are an integral part of these consolidated financial statements. F - 3 METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME For the years ended December 31 (In thousands, except share data) 2014 2013 2012 Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 338,241 $ 306,094 $ 290,847 Other comprehensive income (loss), net of tax: Foreign currency translation adjustment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Unrealized gains (losses) on cash flow hedging arrangements: (82,875) 21,903 15,641 Unrealized gains (losses). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Effective portion of (gains) losses included in net earnings . . . . . . . . . . . . . . . . . . (768) 1,257 (491) 3,496 (1,748) 2,029 Defined benefit pension and post-retirement plans: Net actuarial gains (losses) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Plan amendments and prior service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (106,837) 1,607 Amortization of actuarial (gains) losses and plan amendments and prior service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Impact of foreign currency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total other comprehensive income (loss), net of tax . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,614 8,089 (177,913) 30,381 2,371 6,775 (2,010) 62,425 (46,792) 18,017 4,261 (1,931) (10,523) Comprehensive income. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 160,328 $ 368,519 $ 280,324 The accompanying notes are an integral part of these consolidated financial statements. F - 4 METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED BALANCE SHEETS As of December 31 (In thousands, except share data) ASSETS 2014 2013 Current assets: Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Trade accounts receivable, less allowances of $15,961 in 2014 and $14,856 in 2013 . . . . . . Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Current deferred tax assets, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other current assets and prepaid expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Property, plant, and equipment, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other intangible assets, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-current deferred tax assets, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other non-current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Trade accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Accrued and other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accrued compensation and related items. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred revenue and customer prepayments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Taxes payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Current deferred tax liabilities, net. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Short-term borrowings and current maturities of long-term debt . . . . . . . . . . . . . . . . . . . . . . Total current liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-current deferred tax liabilities, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other non-current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total liabilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commitments and contingencies (Note 15) Shareholders’ equity: $ $ $ 85,263 435,648 204,531 62,341 61,647 849,430 511,462 444,085 112,784 30,273 61,076 2,009,110 145,896 120,530 136,107 82,219 59,297 18,677 116,164 678,890 335,790 56,727 218,108 1,289,515 111,874 466,703 210,414 57,934 67,062 913,987 514,438 455,842 114,418 24,121 130,013 2,152,819 145,993 116,831 123,493 83,083 61,502 16,219 17,067 564,188 395,960 64,449 193,170 1,217,767 Preferred stock, $0.01 par value per share; authorized 10,000,000 shares . . . . . . . . . . . . . . . Common stock, $0.01 par value per share; authorized 125,000,000 shares; issued 44,786,011 and 44,786,011 shares, outstanding 28,243,007 and 29,487,075 shares at December 31, 2014 and 2013, respectively . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Additional paid-in capital. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Treasury stock at cost (16,543,004 and 15,298,936 shares at December 31, 2014 and 2013, respectively) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accumulated other comprehensive income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total shareholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total liabilities and shareholders’ equity. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — — 448 670,418 448 653,250 (2,095,656) 2,357,334 (212,949) 719,595 2,009,110 $ (1,721,030) 2,037,420 (35,036) 935,052 2,152,819 The accompanying notes are an integral part of these consolidated financial statements. F - 5 METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY For the years ended December 31 (In thousands, except share data) Common Stock Shares Amount Additional Paid-In Capital Treasury Stock Retained Earnings Accumulated Other Comprehensive Income (Loss) Total Balance at December 31, 2011 . . . . . . . . . . . . . . . . . 31,590,101 $ 448 $ 616,202 $ (1,225,125) $ 1,476,550 $ (86,938) $ 781,137 Exercise of stock options and restricted stock units . 457,732 Repurchases of common stock . . . . . . . . . . . . . . . . . (1,637,827) Tax benefit resulting from exercise of certain employee stock options . . . . . . . . . . . . . . . . . . . . Share-based compensation . . . . . . . . . . . . . . . . . . . . Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other comprehensive income (loss), net of tax . . . . — — — — — — — — — — — — 9,318 13,185 — — 39,873 (17,946) (278,672) — — — — — — — 290,847 — — 21,927 — (278,672) — — 9,318 13,185 — 290,847 (10,523) (10,523) Balance at December 31, 2012 . . . . . . . . . . . . . . . . . 30,410,006 $ 448 $ 638,705 $ (1,463,924) $ 1,749,451 $ (97,461) $ 827,219 Exercise of stock options and restricted stock units . 398,646 Repurchases of common stock . . . . . . . . . . . . . . . . . (1,321,577) Tax benefit resulting from exercise of certain employee stock options . . . . . . . . . . . . . . . . . . . . Share-based compensation . . . . . . . . . . . . . . . . . . . . Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other comprehensive income (loss), net of tax . . . . — — — — — — — — — — — — 1,906 12,639 — — 37,870 (18,125) (294,976) — — — — — — — 306,094 — — 19,745 — (294,976) — — 1,906 12,639 — 306,094 62,425 62,425 Balance at December 31, 2013 . . . . . . . . . . . . . . . . . 29,487,075 $ 448 $ 653,250 $ (1,721,030) $ 2,037,420 $ (35,036) $ 935,052 Exercise of stock options and restricted stock units . 373,431 Repurchases of common stock . . . . . . . . . . . . . . . . . (1,617,499) Tax benefit resulting from exercise of certain employee stock options . . . . . . . . . . . . . . . . . . . . Share-based compensation . . . . . . . . . . . . . . . . . . . . Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other comprehensive income (loss), net of tax . . . . — — — — — — — — — — — — 3,557 13,611 — — 39,374 (18,327) (414,000) — — — — — — — 338,241 — — 21,047 — (414,000) — — 3,557 13,611 — 338,241 (177,913) (177,913) Balance at December 31, 2014 . . . . . . . . . . . . . . . . . 28,243,007 $ 448 $ 670,418 $ (2,095,656) $ 2,357,334 $ (212,949) $ 719,595 The accompanying notes are an integral part of these consolidated financial statements. F - 6 METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF CASH FLOWS For the years ended December 31 (In thousands) Cash flows from operating activities: Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 338,241 $ 306,094 $ 290,847 2014 2013 2012 Adjustments to reconcile net earnings to net cash provided by operating activities: Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred tax provision . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Excess tax benefits from share-based payment arrangements . . . . . . . . . . . . . . . Share-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Increase (decrease) in cash resulting from changes in: Trade accounts receivable, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Trade accounts payable. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Taxes payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accruals and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net cash provided by operating activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash flows from investing activities: Proceeds from sale of property, plant, and equipment. . . . . . . . . . . . . . . . . . . . . . . . Purchase of property, plant, and equipment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acquisitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net cash used in investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash flows from financing activities: Proceeds from borrowings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Repayments of borrowings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Proceeds from exercise of stock options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Repurchases of common stock. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Excess tax benefits from share-based payment arrangements. . . . . . . . . . . . . . . . . . Acquisition contingent consideration paid. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Debt issuance costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other financing activities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net cash provided by (used in) financing activities . . . . . . . . . . . . . . . . . . . . Effect of exchange rate changes on cash and cash equivalents . . . . . . . . . . . . . . . . . . Net increase (decrease) in cash and cash equivalents. . . . . . . . . . . . . . . . . . . . . . . . . . Cash and cash equivalents: 33,617 29,185 13,033 (3,557) 13,611 211 7,492 (9,302) 4,392 6,298 1,868 (16,177) 418,912 728 (89,388) (5,784) (94,444) 628,832 (585,867) 21,047 (414,000) 3,557 (859) (941) 123 (348,108) (2,971) (26,611) 34,765 24,539 8,816 (1,847) 12,639 498 (28,995) (8,484) 1,606 295 (3,540) (458) 345,928 211 (82,349) (2,661) (84,799) 556,059 (531,045) 19,745 (294,976) 1,847 — (1,522) (1,224) 33,421 21,357 5,420 (9,365) 13,185 1,455 (8,760) 46,831 3,583 (27,881) 7,482 (49,871) 327,704 426 (95,588) (2,098) (97,260) 445,425 (563,109) 21,927 (278,672) 9,365 (325) (363) (645) (251,116) (366,397) 159 10,172 2,054 (133,899) 235,601 101,702 Beginning of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111,874 101,702 End of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 85,263 $ 111,874 $ Supplemental disclosures of cash flow information: Cash paid during the year for: Interest. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 23,219 95,143 $ $ 16,998 83,200 $ $ 19,252 78,009 The accompanying notes are an integral part of these consolidated financial statements. F - 7 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (In thousands, except share data, unless otherwise stated) 1. BUSINESS DESCRIPTION AND BASIS OF PRESENTATION Mettler-Toledo International Inc. (“Mettler-Toledo” or the “Company”) is a leading global supplier of precision instruments and services. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics, and food retailing applications. The Company also manufactures several related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development. In addition, the Company manufactures metal detection and other end-of-line inspection systems used in production and packaging and provides solutions for use in certain process analytics applications. The Company’s primary manufacturing facilities are located in China, Switzerland, the United States, Germany, and the United Kingdom. The Company’s principal executive offices are located in Columbus, Ohio and Greifensee, Switzerland. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include all entities in which the Company has control, which are its wholly-owned subsidiaries. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results may differ from those estimates. All intercompany transactions and balances have been eliminated. Certain reclassifications have been made to prior year amounts to conform to the current year presentation. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Cash and Cash Equivalents Cash and cash equivalents include highly liquid investments with original maturity dates of three months or less. The carrying value of these cash equivalents approximates fair value. Trade Accounts Receivable Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts represents the Company’s best estimate of probable credit losses in its existing trade accounts receivable. The Company determines the allowance based upon a review of both specific accounts for collection and the age of the accounts receivable portfolio. Inventories Inventories are valued at the lower of cost or net realizable value. Cost, which includes direct materials, labor, and overhead, is generally determined using the first in, first out (FIFO) method. The estimated net realizable value is based on assumptions for future demand and related pricing. Adjustments to the cost basis of the Company’s inventory are made for excess and obsolete items based on usage, orders, and technological obsolescence. If actual market conditions are less favorable than those projected by management, reductions in the value of inventory may be required. F - 8 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) Long-Lived Assets a) Property, Plant, and Equipment Property, plant, and equipment are stated at cost less accumulated depreciation. Repair and maintenance costs are charged to expense as incurred. The Company expenses all internal-use software costs incurred in the preliminary project stage and capitalizes certain direct costs associated with the development and purchase of internal-use software within property, plant, and equipment. Capitalized costs are amortized on a straight-line basis over the estimated useful lives of the software, generally not exceeding 10 years. Depreciation and amortization are charged on a straight-line basis over the estimated useful lives of the assets as follows: Buildings and improvements. . . . . . . . . . . . . . . . . . . 15 to 50 years Machinery and equipment. . . . . . . . . . . . . . . . . . . . . 3 to 12 years Computer software . . . . . . . . . . . . . . . . . . . . . . . . . . 3 to 10 years Leasehold improvements. . . . . . . . . . . . . . . . . . . . . . Shorter of useful life or lease term b) Goodwill and Other Intangible Assets Goodwill, representing the excess of purchase price over the net asset value of companies acquired, and indefinite-lived intangible assets are not amortized, but are reviewed for impairment annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that an asset might be impaired. The annual evaluation for goodwill and indefinite-lived intangible assets are generally based on an assessment of qualitative and quantitative factors to determine whether it is more likely than not that the fair value of the asset is less than its carrying amount. Other intangible assets include indefinite-lived assets and assets subject to amortization. Where applicable, amortization is charged on a straight-line basis over the expected period of benefit. The straight-line method of amortization reflects an appropriate allocation of the cost of the intangible assets to earnings in proportion to the amount of economic benefits obtained by the Company in each reporting period. The Company assesses the initial acquisition of intangible assets in accordance with the provisions of ASC 805 "Business Combinations" and the continued accounting for previously recognized intangible assets and goodwill in accordance with the provisions of ASC 350 "Intangible - Goodwill and Other" and ASC 360 "Property, Plant, and Equipment." Accounting for Impairment of Long-Lived Assets The Company assesses the need to record impairment losses on long-lived assets with finite lives when events or changes in circumstances indicate that the carrying amount of assets may not be recoverable. An impairment loss would be recognized when future estimated undiscounted cash flows expected to result from use of the asset are less than the asset’s carrying value, with the loss measured as the difference between carrying value and fair value. Taxation The Company files tax returns in each jurisdiction in which it operates. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities, their respective tax bases, and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates in the F - 9 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) respective jurisdictions in which the Company operates. In assessing the ability to realize deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred taxes are not provided on the unremitted earnings of subsidiaries outside of the United States when it is expected that these earnings are permanently reinvested. Such earnings may become taxable upon the sale or liquidation of these subsidiaries or upon the remittance of dividends. Deferred taxes are provided when the Company no longer considers subsidiary earnings to be permanently invested, such as in situations where the Company’s subsidiaries plan to make future dividend distributions. The Company recognizes accrued amounts of interest and penalties related to its uncertain tax positions as part of income tax expense within its consolidated statement of operations. Currency Translation and Transactions The reporting currency for the consolidated financial statements of the Company is the U.S. dollar. The functional currency for the Company’s operations is generally the applicable local currency. Accordingly, the assets and liabilities of companies whose functional currency is other than the U.S. dollar are included in the consolidated financial statements by translating the assets and liabilities into the reporting currency at the exchange rates applicable at the end of the reporting period. The statements of operations and cash flows of such non-U.S. dollar functional currency operations are translated at the monthly average exchange rates during the year. Translation gains or losses are accumulated in other comprehensive income (loss) in the consolidated statements of shareholders’ equity. Transaction gains and losses are included as a component of net earnings. Revenue Recognition Revenue is recognized when title to a product has transferred and any significant customer obligations have been fulfilled. Standard shipping terms are generally FOB shipping point in most countries and, accordingly, title and risk of loss transfers upon shipment. In countries where title cannot legally transfer before delivery, the Company defers revenue recognition until delivery has occurred. The Company generally maintains the right to accept or reject a product return in its terms and conditions and also maintains appropriate accruals for outstanding credits. Shipping and handling costs charged to customers are included in total net sales and the associated expense is recorded in cost of sales for all periods presented. Other than a few small software applications, the Company does not sell software products without the related hardware instrument as the software is embedded in the instrument. The Company’s products typically require no significant production, modification or customization of the hardware or software that is essential to the functionality of the products. To the extent the Company’s solutions have a post-shipment obligation, such as customer acceptance, revenue is deferred until the obligation has been completed. The Company defers product revenue where installation is required, unless such installation is deemed perfunctory. The Company also sometimes enters into certain arrangements that require the separate delivery of multiple goods and/or services. These deliverables are accounted for separately if the deliverables have stand-alone value and the performance of undelivered items is probable and within the Company's control. The allocation of revenue between the separate deliverables is typically based on the relative selling price at the time of the sale in accordance with a number of factors including service technician billing rates, time to install, and geographic location. Further, certain products are also sold through indirect distribution channels whereby the distributor assumes any further obligations to the customer upon title transfer. Revenue is recognized on these F - 10 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) products upon transfer of title and risk of loss to its distributors. Distributor discounts are offset against revenue at the time such revenue is recognized. Service revenue not under contract is recognized upon the completion of the service performed. Spare parts sold on a stand-alone basis are recognized upon title and risk of loss transfer which is generally at the time of shipment. Revenues from service contracts are recognized ratably over the contract period. These contracts represent an obligation to perform repair and other services including regulatory compliance qualification, calibration, certification, and preventative maintenance on a customer’s pre-defined equipment over the contract period. Service contracts are separately priced and payment is typically received from the customer at the beginning of the contract period. Research and Development Research and development costs primarily consist of salaries, consulting, and other costs. The Company expenses these costs as incurred. Warranty The Company generally offers one-year warranties on most of its products. Product warranties are recorded at the time revenue is recognized. While the Company engages in extensive product quality programs and processes, its warranty obligation is affected by product failure rates, material usage, and service costs incurred in correcting a product failure. Employee Termination Benefits In situations where contractual termination benefits exist, the Company records accruals for employee termination benefits when it is probable that a liability has been incurred and the amount of the liability is reasonably estimable. All other employee termination arrangements are recognized and measured at their fair value at the communication date unless the employee is required to render additional service beyond the legal notification period, in which case the liability is recognized ratably over the future service period. Earnings per Common Share In accordance with the treasury stock method, the Company has included 680,537, 782,528, and 779,545 common equivalent shares in the calculation of diluted weighted average number of common shares for the years ended December 31, 2014, 2013, and 2012, respectively, relating to outstanding stock options and restricted stock units. Outstanding options and restricted stock units to purchase or receive 127,995, 23,951, and 241,205 shares of common stock for the years ended December 31, 2014, 2013, and 2012, respectively, have been excluded from the calculation of diluted weighted average number of common and common equivalent shares as such options and restricted stock units would be anti-dilutive. Equity-Based Compensation The Company applies the fair value methodology in accounting for its equity-based compensation plan. F - 11 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) Derivative Financial Instruments The Company has limited involvement with derivative financial instruments and does not use them for trading purposes. As described more fully in Note 4, the Company enters into foreign currency forward exchange contracts to economically hedge certain short-term intercompany balances involving its international businesses. Such contracts limit the Company’s exposure to currency fluctuations on the items they hedge. These contracts are adjusted to fair market value as of each balance sheet date, with the resulting changes in fair value being recognized in other charges (income), consistent with the underlying hedged item. The Company also enters into foreign currency forward contracts, designated as cash flow hedges, to hedge certain forecasted sales. Such contracts limit the Company’s exposure to currency fluctuations on the items they hedge. Changes in fair value of outstanding foreign currency forward contract agreements that are effective as cash flow hedges are recognized in other comprehensive income as incurred. The Company also enters into interest rate swap agreements in order to manage its exposure to changes in interest rates. The differential paid or received on interest rate swap agreements is recognized in interest expense over the life of the agreements as incurred. Floating to fixed interest rate swap agreements are accounted for as cash flow hedges. Changes in fair value of outstanding interest rate swap agreements that are effective as cash flow hedges are recognized in other comprehensive income as incurred. Fair Value Measurements The Company measures or monitors certain assets and liabilities on a fair value basis. Fair value is used on a recurring basis for assets and liabilities in which fair value is the primary basis of accounting, mainly derivative instruments. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability. The Company applies the fair value hierarchy established under U.S. GAAP and when possible looks to active and observable markets to price identical assets and liabilities. If identical assets and liabilities are not traded in active markets, the Company looks to market observable data for similar assets and liabilities. Recent Accounting Pronouncements In May 2014, the FASB issued ASU 2014-09, to ASC 606 "Revenue from Contracts with Customers." ASU 2014-09 provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. GAAP. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. Additionally, the guidance requires improved disclosure to help users of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized. The guidance becomes effective for the Company for the year beginning January 1, 2017. The Company is currently evaluating the impact the adoption of this guidance will have on the consolidated results of operations, financial position, and disclosures. In July 2014, the Company adopted ASU 2013-11 "Income Taxes." The amendment provided further guidance to the balance sheet presentation of unrecognized tax benefit when a net operating loss or F - 12 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) similar tax loss carryforward, or a tax credit carryforward exists. The adoption of this guidance did not have a material impact to the Company's consolidated results of operations or financial position. 3. INVENTORIES Inventory consisted of the following at December 31: Raw materials and parts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Work-in-progress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Finished goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97,969 $ 34,973 71,589 98,244 38,061 74,109 2014 2013 $ 204,531 $ 210,414 4. FINANCIAL INSTRUMENTS The Company has limited involvement with derivative financial instruments and does not use them for trading purposes. As described below, the Company enters into certain interest rate swap agreements in order to manage its exposure to changes in interest rates. At December 31, 2014, the interest payments associated with 94% of the Company's debt are fixed obligations. The amount of the Company's fixed obligation interest payments may change based upon the expiration dates of its interest rate swap agreement and the level and composition of its debt. The Company also enters into foreign currency forward contracts to limit the Company's exposure to currency fluctuations on the respective hedged items. Cash Flow Hedges In July 2012, the Company began entering into foreign currency forward contracts, designated as cash flow hedges, to hedge certain forecasted intercompany sales denominated in euro with its Swiss- based business. The notional amount and average forward rate of foreign currency forward contracts outstanding at December 31, 2014 and 2013 were $87 million (Euro 72 million) and 1.21 for contracts that mature in 2015 and $78 million (Euro 57 million) and 1.23 for contracts that matured in 2014, respectively. In January 2015 we increased the notional amount of the Company's cash flow hedges to a total notional value and average forward rate of Euro 86 million and 1.21 for contracts that mature in 2015, and Euro 67 million and 1.19 for contracts that mature in 2016, prior to the Swiss National Bank's abandonment of its previously established exchange rate floor of 1.20 Swiss francs per euro. The Company has an interest rate swap agreement designated as a cash flow hedge. The agreement is a forward-starting swap which has the effect of changing the floating rate LIBOR-based interest payments associated with $100 million in forecasted borrowings under the Company’s credit facility to a fixed obligation of 3.24% beginning in October 2010. In June 2013, the Company entered into a forward starting interest rate swap agreement, designated as a cash flow hedge. The agreement will change the floating rate LIBOR-based interest payments associated with $50 million in forecasted borrowings under the Company's credit agreement to a fixed obligation of 2.52% beginning in October 2015. The cash flow hedges are recorded gross at fair value in the consolidated balance sheet at December 31, 2014 and 2013, respectively, and disclosed in Note 5 to the consolidated financial statements. Amounts reclassified into other comprehensive income and the effective portions of the cash flow hedges are further disclosed in Note 9 to the consolidated financial statements. A derivative loss of F - 13 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) $1.2 million based upon interest rates and foreign currency rates at December 31, 2014, is expected to be reclassified from other comprehensive income (loss) to earnings in the next 12 months. Through December 31, 2014, no hedge ineffectiveness has occurred in relation to the cash flow hedges. Other Derivatives The Company enters into foreign currency forward contracts in order to economically hedge short- term intercompany balances largely denominated in Swiss franc, other major European currencies, and the Chinese Renminbi with its foreign businesses. In accordance with U.S. GAAP, these contracts are considered “derivatives not designated as hedging instruments.” Gains or losses on these instruments are reported in current earnings. The foreign currency forward contracts are recorded at fair value in the consolidated balance sheet at December 31, 2014 and 2013, respectively, disclosed in Note 5 to the consolidated financial statements. The Company recognized in other charges (income), a net loss of $3.5 million during the year ended December 31, 2014. At December 31, 2014 and 2013, these contracts had a notional value of $325.4 million and $180.3 million, respectively. The Company may be exposed to credit losses in the event of nonperformance by the counterparties to its derivative financial instrument contracts. Counterparties are established banks and financial institutions with high credit ratings. The Company believes that such counterparties will be able to fully satisfy their obligations under these contracts. 5. FAIR VALUE MEASUREMENTS At December 31, 2014 and 2013, the Company had derivative assets totaling $2.2 million and $2.3 million, respectively, and derivative liabilities totaling $5.6 million and $5.8 million, respectively. The fair values of the interest rate swap agreements, foreign currency forward contracts designated as cash flow hedges and foreign currency forward contracts that economically hedge short-term intercompany balances are estimated based upon inputs from current valuation information obtained from dealer quotes and priced with observable market assumptions and appropriate valuation adjustments for credit risk. The Company has evaluated the valuation methodologies used to develop the fair values by dealers in order to determine whether such valuations are representative of an exit price in the Company’s principal market. In addition, the Company uses an internally developed model to perform testing on the valuations received from brokers. The Company has also considered both its own credit risk and counterparty credit risk in determining fair value and determined these adjustments were insignificant for the years ended December 31, 2014 and 2013. The Company had $14.2 million and $16.9 million of cash equivalents at December 31, 2014 and 2013, respectively, the fair value of which is determined through quoted and corroborated prices in active markets. The fair value of cash equivalents approximates cost. The fair value of the Company's fixed interest rate debt was estimated using Level 2 inputs, primarily discounted cash flow models, based on estimated current rates offered for similar debt under current market conditions for the Company. The fair value of the Company's debt exceeds the carrying value by approximately $17.8 million and $4.2 million at December 31, 2014 and 2013, respectively. Under U.S. GAAP, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement consists of observable and unobservable inputs that reflect the assumptions that a market participant would use in pricing an asset or liability. F - 14 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) A fair value hierarchy has been established that categorizes these inputs into three levels: Level 1: Quoted prices in active markets for identical assets and liabilities Level 2: Observable inputs other than quoted prices in active markets for identical assets and liabilities Level 3: Unobservable inputs The following table presents for each of these hierarchy levels, the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2014 and 2013: December 31, 2014 December 31, 2013 Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Assets: Cash equivalents . . . . . . . . . . . . . . . . . . $ 14,188 — Interest rate swap agreement. . . . . . . . . Foreign currency forward contracts designated as cash flow hedges . . . . . Foreign currency forward contracts not designated as hedging instrument . . . 1,611 Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 16,366 567 Liabilities: Interest rate swap agreements . . . . . . . . $ 2,484 Foreign currency forward contracts designated as cash flow hedges . . . . . Foreign currency forward contracts not designated as hedging instrument . . . 1,799 Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 5,567 1,284 $ — $ 14,188 $ — $ 16,868 $ — $ 16,868 $ — — — — — 567 1,611 — — — 1,269 268 719 — — — 1,269 268 719 — — — $ — $ 16,366 $ — $ 19,124 $ — $ 19,124 $ — $ — $ 2,484 $ — $ 5,312 $ — $ 5,312 $ — — — 1,284 1,799 — — 103 355 — — 103 355 — — $ — $ 5,567 $ — $ 5,770 $ — $ 5,770 $ — 6. PROPERTY, PLANT, AND EQUIPMENT, NET Property, plant, and equipment, net consisted of the following at December 31: Land Building and leasehold improvements Machinery and equipment Computer software Less accumulated depreciation and amortization 2014 2013 $ 51,123 $ 210,008 345,888 327,753 934,772 (423,310) 511,462 $ $ 56,214 212,277 361,978 302,681 933,150 (418,712) 514,438 F - 15 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) 7. GOODWILL AND OTHER INTANGIBLE ASSETS The following table shows the changes in the carrying amount of goodwill for the years ended December 31: Balance at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Goodwill acquired . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Balance at year end. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2014 2013 455,842 $ 452,351 1,282 (13,039) 444,085 1,049 2,442 $ 455,842 Goodwill and indefinite-lived assets are reviewed for impairment on an annual basis in the fourth quarter. The Company completed its impairment review and determined that, through December 31, 2014, there had been no impairment of these assets. The components of other intangible assets as of December 31 are as follows: 2014 2013 Gross Amount Accumulated Amortization Intangibles, Net Gross Amount Accumulated Amortization Intangibles, Net Customer relationships. . . . . . . $ Proven technology and patents. Tradename (finite life) . . . . . . . Tradename (indefinite life). . . . Other. . . . . . . . . . . . . . . . . . . . . 98,325 $ (28,159) $ 70,166 $ 98,374 $ 45,588 4,140 24,947 1,573 (30,761) (1,786) — (1,083) 14,827 2,354 24,947 490 43,233 4,300 25,108 757 $ 174,573 $ (61,789) $ 112,784 $ 171,772 $ (25,313) $ (29,763) (1,619) — (659) (57,354) $ 73,061 13,470 2,681 25,108 98 114,418 The Company recognized amortization expense associated with the above intangible assets of $6.5 million, $5.9 million, and $7.2 million for the years ended December 31, 2014, 2013, and 2012, respectively. The annual aggregate amortization expense based on the current balance of other intangible assets is estimated at $6.2 million for 2015, $5.7 million for 2016, $5.4 million for 2017, $5.1 million for 2018 and $4.8 million for 2019. The finite-lived intangible assets are amortized on a straight-line basis over periods ranging from 3 to 45 years. The straight-line method of amortization reflects an appropriate allocation of the cost of the intangible assets to earnings in proportion to the amount of economic benefits obtained by the Company in each reporting period. Purchased intangibles amortization was $5.6 million, $3.9 million after tax, $5.3 million, $3.6 million after tax, and $6.8 million, $4.5 million after tax, for the years ended December 31, 2014, 2013, and 2012, respectively. In addition to the above amortization, the Company recorded amortization expense associated with capitalized software of $22.4 million, $18.6 million, and $13.9 million for the years ended December 31, 2014, 2013, and 2012, respectively. F - 16 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) 8. DEBT Debt consisted of the following at December 31: $100 million Senior Notes, interest at 6.30%, due June 25, 2015 . . . . . . . . . . . . . . . . . . . . . . . $ $50 million Senior Notes, interest at 3.67%, due December 17, 2022. . . . . . . . . . . . . . . . . . . . $50 million Senior Notes, interest at 4.10%, due September 19, 2023 . . . . . . . . . . . . . . . . . . . $125 million Senior Notes, interest at 3.84%, due September 19, 2024 . . . . . . . . . . . . . . . . . . $800 million Credit Agreement, interest at LIBOR plus 75 basis points. . . . . . . . . . . . . . . . . . Other local arrangements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less: current portion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2014 2013 100,000 $ 100,000 50,000 50,000 125,000 110,790 16,164 451,954 (116,164) 335,790 $ 50,000 50,000 — 195,960 17,067 413,027 (17,067) 395,960 6.30% Senior Notes In 2009, the Company issued and sold $100 million of 6.30% Senior Notes due June 25, 2015 in a private placement. The 6.30% Senior Notes are senior unsecured obligations of the Company. Interest on the 6.30% Senior Notes is payable semi-annually in June and December. The Company may at any time prepay the 6.30% Senior Notes, in whole or in part (but in an amount not less than 10% of the original aggregate principal amount), at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, plus a “make-whole” prepayment premium. In the event of a change in control of the Company (as defined in the note purchase agreement), the Company may be required to offer to prepay the 6.30% Senior Notes in whole at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest. The 6.30% Senior Notes contain customary affirmative and negative covenants including, among others, limitations on the Company and its subsidiaries with respect to incurrence of liens and priority indebtedness, disposition of assets, mergers, and transactions with affiliates. The note purchase agreement also requires the Company to maintain a consolidated interest coverage ratio of not less than 3.5 to 1.0 and a consolidated leverage ratio of not more than 3.5 to 1.0. The agreement contains customary events of default with customary grace periods, as applicable. The Company was in compliance with these covenants at December 31, 2014. Issuance costs approximating $0.7 million will be amortized to interest expense over the six-year term of the 6.30% Senior Notes. 3.67% Senior Notes In 2012, the Company issued and sold $50 million of 3.67% Senior Notes due December 17, 2022 in a private placement. The 3.67% Senior Notes are senior unsecured obligations of the Company. Interest is payable semi-annually in June and December. The 3.67% Senior Notes contain customary affirmative and negative covenants, change in control and prepayment provisions, that are substantially similar to those contained in the previously issued debt of the Company as described above. The 3.67% Senior Notes also contain customary events of default with customary grace periods, as applicable. The Company was in compliance with these covenants at December 31, 2014. F - 17 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) Issuance costs approximating $0.4 million will be amortized to interest expense over the ten-year term of the 3.67% Senior Notes. 4.10% Senior Notes In 2013, the Company issued and sold $50 million of 4.10% Senior Notes due September 19, 2023 in a private placement. The 4.10% Senior Notes are senior unsecured obligations of the Company. Interest on the 4.10% Senior Notes is payable semi-annually in March and September of each year, beginning in March 2014. The 4.10% Senior Notes contain customary affirmative and negative covenants, change in control and prepayment provisions, that are substantially similar to those contained in the previously issued debt of the Company as described above. The 4.10% Senior Notes also contain customary events of default with customary grace periods, as applicable. The Company was in compliance with these covenants at December 31, 2014. Issuance costs approximating $0.4 million will be amortized to interest expense over the ten-year term of the 4.10% Senior Notes. 3.84% Senior Notes and 4.24% Senior Notes In the second quarter of 2014, the Company entered into an agreement to issue and sell $250 million of ten-year Senior Notes in a private placement. The Company issued $125 million with a fixed interest rate of 3.84% ("3.84% Senior Notes") in September 2014 and will issue $125 million with a fixed interest rate of 4.24% ("4.24% Senior Notes") in June 2015. The Senior Notes are senior unsecured obligations of the Company. Interest on the 3.84% Senior Notes is payable semi-annually in March and September each year, beginning in March 2015. Interest on the 4.24% Senior Notes is payable semi-annually in June and December of each year, beginning in December 2015. The 3.84% Senior Notes and 4.24% Senior Notes contain customary affirmative and negative covenants, change in control and prepayment provisions, that are substantially similar to those contained in the previously issued debt of the Company as described above. The 3.84% Senior Notes and 4.24% Senior Notes also contain customary events of default with customary grace periods, as applicable. The Company was in compliance with these covenants at December 31, 2014. Issuance costs approximating $0.9 million will be amortized to interest expense over the ten-year term of the Senior Notes. Credit Agreement In 2013, the Company entered into an $800 million Credit Agreement (the "Credit Agreement"), which amended its $880 million Amended and Restated Credit Agreement (the "Prior Credit Agreement"). The Credit Agreement is provided by a group of financial institutions (similar to the Company's Prior Credit Agreement) and has a maturity date of November 26, 2018. It is a revolving credit facility and is not subject to any scheduled principal payments prior to maturity. The obligations under the Credit Agreement are unsecured. Borrowings under the Credit Agreement bear interest at current market rates plus a margin based on the Company’s consolidated leverage ratio, which was, as of December 31, 2014, set at LIBOR plus 75 basis points. The Company must also pay facility fees that are tied to its leverage ratio. The Credit Agreement contains covenants that are substantially similar to those contained in the previously issued F - 18 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) debt of the Company as described above, with which the Company was in compliance as of December 31, 2014. The Credit Agreement also places certain limitations on the Company, including limiting the ability to incur liens or indebtedness at a subsidiary level. In addition, the Credit Agreement has several events of default. The Company incurred approximately $0.4 million of debt extinguishment costs during 2013 related to the Prior Credit Agreement. The Company capitalized $1.1 million in financing fees during 2013 associated with the Credit Agreement which will be amortized to interest expense through 2018. As of December 31, 2014, approximately $684.8 million was available under the facility. The Company’s weighted average interest rate was approximately 5% for the years ended December 31, 2014 and 2013. 9. SHAREHOLDERS’ EQUITY Common Stock The number of authorized shares of the Company’s common stock is 125,000,000 shares with a par value of $0.01 per share. Holders of the Company’s common stock are entitled to one vote per share. At December 31, 2014, 4,389,320 shares of the Company’s common stock were reserved for issuance pursuant to the Company’s stock option plans. Preferred Stock The Board of Directors, without further shareholder authorization, is authorized to issue up to 10,000,000 shares of preferred stock, par value $0.01 per share in one or more series and to determine and fix the rights, preferences, and privileges of each series, including dividend rights and preferences over dividends on the common stock and one or more series of the preferred stock, conversion rights, voting rights (in addition to those provided by law), redemption rights, and the terms of any sinking fund therefore, and rights upon liquidation, dissolution, or winding up, including preferences over the common stock and one or more series of the preferred stock. The issuance of shares of preferred stock, or the issuance of rights to purchase such shares, may have the effect of delaying, deferring or preventing a change in control of the Company or an unsolicited acquisition proposal. Share Repurchase Program The Company has a $3 billion share repurchase program, of which there were $478.4 million remaining to be repurchased under the program as of December 31, 2014. The Company expects that the authorization will be utilized over the next couple years. The share repurchases are expected to be funded from cash balances, borrowings, and cash generated from operating activities. Repurchases will be made through open market transactions, and the amount and timing of purchases will depend on business and market conditions, the stock price, trading restrictions, the level of acquisition activity, and other factors. The Company has purchased 23.1 million shares since the inception of the program through December 31, 2014. During the years ended December 31, 2014 and 2013, the Company spent $414.0 million and $295.0 million on the repurchase of 1,617,499 shares and 1,321,577 shares at an average price per share of $255.93 and $223.18, respectively. The Company reissued 373,431 shares and 398,646 shares held in treasury for the exercise of stock options and restricted stock units during 2014 and 2013, respectively. F - 19 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) Accumulated Other Comprehensive Income (Loss) The following table presents changes in accumulated other comprehensive income by component for the period ended December 31, 2014 and 2013: Currency Translation Adjustment, Net of Tax Net Unrealized Gain (Loss) on Cash Flow Hedging Arrangements, Net of Tax Pension and Post- Retirement Benefit Related Items, Net of Tax 56,012 $ (5,438) $ (148,035) $ Total (97,461) — — 21,903 — — 32,752 32,752 (448) (43) — (2,010) (448) 19,850 3,496 6,775 10,271 21,903 77,915 $ 3,005 (2,433) $ 37,517 (110,518) $ 62,425 (35,036) — — (105,230) (105,230) — (82,875) — (713) (55) 1,257 — 8,089 1,614 (713) (74,841) 2,871 489 (1,944) $ (177,913) (95,527) (206,045) $ (212,949) Balance at December 31, 2012 . . . . . . . . . . . . . . . . . $ Other comprehensive income (loss), net of tax: Unrealized actuarial gains (loss), prior service costs and plan amendments . . . . . . . . . . . . . . . . Unrealized gains (loss) on cash flow hedging arrangements. . . . . . . . . . . . . . . . . . . . . . . . . . . . Foreign currency translation adjustment . . . . . . . . Amounts recognized from accumulated other comprehensive income (loss), net of tax . . . . . . . . Net change in other comprehensive income (loss), net of tax. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Balance at December 31, 2013 . . . . . . . . . . . . . . . . . $ Other comprehensive income (loss), net of tax: Unrealized actuarial gains (loss), prior service costs and plan amendments . . . . . . . . . . . . . . . . Unrealized gains (loss) on cash flow hedging arrangements. . . . . . . . . . . . . . . . . . . . . . . . . . . . Foreign currency translation adjustment . . . . . . . . Amounts recognized from accumulated other comprehensive income (loss), net of tax . . . . . . . . Net change in other comprehensive income (loss), net of tax. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Balance at December 31, 2014 . . . . . . . . . . . . . . . . . $ (82,875) (4,960) $ F - 20 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) The following table presents amounts recognized from accumulated other comprehensive income (loss) for the twelve months period ended December 31, 2014 and 2013: Effective portion of losses (gains) on cash flow hedging arrangements: Interest rate swap agreements. . . . . . . . . . . . . . . . . . . . . . . Foreign currency forward contracts . . . . . . . . . . . . . . . . . . Total before taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Provision for taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total, net of taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Recognition of defined benefit pension and post-retirement items: Recognition of actuarial losses, plan amendments and prior service cost, before taxes . . . . . . . . . . . . . . . . . . . . Provision for taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total, net of taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ $ $ $ 2014 2013 Location of Amounts Recognized in Earnings 3,119 (831) 2,288 1,031 $ 3,081 Interest expense 2,013 Cost of sales - products 5,094 1,598 Provision for taxes 1,257 $ 3,496 2,877 1,263 1,614 $ $ 10,426 (a) 3,651 Provision for taxes 6,775 (a) These accumulated other comprehensive income (loss) components are included in the computation of net periodic pension and post-retirement cost. See Note 11 for additional details for the twelve months ended December 31, 2014. 10. EQUITY INCENTIVE PLAN The Company’s equity incentive plan provides employees and directors of the Company additional incentives to join and/or remain in the service of the Company as well as to maintain and enhance the long-term performance and profitability of the Company. The Company’s 2013 equity incentive plan was approved by shareholders on May 2, 2013 and provides that 2 million shares of common stock, plus any options outstanding under the Company’s prior option plan that terminate without being exercised, may be the subject of awards. The plan provides for the grant of options, restricted stock, restricted stock units and other equity-based awards. The exercise price of options granted shall not be less than the fair market value of the common stock on the date of the award. Options primarily vest equally over a five-year period from the date of grant and have a maximum term of up to ten years and six months. Restricted units primarily vest equally over a five-year period from the date of grant. Since 2005, the compensation committee of the Board of Directors has generally granted restricted share units to participating managers and non-qualified stock options to executive officers. All share-based compensation arrangements granted to employees, including stock option grants, are recognized in the consolidated statement of operations based on the grant-date fair value of the award over the period during which an employee is required to provide service in exchange for the award. Share- based compensation expense is recorded within selling, general, and administrative in the consolidated statement of operations with a corresponding offset to additional paid-in capital in the consolidated balance sheet. F - 21 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) The fair values of stock options granted were calculated using the Black-Scholes pricing model. The aggregate intrinsic value of an option is the amount by which the fair value of the underlying stock exceeds its exercise price. The following table summarizes all stock option activity from December 31, 2013 through December 31, 2014: Outstanding at December 31, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Exercised . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Outstanding at December 31, 2014. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Options exercisable at December 31, 2014. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Number of Options Weighted Average Exercise Price Aggregate Intrinsic Value (in millions) 1,871,694 $112.57 $243.7 123,226 (335,848) (12,589) 1,646,483 263.62 62.67 145.39 $133.80 1,221,408 $107.39 $277.7 $238.3 The following table details the weighted average remaining contractual life of options outstanding at December 31, 2014 by range of exercise prices: Number of Options Outstanding Weighted Average Exercise Price Remaining Contractual Life of Options Outstanding Options Exercisable 131,950 455,423 277,550 348,555 433,005 $ $ $ $ $ 1,646,483 64.99 81.47 108.64 141.45 219.79 1.9 4.3 2.9 6.3 8.7 5.6 131,950 455,423 277,550 249,485 107,000 1,221,408 As of the date granted, the weighted average grant-date fair value of the options granted during the years ended December 31, 2014, 2013, and 2012 was $77.64, $66.33, and $46.72, respectively. Such weighted average grant-date fair value was determined using the following assumptions: Risk-free interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Expected life in years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Expected volatility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Expected dividend yield . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.66% 5.6 28% — 1.31% 5 28% — 0.71% 5 30% — 2014 2013 2012 The total intrinsic value of options exercised during the years ended December 31, 2014, 2013, and 2012 was approximately $66.9 million, $60.0 million, and $50.9 million, respectively. The total fair value of options vested during the years ended December 31, 2014, 2013, and 2012 was approximately $6.4 million, $5.7 million, and $6.9 million, respectively. F - 22 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) The following table summarizes all restricted stock unit activity from December 31, 2013 through December 31, 2014: Outstanding at December 31, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Outstanding at December 31, 2014. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Number of Restricted Stock Units Aggregate Intrinsic Value (in millions) 107,782 $ 26.1 29,683 (37,583) (3,785) 96,097 $ 29.1 The weighted average grant-date fair value of the restricted stock units granted during years ended 2014 and 2013 was $263.58 and $244.90 per unit, respectively, and the restricted units vest ratably primarily over a five-year period. The total fair value of the restricted stock units on the date of grant of $7.8 million for 2014 and $7.2 million for 2013 will be recorded as compensation expense straight-line over the vesting period. The total fair value of restricted stock units vested during the years ended December 31, 2014, 2013, and 2012 was approximately $5.8 million, $5.6 million, and $5.3 million, respectively. Approximately $5.6 million and $5.5 million of compensation expense was recognized during the years ended December 31, 2014 and 2013, respectively. At December 31, 2014, a total of 2,588,311 shares of common stock were available for grant in the form of stock options or restricted stock units. As of December 31, 2014, the unrecorded deferred share-based compensation balance related to both stock options and restricted stock units was $43.0 million and will be recognized using a straight-line method over an estimated weighted average amortization period of 2.3 years. 11. BENEFIT PLANS The Company maintains a number of retirement and other post-retirement employee benefit plans. Certain subsidiaries sponsor defined contribution plans. Benefits are determined and funded annually based upon the terms of the plans. Amounts recognized as cost under these plans amounted to $15.6 million, $15.1 million, and $15.7 million for the years ended December 31, 2014, 2013, and 2012, respectively. Certain subsidiaries sponsor defined benefit plans. Benefits are provided to employees primarily based upon years of service and employees’ compensation for certain periods during the last years of employment. Prior to 2002, the Company’s U.S. operations also provided post-retirement medical benefits to their employees. Contributions for medical benefits are related to employee years of service. F - 23 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) The following tables set forth the change in benefit obligation, the change in plan assets, the funded status, and amounts recognized in the consolidated financial statements for the Company’s defined benefit plans and post-retirement plan at December 31, 2014 and 2013: U.S. Pension Benefits Non-U.S. Pension Benefits Other Benefits Total 2014 2013 2014 2013 2014 2013 2014 2013 Change in benefit obligation: Benefit obligation at $ 156,804 $ 814,200 $ 798,657 $ 5,295 $ 11,267 $ 957,642 $ 966,728 494 5,755 6,396 25,848 (18,226) — — (6,917) (6,680) — — 28,579 21,445 117,902 (453) (35,279) (82,755) 30,315 19,566 (11,477) 293 (43,271) 20,117 170 240 477 (1,951) (477) — 216 405 (1,988) (3,733) (872) — 29,642 28,081 144,227 (2,404) (42,673) (82,755) 31,025 25,726 (31,691) (3,440) (50,823) 20,117 year . . . . . . . . . . . . . . . . . . $ 164,367 $ 138,147 $ 863,639 $ 814,200 $ 3,754 $ 5,295 $1,031,760 $ 957,642 Change in plan assets: Fair value of plan assets at $ 94,734 $ 786,532 $ 731,040 $ — $ — $ 904,435 $ 825,774 beginning of year. . . . . . . . $ 138,147 893 Service cost, gross. . . . . . . . . Interest cost . . . . . . . . . . . . . . Actuarial losses (gains) . . . . . Plan amendments and other . Benefits paid . . . . . . . . . . . . . Impact of foreign currency . . Benefit obligation at end of beginning of year. . . . . . . . $ 117,903 2,974 Actual return on plan assets . Employer contributions. . . . . Plan participants’ contributions . . . . . . . . . . . Benefits paid . . . . . . . . . . . . . Impact of foreign currency and other . . . . . . . . . . . . . . Fair value of plan assets at 18,070 12,073 17,776 40,893 25,448 42,480 25,147 — — (6,917) (6,680) 13,409 (35,279) 13,255 (43,271) — 343 134 (477) — 723 149 (872) 43,867 43,861 54,553 43,646 13,543 (42,673) 13,404 (50,823) — — (79,810) 17,881 — — (79,810) 17,881 end of year . . . . . . . . . . . . . $ 132,030 $ 904,435 Funded status. . . . . . . . . . . . . $ (32,337) $ (20,244) $(112,446) $ (27,668) $ (3,754) $ (5,295) $ (148,537) $ (53,207) $ — $ — $ 883,223 $ 751,193 $ 117,903 $ 786,532 Amounts recognized in the consolidated balance sheets consist of: U.S. Pension Benefits Non-U.S. Pension Benefits Other Benefits Total 2014 2013 2014 2013 2014 2013 2014 2013 — $ — $ 38,922 $ 105,132 $ — $ — $ 38,922 $ 105,132 Other non-current assets . . . . $ Pension and other post- retirement liabilities. . . . . . (32,337) (20,244) (151,368) (132,800) (3,754) (5,295) (187,459) (158,339) Accumulated other comprehensive loss (income). . . . . . . . . . . . . . . 85,636 59,013 213,702 110,965 (15,303) (15,910) 284,035 154,068 Total. . . . . . . . . . . . . . . . . . . . $ 53,299 $ 38,769 $ 101,256 $ 83,297 $ (19,057) $ (21,205) $ 135,498 $ 100,861 The prepaid pension asset is recorded in other non-current assets on the consolidated balance sheet. The short-term and long-term portion of the accrued pension liability is recorded on the consolidated balance sheet within accrued and other liabilities and other non-current liabilities, respectively. The long- term portion of the accrued pension liabilities and other post-retirement liabilities at December 31, 2014 and 2013 was $32.3 million and $20.2 million, respectively, for the U.S. defined benefit pension plan, $146.7 million and $127.8 million, respectively, for the non-U.S. plans, and $3.2 million and $4.8 million, F - 24 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) respectively, for the U.S. post-retirement plan. The current portion of accrued pension liabilities was $0.1 million for the U.S. defined benefit pension plan at both December 31, 2014 and 2013, respectively. The current portion of accrued pension liabilities was $4.7 million and $5.0 million for the non-U.S. plans at December 31, 2014 and 2013, respectively. The current portion of the U.S. post-retirement plan was $0.6 million and $0.5 million at December 31, 2014 and 2013, respectively. The following amounts have been recognized in accumulated other comprehensive income (loss), before taxes, at December 31, 2014 and have not yet been recognized as a component of net periodic pension cost: U.S. Pension Benefits Non-U.S. Pension Benefits Other Benefits Total Total, After Tax Plan amendments and prior service cost . . . . . . $ Actuarial losses (gains) . . . Total. . . . . . . . . . . . . . . . . . $ — $ 85,636 85,636 $ (19,291) $ 232,993 213,702 $ (4,904) $ (10,399) (15,303) $ (24,195) $ 308,230 284,035 $ (18,436) 224,481 206,045 The following changes in plan assets and benefit obligations were recognized in other comprehensive income (loss), before taxes, for the year ended December 31, 2014: Net actuarial losses (gains) . $ Plan amendments and prior service cost, net . . . . Amortization of: Actuarial (losses) gains . . . Plan amendments and prior service cost . . . . . . . . Impact of foreign currency. . Total . . . . . . . . . . . . . . . . . . . $ U.S. Pension Benefits Non-U.S. Pension Benefits Other Benefits Total Total, After Tax 31,423 $ 114,370 $ 477 $ 146,270 $ 106,837 — (526) (2,085) (2,611) (1,607) (4,800) (4,308) — — 26,623 $ 4,016 (10,815) 102,737 $ 1,436 779 — 607 $ (7,672) 4,795 (10,815) 129,967 $ (5,310) 3,696 (8,089) 95,527 The accumulated benefit obligations at December 31, 2014 and 2013 were $164.4 million and $138.1 million, respectively, for the U.S. defined benefit pension plan and $834.7 million and $785.8 million, respectively, for all non-U.S. plans. Certain of the plans included within non-U.S. pension benefits have benefit obligations which exceed the fair value of plan assets. The projected benefit obligation, the accumulated benefit obligation, and fair value of assets of these plans as of December 31, 2014 were $200.5 million, $188.9 million, and $49.2 million, respectively. The assumed discount rates and rates of increase in future compensation levels used in calculating the projected benefit obligations vary according to the economic conditions of the country in which the retirement plans are situated. The weighted average rates used for the purposes of the Company’s plans are as follows: Discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Compensation increase rate . . . . . . . . . . . . . . . . . . . . . Expected long-term rate of return on plan assets . . . . . 4.00% 4.75% 3.75% n/a n/a n/a 7.50% 7.50% 7.75% 1.65% 1.61% 4.82% 2.73% 1.61% 4.87% 2.50% 1.60% 4.89% 2014 U.S. 2013 2012 2014 2013 2012 Non-U.S. F - 25 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) The assumed discount rates, rates of increase in future compensation levels, and the long-term rate of return used in calculating the net periodic pension cost vary according to the economic conditions of the country in which the retirement plans are situated. The weighted average rates used for the purposes of the Company’s plans are as follows: 2014 U.S. 2013 2012 2014 2013 2012 Non-U.S. Discount rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Compensation increase rate . . . . . . . . . . . . . . . . . . . . . Expected long-term rate of return on plan assets . . . . . 4.75% 3.75% 4.25% n/a n/a n/a 7.50% 7.75% 8.00% 2.73% 1.61% 4.87% 2.50% 1.60% 4.89% 3.10% 1.75% 4.80% Net periodic pension cost for the defined benefit plans includes the following components for the years ended December 31: Service cost, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Interest cost on projected benefit obligations. . . . . . . . Expected return on plan assets . . . . . . . . . . . . . . . . . . . Recognition of actuarial losses/(gains) and prior service costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net periodic pension cost . . . . . . . . . . . . . . . . . . . . . . . $ 2014 U.S. 2013 2012 2014 2013 2012 Non-U.S. 893 $ 494 $ 455 $ 15,189 $ 17,386 $ 15,011 6,396 (8,549) 5,755 (7,154) 6,093 (6,965) 21,445 (37,361) 19,566 (35,048) 22,104 (32,989) 4,800 7,782 7,664 3,540 $ 6,877 $ 7,247 $ 292 (435) $ 3,545 210 5,449 $ 4,336 Net periodic post-retirement benefit (credit)/cost for the U.S. post-retirement plan includes the following components for the years ended December 31: 2014 2013 2012 Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Interest cost on projected benefit obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net amortization and deferral . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net periodic post-retirement benefit (credit)/cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ (1,805) $ 240 (2,215) 170 $ 216 $ 405 (901) (280) $ 333 539 (753) 119 The amounts remaining in accumulated other comprehensive income (loss) that are expected to be recognized as a component of net periodic pension cost during 2015 are as follows: Plan amendments and prior service costs . . . . . . $ Actuarial losses (gains) . . . . . . . . . . . . . . . . . . . . Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ — $ 7,626 7,626 $ (4,254) $ 16,862 12,608 $ (1,877) $ (3,370) (5,247) $ (6,131) 21,118 14,987 U.S. Pension Benefits Non-U.S. Pension Benefits Other Benefits Total The projected post-retirement benefit obligation was principally determined using discount rates of 4.00% in 2014, 4.75% in 2013, and 3.75% in 2012. Net periodic post-retirement benefit cost was principally determined using discount rates of 4.75% in 2014, and 3.75% in 2013, and 4.25% in 2012. The health care cost trend rate ranged from 7.75% to 8.50% in 2014, and was 8.00% in both 2013 and 2012, decreasing to 5.00% in 2021. F - 26 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) The health care cost trend rate assumption has a significant effect on the accumulated post-retirement benefit obligation and net periodic post-retirement benefit cost. A one-percentage-point change in health care cost trend rates would have the following effects: Effect on total of service and interest cost components . . . . . . $ Effect on post-retirement benefit obligation. . . . . . . . . . . . . . . $ 32 25 $ $ (29) (25) One-Percentage-Point Increase One-Percentage-Point Decrease The Company’s overall asset investment strategy is to achieve long-term growth while minimizing volatility by widely diversifying among asset types and strategies. Target asset allocations and investment return criteria are established by the pension committee or designated officers of each plan. Target asset allocation ranges for the U.S. pension plan include 33-53% equity securities, 11-21% fixed income securities, and 30-50% other types of investments. International plan assets relate primarily to the Company’s Swiss plan with target allocations of 25-45% in equities, 35-55% in fixed income securities, and 15-25% in other types of investments. Actual results are monitored against targets and the trustees are required to report to the members of each plan, including an analysis of investment performance on an annual basis at a minimum. Day-to-day asset management is typically performed by third-party asset managers, reporting to the pension committees or designated officers. The long-term rate of return on plan asset assumptions used to determine pension expense under U.S. GAAP are generally based on estimated future returns for the target investment mix determined by the trustees as well as historical investment performance. F - 27 Equity Mutual Funds: . . . . . . U.S.(1) . . . . . . . . . . . . . . . . International(2) . . . . . . . . . . Emerging Markets(3) . . . . . Fixed Income Securities: Corporate/Government Bonds(4) . . . . . . . . . . . . . . . Fixed Income Mutual Funds: Insurance Contracts(5) . . . . Core Bond(6) . . . . . . . . . . . Real Asset Mutual Funds: Real Estate(7) . . . . . . . . . . . Commodities(8) . . . . . . . . . Other Types of Investments: Global Allocation Funds(9) Multi-Strategy Fund of. . . Hedge Funds(10) . . . . . . . . . METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) The following table presents the fair value measurement of the Company’s plan assets by hierarchy level: Asset Category: December 31, 2014 December 31, 2013 Quoted Prices in Active Markets for Identical Assets (Level 1) Observable Inputs for Identical Assets (Level 2) Unobservable Inputs (Level 3) Total Quoted Prices in Active Markets for Identical Assets (Level 1) Observable Inputs for Identical Assets (Level 2) Unobservable Inputs (Level 3) Total Cash and Cash Equivalents. . $ 140,959 $ — $ — $ 140,959 $ 129,932 $ — $ — $ 129,932 Equity Securities: Mettler-Toledo Stock . . . . . 3,638 — 7,377 39,515 72,360 30,268 52,476 6,679 — — — — 3,638 3,425 — 37,645 91,991 79,039 5,960 44,149 78,392 27,652 54,120 5,773 — — — — 3,425 33,612 98,269 84,165 124,709 — — 124,709 129,155 — — 129,155 — 120,840 61,849 20,920 23,288 38,757 — 3,118 1,388 — — 28,196 24,676 159,597 — 146,857 61,849 52,234 66,431 23,293 24,633 36,327 — 3,323 1,475 — — 23,136 26,108 183,184 66,431 49,752 13,790 12,145 — 25,935 12,002 11,088 — 23,090 — — 80,951 80,951 — — 77,312 77,312 $ 605,957 $ 166,731 $ 110,535 $ 883,223 $ 639,596 $ 162,916 $ 101,923 $ 904,435 _______________________________________ (1) Represents primarily large capitalization equity mutual funds tracking the S&P 500 Index. (2) Represents all capitalization core and value equity mutual funds located primarily in Switzerland, the United Kingdom, and Canada. (3) Represents core and growth mutual funds and funds of mutual funds invested in emerging markets primarily in Eastern Europe, Latin America, and Asia. (4) Represents investments in high-grade corporate and government bonds located in Switzerland and the European Union. (5) Represents fixed and variable rate annuity contracts provided by insurance companies. (6) Represents fixed income mutual funds invested in the U.S., the United Kingdom, Switzerland, and European government bonds, high-grade corporate bonds, mortgage-backed securities, and collateralized mortgage obligations. (7) Represents mutual funds invested in real estate located primarily in Switzerland. (8) Represents commodity funds invested across a broad range of sectors. (9) Represents mutual funds invested globally in both equities and fixed income securities. (10) Represents primarily equity investments to profit from long and short equity positions, economic and government driven events and relative value, and tactical trading strategies. The fair value of the Company’s stock and corporate and government bonds are valued at the year end closing price as reported on the securities exchange on which they are traded. Mutual funds are valued at the exchange-listed year end closing price or at the net asset value of shares held by the fund at the end of the year. Insurance contracts are valued by discounting the related cash flows using a current year end F - 28 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) market rate or at cash surrender value, which is presumed to equal fair value. Funds of hedge funds are valued at the net asset value of shares held by the fund at the end of the year. The following table presents a rollforward of activity for the years ended December 31, 2014 and 2013 for level 3 asset categories: Multi- Strategy Fund of Hedge Funds Balance at December 31, 2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 74,985 Actual return on plan assets: Related to assets held at end of year. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Purchases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,792 (12,691) Sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Impact of foreign currency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,806 Balance at December 31, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 77,312 Actual return on plan assets: 1,420 Related to assets held at end of year. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Related to assets sold during the year. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22,867 Purchases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (21,649) Sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (6,846) Impact of foreign currency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Balance at December 31, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 80,951 4,456 4,811 Commodities Insurance Contract Total $ 22,986 $ 1,726 $ 99,697 (449) — — 599 69 127 (519) 72 1,040 11,919 (13,210) 2,477 $ 23,136 $ 1,475 $ 101,923 2,952 — 5,030 — (2,922) 28,196 $ 34 — 7,442 4,811 115 (54) (182) 1,388 28,012 (21,703) (9,950) $ 110,535 $ There were no transfers between any asset levels during the years ended December 31, 2014 and 2013. The following benefit payments, which reflect expected future service as appropriate, are expected to be paid: 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2020-2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U.S. Pension Benefits Non-U.S. Pension Benefits Other Benefits Net of Subsidy $ 7,228 7,467 7,842 8,198 8,480 $ 39,708 39,276 40,098 40,073 40,371 $ 579 505 464 403 348 Total 47,515 47,248 48,404 48,674 49,199 46,986 202,059 1,091 250,136 The Company made voluntary incremental pension contributions of $18.0 million in 2014 and $17.6 million in 2013 to increase the funded status of its pension plans. The Company does not expect to receive any refunds from its benefit plans during 2015. In 2015, the Company expects to make employer pension contributions of approximately $19.6 million to its non-U.S. pension plan and employer contributions of approximately $0.7 million to its U.S. post-retirement medical plan. F - 29 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) 12. TAXES The sources of the Company’s earnings before taxes were as follows for the years ended December 31: United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Non-United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Earnings before taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 33,157 411,847 445,004 $ $ 18,119 384,590 402,709 $ $ 32,296 350,305 382,601 2014 2013 2012 The provisions for taxes consist of: Year ended December 31, 2014: United States federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ State and local . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Year ended December 31, 2013: United States federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ State and local . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Year ended December 31, 2012: United States federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ State and local . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Current Deferred Total — $ 5,676 $ 1,372 92,358 93,730 $ — $ 1,459 86,340 87,799 $ — $ 1,372 84,962 86,334 $ 527 6,830 13,033 8,249 965 (398) 8,816 12,341 87 (7,008) 5,420 $ $ $ $ $ 5,676 1,899 99,188 106,763 8,249 2,424 85,942 96,615 12,341 1,459 77,954 91,754 The provisions for tax expense for the years ended December 31, 2014, 2013, and 2012 differed from the amounts computed by applying the United States federal income tax rate of 35% to the earnings before taxes as a result of the following: Expected tax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ United States state and local income taxes, net of federal income tax benefit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Change in valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Non-United States income taxes at other than a 35% rate . . . . . . . . . . . . . . . Other, net. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total provision for taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2014 2013 2012 155,751 $ 140,948 $ 133,910 1,899 (172) (51,360) 645 1,167 1,178 (50,041) 3,363 106,763 $ 96,615 $ 1,459 — (44,288) 673 91,754 F - 30 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are presented below at December 31, 2014: Deferred tax assets: Inventory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Accrued and other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Accrued post-retirement benefit and pension costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net operating loss and tax credit carryforwards. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Less valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred tax assets less valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deferred tax liabilities: Inventory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Property, plant, and equipment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Rainin intangibles amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Prepaid post-retirement benefit and pension costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . International earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net deferred tax (liability) asset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2014 2013 27,164 $ 84,521 68,709 45,806 9,044 235,244 (36,263) 198,981 3,918 47,547 65,409 51,391 13,506 181,771 17,210 $ 23,957 74,755 48,296 43,939 12,832 203,779 (31,697) 172,082 4,155 51,763 59,889 44,049 10,838 170,694 1,388 A reconciliation of the beginning and end amounts of unrecognized tax benefits is as follows: Unrecognized tax benefits at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Increases related to current tax positions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Increases related to prior year tax positions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Decreases related to prior year tax positions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Foreign currency translation (decreases) increases to prior year tax positions . . . . . . . . . . . . . Decreases relating to taxing authority settlements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Decreases resulting from a lapse of the applicable statute of limitations. . . . . . . . . . . . . . . . . . Unrecognized tax benefits at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2014 2013 18,848 $ 990 1,944 — (926) (1,886) (2,106) 16,864 $ 17,780 2,024 1,137 (362) 101 (393) (1,439) 18,848 Included in the balance of unrecognized tax benefits at December 31, 2014 and 2013 were $13.6 million and $15.5 million, respectively, of tax benefits that if recognized would reduce the Company’s effective tax rate. The Company recognizes accrued amounts of interest and penalties related to its uncertain tax positions as part of its income tax expense within its consolidated statement of operations. The amount of accrued interest and penalties included within other non-current liabilities within the Company’s consolidated balance sheet as of both December 31, 2014 and 2013 was $1.6 million. The Company believes that it is reasonably possible that the unrecognized tax benefit balance could change over the next twelve months, primarily related to potential disputes raised by the taxing authorities over income and expense recognition. The Company does not expect a change would have a material impact on its financial position, results of operations, or cash flows. The Company has recorded valuation allowances related to certain of its deferred income tax assets due to the uncertainty of the ultimate realization of future benefits from such assets. The potential F - 31 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) decrease or increase of the valuation allowance in the near term is dependent on the future ability of the Company to realize the deferred tax assets that are affected by the future profitability of operations in various worldwide jurisdictions. The $4.6 million and $8.5 million increases in the total valuation allowance during 2014 and 2013, respectively, are primarily attributable to changes in the foreign tax credit carryforward and foreign currency fluctuation. The deferred tax assets and valuation allowance as of December 31, 2014 do not include certain deferred tax assets that arose directly from (or the use of which was postponed by) tax deductions related to equity compensation in excess of compensation expense recorded. Shareholders' equity will be increased by $51.8 million if and when such tax assets are ultimately realized. At December 31, 2014, the Company has various U.S. state net operating losses and various foreign net operating losses that have various expiration periods. The Company plans to repatriate earnings from China, Switzerland, Germany, the United Kingdom, and certain other countries in future years and believes that there will be no additional cost associated with the repatriation of such foreign earnings other than withholding taxes. All other undistributed earnings are considered to be permanently reinvested. As of December 31, 2014, the major jurisdictions for which the Company is subject to examinations are Germany for years after 2011, the United States after 2011, France after 2010, Switzerland after 2010, the United Kingdom after 2012, and China after 2011. Additionally, the Company is currently under examination in various taxing jurisdictions in which it conducts business operations. While the Company has not yet received any material assessments from these taxing authorities, the Company believes that adequate amounts of taxes and related interest and penalties have been provided for any adverse adjustments as a result of these examinations and that the ultimate outcome of these examinations will not result in a material impact on the Company’s consolidated results of operations or financial position. 13. RESTRUCTURING CHARGES During the past few years, we initiated additional cost reduction measures in response to global economic conditions. For the years ended December 31, 2014 and 2013, we have incurred $5.9 million and $19.8 million, respectively, of restructuring expenses which primarily comprise employee related costs. Liabilities related to restructuring activities are included in accrued and other liabilities in the consolidated balance sheet. A rollforward of the Company’s accrual for restructuring activities for the years ended December 31, 2014 and 2013 is as follows: Employee Related Other Total (cid:7) Balance at December 31, 2012 . . . . . . . . . . . . . . . . . . . . . . Restructuring charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash payments / utilization . . . . . . . . . . . . . . . . . . . . . . . . . Impact of foreign currency . . . . . . . . . . . . . . . . . . . . . . . . . Balance at December 31, 2013 . . . . . . . . . . . . . . . . . . . . . . Restructuring charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cash payments / utilization . . . . . . . . . . . . . . . . . . . . . . . . . Impact of foreign currency . . . . . . . . . . . . . . . . . . . . . . . . . Balance at December 31, 2014 . . . . . . . . . . . . . . . . . . . . . . $ 11,655 $ 290 $ 15,196 (14,156) 359 13,054 4,669 (8,297) (1,007) 8,419 4,634 (4,793) — 131 1,246 (1,360) — $ 17 $ 11,945 19,830 (18,949) 359 13,185 5,915 (9,657) (1,007) 8,436 F - 32 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) 14. OTHER CHARGES (INCOME), NET Other charges (income), net consists primarily of (gains) losses from foreign currency transactions, interest income and other items. 15. COMMITMENTS AND CONTINGENCIES Operating Leases The Company leases certain of its facilities and equipment under operating leases. The future minimum lease payments under non-cancelable operating leases are as follows at December 31, 2014: 2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2017 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30,745 24,739 15,620 10,827 8,010 13,595 Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 103,536 Rent expense for operating leases amounted to $34.9 million, $37.0 million, and $36.7 million for the years ended December 31, 2014, 2013, and 2012, respectively. Legal The Company is party to various legal proceedings, including certain environmental matters, incidental to the normal course of business. Management does not expect that any of such proceedings will have a material adverse effect on the Company’s financial condition, results of operations, or cash flows. 16. SEGMENT REPORTING The Company has five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. U.S. Operations represent certain of the Company’s marketing and producing organizations located in the United States. Western European Operations include the Company’s marketing and producing organizations in Western Europe, excluding operations located in Switzerland. Swiss Operations include marketing and producing organizations located in Switzerland as well as extensive R&D operations that are responsible for the development, production, and marketing of precision instruments, including weighing, analytical, and measurement technologies for use in a variety of laboratory and industrial applications. Chinese Operations represent the Company’s marketing and producing organizations located in China. The Company’s market organizations are geographically focused and are responsible for all aspects of the Company’s sales and service. Operating segments that exist outside these reportable segments are included in Other. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies. The Company evaluates performance based on segment profit for segment reporting (gross profit less research and development and selling, general, and administrative expenses, before amortization, interest expense, restructuring charges, other charges (income), net, and taxes). Inter- F - 33 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) segment sales and transfers are priced to reflect consideration of market conditions and the regulations of the countries in which the transferring entities are located. The following tables show the operations of the Company’s operating segments: For the Year Ended December 31, 2014 Net Sales to External Customers Net Sales to Other Segments Total Net Sales Segment Profit Depreciation Total Assets Purchase of Property, Plant and Equipment Goodwill U.S. Operations. . . . . . . . $ 755,922 $ 90,463 $ 846,385 $ 134,045 $ 6,068 $ 1,294,037 $ (6,627) $ 308,861 Swiss Operations. . . . . . . 137,231 461,171 598,402 170,764 6,621 1,018,941 (6,567) 21,873 Western European Operations . . . . . . . . . . . . Chinese Operations . . . . . Other(a). . . . . . . . . . . . . . . Eliminations and Corporate(b) . . . . . . . . . . . Total . . . . . . . . . . . . . . . . 713,318 415,474 464,038 124,349 155,690 7,527 837,667 571,164 471,565 120,659 132,521 52,461 4,422 6,746 2,820 1,061,455 816,801 261,036 (5,581) (19,793) (3,315) 99,341 740 13,270 — (839,200) (839,200) (103,579) 6,940 (2,443,160) (47,505) — $ 2,485,983 $ — $ 2,485,983 $ 506,871 $ 33,617 $ 2,009,110 $ (89,388) $ 444,085 For the Year Ended December 31, 2013 Net Sales to External Customers Net Sales to Other Segments Total Net Sales Segment Profit Depreciation Total Assets Purchase of Property, Plant and Equipment Goodwill U.S. Operations. . . . . . . . $ 718,671 $ 83,182 $ 801,853 $ 137,837 $ 6,223 $ 1,242,501 $ (6,297) $ 307,933 Swiss Operations. . . . . . . 132,240 435,904 568,144 147,990 6,576 1,090,353 (6,801) 24,288 Western European Operations . . . . . . . . . . . . Chinese Operations . . . . . Other(a). . . . . . . . . . . . . . . Eliminations and Corporate(b) . . . . . . . . . . . Total . . . . . . . . . . . . . . . . 674,278 407,131 446,652 112,049 149,084 6,308 786,327 556,215 452,960 111,951 122,214 49,673 4,708 6,527 2,694 1,059,525 731,650 257,141 (6,096) (6,200) (7,172) 108,662 746 14,213 — (786,527) (786,527) (96,773) 8,037 (2,228,351) (49,783) — $ 2,378,972 $ — $ 2,378,972 $ 472,892 $ 34,765 $ 2,152,819 $ (82,349) $ 455,842 For the Year Ended December 31, 2012 Net Sales to External Customers Net Sales to Other Segments Total Net Sales Segment Profit Depreciation Total Assets Purchase of Property, Plant and Equipment Goodwill U.S. Operations. . . . . . . . $ 697,956 $ 80,164 $ 778,120 $ 138,894 $ 5,799 $ 1,128,902 $ (10,988) $ 307,933 Swiss Operations. . . . . . . 124,362 406,485 530,847 127,011 7,194 922,620 (5,529) 23,684 Western European Operations . . . . . . . . . . . . Chinese Operations . . . . . Other(a). . . . . . . . . . . . . . . Eliminations and Corporate(b) . . . . . . . . . . . Total . . . . . . . . . . . . . . . . 644,361 432,255 442,594 101,952 123,669 5,133 746,313 555,924 447,727 95,523 125,217 48,857 4,947 5,567 2,653 975,174 631,075 237,232 (5,504) (9,872) (5,542) 105,522 717 14,495 — (717,403) (717,403) (91,003) 7,261 (1,872,715) (58,153) — $ 2,341,528 $ — $ 2,341,528 $ 444,499 $ 33,421 $ 2,022,288 $ (95,588) $ 452,351 _______________________________________ (a) Other includes reporting units in Eastern Europe, Latin America, Southeast Asia, and other countries. (b) Eliminations and Corporate includes the elimination of inter-segment transactions as well as certain corporate expenses and intercompany investments, which are not included in the Company’s operating segments. F - 34 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) A reconciliation of earnings before taxes to segment profit follows: Earnings before taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest expense. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Restructuring charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other charges (income), net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Segment profit. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2014 2013 2012 445,004 $ 402,709 $ 382,601 29,185 24,537 5,915 2,230 24,539 22,711 19,830 3,103 21,357 22,764 16,687 1,090 506,871 $ 472,892 $ 444,499 During 2014, restructuring charges of $5.9 million were recognized, of which $2.0 million, $1.3 million, $0.7 million, $1.2 million, and $0.7 million relate to the Company’s U.S., Swiss, Western European, Chinese, and Other Operations, respectively. Restructuring charges of $19.8 million were recognized in 2013, of which $1.7 million, $8.0 million, $7.7 million, $2.0 million, and $0.4 million relate to the Company's U.S., Swiss, Western European, Chinese, and Other Operations, respectively. The Company sells precision instruments, including weighing instruments and certain analytical and measurement technologies, and related services to a variety of customers and industries. None of these customers account for more than 1% of net sales. Service revenues are primarily derived from repair and other services including regulatory compliance qualification, calibration, certification, and preventative maintenance. A breakdown of the Company's sales by product category for the years ended December 31 follows: Laboratory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Industrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Retail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Total net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1,161,207 $ 1,100,632 $ 1,071,299 1,107,606 217,170 1,065,605 212,735 1,063,653 206,576 2,485,983 $ 2,378,972 $ 2,341,528 2014 2013 2012 F - 35 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) In certain circumstances, our operating segments sell directly into other geographies. A breakdown of net sales to external customers by geographic customer destination and property, plant, and equipment, net for the years ended December 31 follows: United States . . . . . . . . . . . . . . . . . . . . . . $ Other Americas . . . . . . . . . . . . . . . . . . . . Total Americas. . . . . . . . . . . . . . . . . . . . . Germany. . . . . . . . . . . . . . . . . . . . . . . . . . France. . . . . . . . . . . . . . . . . . . . . . . . . . . . United Kingdom. . . . . . . . . . . . . . . . . . . . Switzerland . . . . . . . . . . . . . . . . . . . . . . . Other Europe . . . . . . . . . . . . . . . . . . . . . . Total Europe. . . . . . . . . . . . . . . . . . . . . . . China . . . . . . . . . . . . . . . . . . . . . . . . . . . . Rest of World. . . . . . . . . . . . . . . . . . . . . . Total Asia/Rest of World . . . . . . . . . . . . . Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2014 Net Sales 2013 Property, Plant, and Equipment, Net 2012 2014 2013 708,293 $ 665,365 $ 643,902 $ 128,125 $ 133,323 166,150 874,443 204,747 127,363 77,271 71,347 398,645 879,373 404,293 327,874 732,167 167,647 833,012 195,521 122,658 65,922 74,574 377,353 836,028 396,620 313,312 709,932 161,853 805,755 183,859 123,007 62,389 65,430 355,266 789,951 422,894 322,928 745,822 4,110 132,235 32,984 5,802 6,112 235,593 6,983 287,474 83,412 8,341 91,753 4,831 138,154 29,008 6,737 6,001 243,697 7,936 293,379 74,546 8,359 82,905 2,485,983 $ 2,378,972 $ 2,341,528 $ 511,462 $ 514,438 F - 36 METTLER-TOLEDO INTERNATIONAL INC. NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (In thousands, except share data, unless otherwise stated) 17. QUARTERLY FINANCIAL DATA (UNAUDITED) Quarterly financial data for the years ended December 31, 2014 and 2013 are as follows: First Quarter Second Quarter Third Quarter Fourth Quarter 2014 Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Basic earnings per common share: Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Weighted average number of common shares . . . Diluted earnings per common share: Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Weighted average number of common and common equivalent shares . . . . . . . . . . . . . . . . . . Market price per share: High . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Low. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2013 Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Basic earnings per common share: Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Weighted average number of common shares . . . Diluted earnings per common share: Net earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Weighted average number of common and common equivalent shares . . . . . . . . . . . . . . . . . . Market price per share: 550,621 292,641 58,051 1.98 $ $ $ 608,834 328,176 74,022 2.55 $ $ $ 629,100 343,551 84,996 2.96 $ $ $ 697,428 394,382 121,172 4.27 29,370,232 29,074,695 28,732,152 28,398,579 1.93 $ 2.49 $ 2.89 $ 4.17 30,088,245 29,750,815 29,408,614 29,045,269 255.85 231.19 524,355 279,158 52,544 1.73 $ $ $ $ $ 253.18 223.80 578,680 308,843 69,062 2.29 $ $ $ $ $ 272.84 249.99 591,687 318,573 74,326 2.49 $ $ $ $ $ 305.89 233.85 684,250 375,357 110,162 3.72 30,299,569 30,119,889 29,818,218 29,596,949 1.69 $ 2.24 $ 2.43 $ 3.63 31,101,979 30,849,934 30,579,954 30,366,603 High . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ Low. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 221.56 196.72 $ $ 228.00 197.91 $ $ 242.56 205.55 $ $ 253.27 233.71 F - 37 Schedule II — Valuation and Qualifying Accounts (in thousands) Column A Column B Column C Additions Column D Column E Description Balance at the Beginning of Period (1) Charged to Costs and Expenses (2) Charged to Other Accounts -Deductions- Balance at End of Period Note (A) Note (B) Accounts receivable — allowance for doubtful accounts: Year ended December 31, 2014 Year ended December 31, 2013 Year ended December 31, 2012 Deferred tax valuation allowance: Year ended December 31, 2014 Year ended December 31, 2013 Year ended December 31, 2012 $ $ $ $ $ $ _______________________________________ Note (A) 14,856 14,120 12,317 31,697 23,177 34,738 $ $ $ $ $ $ 2,453 1,775 2,106 $ $ $ — $ — $ — $ (784) $ $ 115 267 5,191 10,131 4,764 $ $ $ $ 564 1,154 570 625 1,611 16,325 $ $ $ $ $ $ 15,961 14,856 14,120 36,263 31,697 23,177 For accounts receivable, amounts comprise currency translation adjustments. For deferred tax valuation allowance in 2014, 2013, and 2012, amounts relate primarily to changes in foreign tax credit carryforwards and foreign currency differences recorded through other comprehensive income. Note (B) For accounts receivable, amounts represent excess of uncollectible balances written off over recoveries of accounts previously written off. For deferred tax valuation allowance, the decrease in 2014 and 2013 relates primarily to decreases in foreign tax loss carryforwards, while in 2012 the reduction relates primarily to a decrease of recorded foreign tax credit and research and development tax credits. S-1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (333-159171) and Form S-8 (Nos. 333-118260, 333-104083, 333-31636 and 333-190181) of Mettler-Toledo International Inc. of our report dated February 6, 2015 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K. EXHIBIT 23.1 /s/ PricewaterhouseCoopers LLP PricewaterhouseCoopers LLP Columbus, Ohio February 6, 2015 EXHIBIT 31.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Olivier A. Filliol, certify that: 1. I have reviewed this annual report on Form 10-K of Mettler-Toledo International Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Date: February 6, 2015 /s/ Olivier A. Filliol Olivier A. Filliol Chief Executive Officer EXHIBIT 31.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, William P. Donnelly, certify that: 1. I have reviewed this annual report on Form 10-K of Mettler-Toledo International Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Date: February 6, 2015 /s/ William P. Donnelly William P. Donnelly Executive Vice President (Principal Financial Officer) EXHIBIT 31.3 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Shawn P. Vadala, certify that: 1. I have reviewed this annual report on Form 10-K of Mettler-Toledo International Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Date: February 6, 2015 /s/ Shawn P. Vadala Shawn P. Vadala Chief Financial Officer (Principal Accounting Officer) CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Mettler-Toledo International Inc. (the “Company”) does hereby certify, to such officer’s knowledge, that: This annual report on Form 10-K for the period ending December 31, 2014 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company. EXHIBIT 32 /s/ Olivier A. Filliol Olivier A. Filliol Chief Executive Officer /s/ William P. Donnelly William P. Donnelly Executive Vice President (Principal Financial Officer) /s/ Shawn P. Vadala Chief Financial Officer (Principal Accounting Officer) Shawn P. Vadala Date: February 6, 2015 is a leading global supplier of precision instruments and services. is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in a majority of believe we hold global number-one market positions in a majority of them. Specifically, we are the largest provider of weighing instruments them. Specifically, we are the largest provider of weighing instruments for use in laboratory, industrial and food retailing applications. We for use in laboratory, industrial and food retailing applications. We are also a leader in analytical instruments, reaction engineering and are also a leader in analytical instruments, reaction engineering and real-time analytic systems, process analytics instruments and end- real-time analytic systems, process analytics instruments and end- of-line product inspection systems. Our solutions are critical in key of-line product inspection systems. Our solutions are critical in key R&D, quality control and manufacturing processes for customers in a R&D, quality control and manufacturing processes for customers in a wide range of industries. Our global sales and service network is one wide range of industries. Our global sales and service network is one of the most extensive in the industry. We have subsidiaries and sales of the most extensive in the industry. We have subsidiaries and sales and service operations in 38 countries, with principal manufacturing and service operations in 38 countries, with principal manufacturing sites located in Switzerland, the United States, China, Germany and sites located in Switzerland, the United States, China, Germany and the United Kingdom. the United Kingdom. Sales Sales $2.486 billion Gross Margin Gross Margin 54.7% Earnings per Share Earnings per Share $11.44 Operating Cash Flow Operating Cash Flow $419 million Workforce 13,100 On the cover: Our New Classic precision balances feature a On the cover: Our New Classic precision balances feature a large, intuitive touchscreen interface while maintaining a compact large, intuitive touchscreen interface while maintaining a compact size. METTLER TOLEDO is a global leader in balances for size. METTLER TOLEDO is a global leader in balances for laboratory applications. laboratory applications. Portions of this report may contain “forward-looking statements” under the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual events or results to differ materially from those expressed in or implied by the statements. Further information concerning issues that could materially affect financial performance is contained in the “Forward-Looking Statements Disclaimer” and “Factors Affecting Our Future Operating Results” sections of the 10-K. Corporate Information Officers Olivier A. Filliol President and Chief Executive Officer Board of Directors Thomas Caratsch Laboratory Marc de La Guéronnière Europe and North America William P. Donnelly Finance, IT and Supply Chain Michael Heidingsfelder Industrial Simon Kirk Product Inspection Christian Magloth Human Resources Waldemar Rauch Process Analytics Richard Wong Asia / Pacific Corporate Offices Mettler-Toledo International Inc. 1900 Polaris Parkway Columbus, Ohio 43240-4035 Phone 614-438-4511 Im Langacher 44 CH-8606 Greifensee, Switzerland Phone +41-44-944 22 11 www.mt.com Transfer Agent and Registrar Computershare Shareowner Services LLC acts as primary Transfer Agent and Registrar for the Company. Questions should be sent to: Computershare P.O. Box 30170 College Station, TX 77845-3170 Phone 866-322-7862 www.computershare.com/investor Shareholders The Company estimates it has approximately 34,700 shareholders. Annual Meeting The annual meeting of shareholders will be held at 8:00 a.m. on Thursday, May 7, 2015 at the offices of Fried, Frank, Harris, Shriver & Jacobson LLP at 375 Park Avenue, New York, NY. A notice of the meeting, together with a form of proxy and a proxy statement, will be mailed to shareholders on or about March 16, 2015. Investor Relations Direct requests for information to: Mary T. Finnegan Treasurer / Investor Relations 1900 Polaris Parkway Columbus, Ohio 43240-4035 Phone 614-438-4748 Fax 614-438-4646 mary.finnegan@mt.com Robert F. Spoerry Chairman of the Board Director since 1996 Wah-Hui Chu Retired Non-Executive Chairman – Asia, PepsiCo International Director since 2007 Francis A. Contino Retired Executive Vice President – Strategic Planning and Chief Financial Officer, McCormick & Company, Inc. Director since 2004 Olivier A. Filliol President and Chief Executive Officer Director since 2009 Michael A. Kelly Executive Vice President – Electronics and Energy, 3M Company Director since 2008 Martin D. Madaus* Chairman and Chief Executive Officer, Ortho-Clinical Diagnostics, Inc. Director since 2009 Hans Ulrich Märki Retired Chairman, IBM Europe / Middle East / Africa Director since 2002 George M. Milne, Jr. Retired Executive Vice President, Pfizer Global R&D, Retired President, Worldwide Strategic and Operations Management, Pfizer Inc. Director since 1999 Thomas P. Salice Co-Founder and Managing Member, SFW Capital Partners, LLC Director since 1996 * Retiring from Board effective May 7, 2015 Annual Report 2014 www.mt.com e e s n e f i e r G , y c n e g A g n i s i t r e v d A l a n r e t n I : n o i t a e r C . c n I l a n o i t a n r e t n I o d e l o T - r e l t t e M © . A . S . U n i d e t n i r P 

Continue reading text version or see original annual report in PDF format above